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SUMMARY
The f i r s t  objective of th is  research was to evaluate the use of 
the immunofluorescent antibody (IFA) test in fe line  coronavirus 
(FCoV) infection. As a result of th is  work, guidelines fo r 
veterinary practitioners were established fo r the use of th is  
tes t. Some differences between the re a l i ty  of FCoV infection 
in the f ie ld  and much of the present wisdom based on the 
extrapolation of experimental infections were found.
The second aim was to determine the fate of seropositive cats. 
Long-term observation of seropositive cats has never previously 
been attempted, so that whether these cats develop disease,
become carriers, remain seropositive or become seronegative was
unknown. We were also curious to discover what happened to 
kittens born to seropositive cats.
Chapter 1 is a review of the relevant l i te ra tu re  to be cited 
la te r  in the thesis and gives the reader an idea of the state 
of the art p r io r to th is  work.
In Chapter 2 the materials and methods which were used in the 
experiments described in th is  thesis are given. Additional 
materials and methods relevant to each chapter are to be found 
at the beginning of the chapter concerned.
In Chapter 3 an epidemiological survey is described. The 
prevalence of FCoV antibodies in cats from d if fe ren t
backgrounds was determined. The cat most l ik e ly  to be 
seropositive was the healthy pedigree (53% were seropositive) 
and the cat least l ik e ly  to be seropositive was the healthy 
domestic (14% seropositive). Cats from multicat households 
(MCH) were more l ik e ly  to be seropositive than those from 
single cat households (SCH).
A picture was formed of the cat most l ik e ly  to succumb to
fe line  coronaviral vascu lit is  (FCoVV): 69% of animals were less
( •
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than 18 months old and 90% were from MCH. The cats were often 
pedigree animals and the highest incidence was in Persians. 
The prevalence of FeLV or FIV was no greater in cats with FCoVV 
than in the ordinary cat population. Cats with non-effusive 
FCoVV appeared to have higher antibody t i t re s  than those with 
effusive FCoVV.
Abnormal gross pathology was noted in a number of cats and 
caused us to re-evaluate our thinking about the nature of the 
disease and to discard the term fe line  infectious p e r i to n it is  
(FIP) in favour of the more descriptive term FCoVV.
Chapter 4 describes a survey of over 700 cats from 72 
households in which cats were seropositive fo r FCoV.
I t  had been believed that most seropositive households were 
infected with a non-pathogenic FCoV or fe line  enteric 
coronavirus (FECV). However, deaths occurred in households 
with a ll kinds of c l in ica l history: those which had had a case 
of FCoVV, or those which were presumed to have FECV or non- 
pathogenic FCoVs. The morta lity  rate was found to be 12% in 
households in which the infection was thought to have newly 
arrived and fe l l  to 3-4% in those households and others in 
which i t  was long-standing.
Twenty-four of the households became seronegative, though 9 of 
them became reinfected, largely by the introduction of a new 
seropositive animal. There was no evidence to suggest that 
seronegative cats could excrete virus. Loss of antibodies was 
related to the in i t ia l  number of seronegative cats within the 
house, how the cats were housed and i f  the highest antibody 
t i t r e  in the household was up to 640 the household was more 
l ik e ly  to become seronegative.
Cats which went on to die of FCoVV had variable antibody 
patterns over the weeks and months that they were followed. 
Only one of 71 cats whose antibody t i t re s  rose from less than
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or equal to 20 to 320 or over went on to die of FCoVV. 
However, one of the 96 cats whose IFA t i t re s  fe l l  from 320 or 
over to 20 or less also died of FCoVV. Thus, looking at serial 
tests from an individual cat does not reveal i t s  prognosis. 
Neither does i t  reveal whether i t  sheds virus unless i ts  t i t r e  
fa l ls  to zero.
Four cats which became seronegative died of microscopic lesions 
in the kidneys and brain (1 cat). More cats die as a result of 
FCoV infection than is apparent by looking only at the 
classical manifestations of p e r i to n it is  or granulomata.
There was no evidence of ADE in cats which appeared to be 
reinfected ( i .e .  th e ir  t i t re s  fe l l  3 or 4 fo ld and rose again).
Households which had endemic FeLV and FIV los t no more cats to 
FCoVV than the negative households.
In Chapter 5, the results of the survey of kittens born into 
the households described in Chapter 4 are presented. The most 
s ign if ican t finding was that careful management of the kittens 
could prevent them from being infected in households where FCoV 
was endemic. Keeping kittens isolated with th e ir  mother 
considerably reduced the chances of the kittens becoming 
infected . and none of the kittens which were to ta l ly  isolated 
from a ll adults from 5-6 weeks of age seroconverted.
The existence of asymptomatic carrie r cats was demonstrated and 
th e ir  IFA t i t re s  were found to be variable and unremarkable. 
S ign if ican tly , seronegative cats were shown not to excrete 
virus. I t  was also shown that virus excretion was transient in 
many cats.
In Chapter 6 experiments are described in which sera from cats 
whose fates were known were immunoblotted.
Many of the sera from cats in the survey described in Chapter 4
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were immunoblotted. A discrepancy was shown between the levels 
of an ti- in tegra l membrane glycoprotein (M) antibody in cats 
which survived compared with cats which developed FCoVV. Cats 
which became i l l  appeared to have greater levels of anti-M. 
However, using immunoblotting, accurate t i t re s  could not be 
obtained. D i f f ic u l ty  was encountered in making reproducible 
immunoblots due to v a r ia b i l i ty  of the M protein entering the 
g e l.
By immunoblotting, many cats which had IFA t i t re s  of zero were 
found to have anti-nucleocapsid (N) antibody which showed that 
they had, in fact, been infected. Cats with only anti-N 
antibodies did not appear to excrete virus but i t  did not 
follow that cats which also had anti-M and anti-S did excrete 
virus.
Chapter 7 is a discussion of the results presented in th is
thesis and compares and contrasts these with previous work
based on experimental infections. Future projects making use
of the serum samples and data accumulated during th is  survey 
are proposed.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 Introduction
In the early 1960s, veterinary practitioners f i r s t  described . a 
chronic fibrinous p e r i to n it is  in the cat [55]. This condition 
was recognized to be infectious and the disease was named 
fe line  infectious p e r i to n it is  (FIP). Soon a coronavirus was 
isolated as the cause and was given the name fe line  infectious 
p e r i to n it is  virus (FIPV) [152].
Subsequently, a granulomatous form of the disease was 
recognised [87] and came to be known as 'd ry ' or 'non-effusive' 
FIP, while the in i t ia l  presentation was dubbed 'wet' or 
'e ffus ive ' [104]. As more information was gathered the 
inappropriateness of th is  nomenclature became clear fo r  two 
reasons [2, 28, 57]. F irs t, serological surveys revealed that 
the majority of infections were asymptomatic, [57, 102, 105,
106, 111, 155]. Secondly, in those animals which became i l l ,
p e r i to n it is  was only one manifestation of a variety of possible 
c l in ica l signs [57].
An early term used to describe the disease was fe line  systemic 
p ro l ife ra t ive  and exudative vascu lit is  [28, 87]. The primary 
lesion which leads to c l in ica l and pathological signs of 
disease is a disseminated pyogranulomatous vascu lit is  [138, 
152]. Therefore in th is  thesis the disease w i l l  be referred to 
as fe line  coronaviral vascu lit is  (FCoVV) [2, 27, 28].
I t  was realised that effusive and non-effusive forms were not 
two d is t in c t  forms but were gradations of the same process. 
The effusive form is a more acute presentation while the non- 
effusi ve FCoVV is an intermediate stage between effusive FCoVV 
and immunity [88, 112, 114]. The nature of the granulomas in 
non-effusive FCoVV results from a p a r t ia l ly  successful attempt
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by the host to wall o f f  and contain the infection. In some 
cats c l in ica l signs progress from effusive to non-effusive 
forms [28, 111, 114]. Both forms can be present
simultaneously: parenchymal, ocular and CNS lesions could be
found in 10% of effusive cases [106] and small quantities of 
f lu id  were present in non-effusive cases [87, 95].
An explanation advanced fo r the discrepancy between the 
serological evidence of high prevalence of infection and low 
prevalence of disease was that d if fe ren t strains of 
coronavirus of d if fe r in g  virulence might exist [85, 110, 111].
A stra in of FCoV was discovered which was named fe line  enteric 
coronavirus (FECV) which did not produce FCoVV even a fte r i /p  
inoculation [106, 111] and i t  was postulated that th is  virus 
was the cause of the majority of asymptomatic infections or 
those which produced only diarrhoea [106, 111]. Later f ie ld  
isolates of FIPV proved to be highly infectious but of low FIP- 
or FCoVV-inducing capacity [114].
Throughout th is  thesis the term fe line  coronavirus (FCoV) w i l l  
be used to cover both FIPV and the la te r  isolated FECV [103, 
110, 111] except where d if fe ren tia t ion  is relevant.
Pedersen's current view is that a ll FCoV infections are enteric 
and that FIPV arises as a v iru len t mutant in each part icu la r 
cat which develops FCoVV. This mutation is postulated to allow 
the virus to replicate in macrophages [104, 108, 114].
As well as virus strain virulence, i t  is l ik e ly  that dose of 
virus, route of in fection, the manner in which v ira l peptides 
are processed by antigen presenting ce lls , response of T 
lymphocytes to processed antigen and a b i l i t y  of virus stra in to 
replicate within macrophages are important factors in the type 
of resulting c l in ica l presentation [27, 106, 114, 138, 141].
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1.2 Feline coronavirus
1 .2 .1  C h aracteris tics  o f the FCoV p a r t ic le
FCoV is an enveloped virus with a fringe of surface peplomers 
l ike  the corona of the sun, from which i t  derives i ts  name 
[103,153]. FECV, FIPV and canine coronavirus (CCV) are 
morphologically indistinguishable [27, 82, 103, 106, 111, 114,
126].
FCoV has been described as a pleomorphic, spherical or 
e l l ip t ic a l  virus with an overall diameter of 70-150 nm. [14, 
26, 39, 43, 57, 62, 94, 95, 103, 104, 111]. I t  has a doughnut 
shaped nucleoid 50-73 nm in diameter with a central lucent area 
of around 30 nm [43, 57, 62, 100, 152]. The envelope consists 
of a tr i lam inar unit membrane with numerous petal-shaped spike­
l ike  projections, 15-21 nm long [14, 43, 57, 62, 95, 100, 104].
FCoV has a reported buoyant density of 1.17-1.18 g/cnf^ in
sucrose [26, 57, 82, 94, 102, 131] and a sedimentation
coeffic ien t of 400S [57].
According to early reports, FCoV is heat-lab ile , losing
in fe c t iv i ty  in 24-48 hours at room temperature [5,31]. The 
virus is inactivated by incubation at 56°C fo r 60 minutes 
[100]. However, in recent studies, FIPV was recovered from 
contaminated dry surfaces fo r 3-7 weeks [64]. I t  is re la t ive ly  
stable at 4°C [31].
FCoV is ether-sensitive and is inactivated by most detergents, 
d isinfectants and household bleach (sodium hypochlorite) [5, 9, 
39, 100, 104]. FCoV is destroyed in 60 minutes at room
temperature in chlorhexidine and benzalkonium chloride in 
concentrations of over 0.5g/l [100] and by 0.2% formaldehyde or 
quarternary ammonium compounds but is resistant to 0.7% phenol 
fo r over 48 hours at 4°C [5,100].
The coronavirus genome is a positive sense single-stranded RNA
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of about 30 kilobases [11, 20, 21, 22]. During replica tion a 
negative strand serves as a template fo r the synthesis of one 
genome-sized and multiple sub-genomic mRNAs. In v irus-infected 
ce lls  6 v irus-spec if ic  mRNAs are produced with sizes ranging
from 1.6 to over 20 kilobases [ 20] .
1.2.2 V ira l proteins
FCoV contains three polypeptides: spike, nucleocapsid and
integral membrane glycoprotein
1.2.2.1. The spike, (S) peplomer, or E2, is a glycoprotein with
a Mr of 180-225.5K [15, 18, 19, 21, 22, 30, 65, 73, 146]. The
protein moiety of S is 1150-1450 amino acid residues in length 
and contains an N-terminal signal sequence, a C-terminal 
transmembrane anchor and 21-35 potential N-glycosylation sites 
[22]. There is also a 90-95kD protein which may be a monomeric 
form of the spike [15, 67]. Precursor proteins of 138K and 
175K have also been noted [73]. Unlike that of IBV, the S of 
FCoV has not been reported to be cleaved [22].
The S glycoprotein contains a hydrophilic trans-membrane domain 
(S2)  and a glycosylated external domain (S j). The part of the 
spike which is anchored in the matrix shows 35% amino acid 
sequence homology with infectious bronchitis virus (IBV), a 
coronavirus of domestic poultry, and 29% homology with mouse 
hepatit is  virus (MHV). There is very l i t t l e  conservation of 
the external domain. Most antigenic v a r ia b i l i ty  between 
laboratory strains of FCoV, as determined by panels of MAbs, 
has been localised to the S glycoprotein [31, 54].
The spike is responsible fo r binding the virus to ce ll 
receptors and for cell membrane fusion [22, 31, 65, 148] and 
therefore fo r CPE in cell culture. Antibodies which neutralize 
virus in v i t ro  are believed to be directed against the spike 
[31, 65, 148].
The spike also e l ic i t s  cell-mediated cy to tox ic ity  and causes
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pH-dependent thermolability  [31].
1.2.2.2. The nucleocapsid (N), or nucleoprotein is a 
phosphorylated protein which has a Mr of 43-50K [15, 21, 30,
59, 65, 67, 73] and as high as 58K fo r one isolate [19]. I t  
is associated with the v ira l RNA. The N is highly conserved 
among FCoVs [30]. One reported difference : , between
FECV and FIPV was that the Mr of the N protein ofI the former 
was 43K and of the la t te r ,  42K [146].
1.2.2.3. The integral membrane glycoprotein, matrix, (M), or 
El glycoprotein commonly forms a diffuse band on PAGE between 
23 and 32K [15, 19, 21, 30, 58, 59, 65, 73, 146]. The
Coronavirus Study Group recommended that th is  protein should no 
longer be referred to as matrix because i ts  function is 
d if fe ren t from that of the matrix proteins of para- and
orthomyxoviruses [18]. The sequence of the M protein is highly
conserved among FCoV isolates [29,30]. I t  is one of the few
v ira l glycoproteins with 0-1 inked glycosylation [65].
1.2.3 Related coronaviruses
FIPV and FECV belong to the same taxonomic cluster of
coronaviruses as transmissible gastroenteritis  virus (TGEV), 
porcine respiratory coronavirus, canine coronavirus (CCV), 
human bronchitis coronavirus serotype 229E (H 229E) and 
coronavirus-1ike partic les (CVLP) [4, 11, 30, 57, 66, 82, 94,
95, 104, 106, 122, 123, 127, 140]. Laboratory strains of FCoV
have been c lassified into types I and I I  according to th e ir  
growth characteristics in ce ll-cu ltu re , pathogenicity and th e ir  
comparative neutralization by anti sera to various strains of 
FECV, FIPV, TGEV and CCV [31, 113].
Antigenically, FECV, FIPV and CCV are v i r tu a l ly  
indistinguishable, [15, 27, 30, 66, 67, 82, 96, 103, 106, 114,
126]. Investigation with polyclonal and monoclonal antibodies 
indicates that FIPV type I I  and FECV type I I  are antigenically 
closer to TGEV or CCV than to FIPV type I viruses [54, 113].
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FIPV UCD 1, FIPV UCD2 and FIPV-Black are type I viruses which 
produce slow CPE in ce ll-cu ltu re  and are mainly c e l l -  
associated. Type I I  includes the v iru len t FIPV-79-1146 which 
grows rapidly in many cell lines, and FECV-79-1683 [31,113].
Antibodies against FECV neutralise FIPV in v it ro  [114]. 
However, some MAbs have been developed which recognise 
d if fe ren t isolates of FIPV and FECV by d if fe ren t epitopes in 
the spike [29, 30, 31, 54]. The peplomer of a FECV isolate was 
very s im ilar to that of a v iru len t FIPV isolate suggesting that 
M, N or some non-structural protein or any combination may form 
the basis of pathogenicity in FCoV [31].
I t  is possible that FECV and FIPV represent pathogenetic 
variants of a single FCoV type which possesses a broad spectrum 
of virulence from asymptomatic infection through e n te r it is  to 
lethal disseminated FCoVV [9, 114]. TGEV, porcine respiratory 
CoV, CCV and FCoV may be regarded as host range mutants, or 
biotypes, rather than d if fe ren t 'species' [7, 9, 11, 58, 95,
106, 122, 123] because of th e ir  considerable antigenic cross-
r e ac t i v i t y .
Feline anti-FIP VNA neutralize CCV [82, 122, 164] and some, but 
not a l l ,  neutralize TGEV [26, 58, 119, 122, 153, 156, 164].
Canine antisera against CCV neutralize FIP poorly [86, 164]
but strongly neutralize TGEV, and antisera against TGEV 
neutralize FIP and CCV [164]. Hence between FIP and CCV there 
is a one-way cross-reactiv ity . T itres by IF and VN are higher 
with homologous virus, so that the 3 viruses can be 
distinguished serologically [ 122] .
By immunoblotting, N and M of TGEV, CCV and FIPV were 
recognised by sera against a ll three viruses despite the 
d if fe ren t sizes of M (Mygpy was 29K, Mpjpy was 24K, M^y was 
22K or 32K). Anti-CCV sera precipitated only trace amounts of 
FIPV N. Results fo r S had been unobtainable by immunoblotting. 
However, by ELISA S of a ll 3 viruses was recognised by
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heterologous sera [58].
A cloned cDNA probe fo r TGEV hybridized with CCV and FIPV but 
not H 229E [82, 130]. I t  may be that the major epitopes
responsible fo r  immunological cross-reactiv ity  of various 
strains of FIPV, FECV, TGEV and CCV are quite discrete from 
sites mediating virulence. Minute deviations in molecular 
sites governing virulence may produce major differences in 
tropism fo r mononuclear phagocytes, perhaps influencing both 
humoral sensitisation as well as a b i l i t y  of pathogenic strains 
to replicate within these target ce lls  [15, 21, 72, 138].
1.2.3.1 TGEV causes vomiting and diarrhoea in p ig lets under 
one month of age though older animals can be affected. TGEV 
mainly replicates in the epithelium covering the t ips  of the 
v i l l i  of the small intestine (SI) and can cause stunting and 
fusion of the v i l l i  [32, 122]. Virus is shed from the GI t ra c t 
fo r as long as 8 weeks p . i .  [84]. A porcine coronavirus which 
grows primarily  in the respiratory trac t and cross-reacts with 
TGEV has been iden tif ied  [32]. This virus d if fe rs  from TGEV by 
only a few epitopes on the spike [17].
The FCoV nucleotide sequence is 79% identical to that of TGEV. 
The amino acid sequence of the M protein has overall homology 
of 84.7%, and the N protein has 82.2% homology [151].
TGEV can in fect cats causing seroconversion and virus shedding 
fo r  up to 3 weeks but no c l in ica l signs are apparent [11, 26,
56, 57, 122, 126, 127, 139]. Exposure to TGEV does not usually 
sensitise cats to FCoV [9].
FCoV readily infects the intestina l mucosa of newborn pigs 
where i t  causes lesions almost indistinguishable from those 
seen in mild TGEV infection [9, 110, 113, 122].
1.2.3.2 CCV was f i r s t  isolated in 1971 from faeces of dogs 
suffering from gastrointestinal disorders [58]. I t  can in fec t
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cats causing seroconversion and is shed from the oropharynx fo r 
at least a week [9, 11, 82, 126, 127, 139]. Reports co n f l ic t  
as to whether CCV sensitises cats to FCoV infection [83] or not 
[9, 138] although d if fe ren t isolates were involved. However,
effusive FCoVV resulted a fter i/m and i /p  inoculation of a 
B rit ish  stra in of CCV [82, 83].
A modified l ive  CCV vaccine inoculated intramuscularly resulted 
in c l in ic a l signs in dogs sim ilar to FCoVV [27, 114].
1.2.3.3 H 229E causes common cold in human beings [84]. In 
cats th is  virus causes seroconversion and asymptomatic 
infection but not antibody dependent enhancement (ADE) of FCoV 
infection [9, 11, 126, 127]. ADE is discussed in 1.4.7.
1.2.3.4 Coronavirus-1ike partic les (CVLP) have been observed 
in the faeces of cats. They are larger than FCoVs, 90-300nm in 
diameter, with spikes which are 25 nm long and have spherical 
or tear-drop l ike  knobs attached to the partic les by th in  
stalks [61]. These viruses have not been grown in culture. 
CVLPs do not e l i c i t  antibodies cross-reactive with FCoV or 
cause disease in cats [61, 103, 113, 136]. They may s t i l l  be 
excreted 12 months post infection [61,136].
1.2.4 Growth o f FCoV in ce ll culture
The growth of FCoV in cell culture has been notoriously 
d i f f i c u l t  to achieve [45, 61, 100, 102, 110, 111, 141].
Primary virus iso lation may need as many as 5 blind passages 
before CPE can be detected [164]. Even where the technique was 
successful, virus could only be isolated from the tissues of 
about 1 in 7 f ie ld  cases of FCoVV [114]. Recovery of cell 
culture-adapted FCoV from experimentally infected cases is also 
d i f f i c u l t  [141, 143].
I n i t ia l l y ,  virus was passaged in laboratory animals: in cats
[111, 158], suckling mice, rats and hamsters [57, 100, 104,
106]. The f i r s t  ce ll culture in which FCoV was found to
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replicate was in ce lls of peritoneal exudate of experimentally 
infected kittens which were mainly macrophages [100, 104, 106,
110, 137, 139]. FCoV has also been grown in fe line  small
in testina l organ cultures [60, 62, 104, £110], tracheal ring 
cultures [104, 110], fe line  embryo lung, [14, 93, 110, 140]
foetal cat head and in testina l culture [164], FEA [140], 
Crandell fe l ine  kidney (CRFK) ce lls  [27, 39, 85, 86] (in which 
FIPV is said to form larger plaques than FECV) [86, 146], and 
fe line  catus whole foetus (fcwf) ce lls  [15, 29, 39, 113, 114].
Fcwf ce lls  can phagocytose latex and carbon partic les, have Fc 
receptors and stain positive fo r aspecific esterases and 
therefore are iden tif ied  as macrophage-like ce lls  [73].
One-step growth of FCoV has been reported [132]. In foetal 
fe line  ce lls  the production of virus begins at 6 hours p . i .  and 
reaches a maximum at 12 hours p . i .  F i f ty  to 99% of the 
in fe c t iv i ty  remains cell-associated [20, 73]. Other authors 
have found peak virus production at 30-48 hours p . i .  in FEL
cells  [14, 86, 140]. In macrophages, virus is f i r s t  detected 
in the supernatant 8 hrs p . i .  peaking at 2 days p . i .  Virus 
production continues fo r 4 days then declines un ti l  8-10 days. 
Each macrophage produces 10-100 infectious virus partic les but 
no CPE is apparent [137].
As early as 6.5 hours p . i .  the f i r s t  cytopathological changes 
(rounding and swelling of ce lls) can be observed. At 8 hours 
p . i .  the ce lls  have formed syncytia [20]. CPE is s im ilar in 
FEL [140], CRFK [67, 140], A-72 [140] and FEA ce lls  [140].
Cell fusion and syncytium formation are mediated by the FCoV 
spike [22, 110]. In fcwf ce lls , v ira l antigen can be detected 
on the cell surface by IF at 16 hours p . i .  when CPE is most 
pronounced [73]. Multinucleated giant ce lls  were observed 3 
days p . i .  in a CRFK culture inoculated with viruses isolated 
from 2 f ie ld  cases and there was complete cell destruction by 5 
days p . i .  [85, 113]. Primary foci enlarge from the peripheries 
and secondary foci are seen only occasionally, indicating that 
infection proceeds mainly by cell to cell contact. As the foci
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grow, ce lls  in the centre slough into the media [113].
FCoV is assembled at the membranes of the smooth endoplasmic 
reticulum (ER). Virions do not bud from the plasma membrane 
[14, 31] but in trace llu la r  budding of v ir ions takes place
between the rough ER and the cis-Golgi [14, 45, 57, 62, 148,
152]. The vir ions acquire th e ir  l ip id  envelope from the ce lls , 
excluding host cell proteins in the process [132]. Matrix 
protein accumulates in the Golgi and is believed to determine 
the s ite  of virus budding. Mature vir ions are released from 
the cell by exocytosis [131, 148].
A proportion of the S is not incorporated into v ir ions and is 
transported to the plasma membrane where i t  induces c e l l - to -  
cell fusion [31, 148]. Conflicting reports exist as to whether 
spike can be detected on cell surface by IF [22, 148].
1.3 Epidemiology
1 .3 .1  Geographical and species d is tr ib u tio n
FCoVV has a worldwide d is tr ibu t ion  [56, 60, 104, 105, 106].
Although primarily a disease of domestic cats FCoVV has been 
recognized in lions, mountain lions, leopards, jaguars, lynx, 
caracal, sand cat and pallas cat [57, 104, 105, 106]. The
cheetah is reported to be pa rt icu la r ly  susceptible [16, 27,
91].
From time to time a FCoVV-like disease occurs in other species 
of animals. To date none of these conditions has been shown to 
be associated with FCoV [126].
1 .3 .2  Genetic predisposition to  FCoVV
The development of FCoVV is l ik e ly  to depend on several 
factors, one of which is genetic predisposition [9, 138].
In a worldwide survey, no difference was found in the
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prevalence of antibody between domestic and pedigree cats [56]. 
S im ilarly , in a series of necropsies at the University of 
California no apparent breed predisposition was found [102]. 
However, taking the figures fo r pedigree cats as a whole in 
that survey, the prevalence was 14.3% compared to 9.8% in 
domestic cats.
In a survey of the prevalence of FCoV antibodies in the USA, a 
higher mean t i t r e  was found in Persians and Himalayans [12]. 
In the UK, of 100 cases of FCoVV 72 were in pedigree cats and 
28 were in domestic cats. A predisposition amongst Burmese was 
noted [140]. The more frequent appearance of FCoVV in pedigree 
than domestic cats may not be due to genetic predisposition, 
but rather to the cattery environment in which these cats are 
usually reared [104, 106].
An incident which favours the argument fo r  genetic 
predisposition is that in 1982/3 90% of a cheetah colony 
succumbed to FCoVV. High FCoVV m orta lity  has. been attributed 
to the genetic uniformity o.f individuals in th is  species 
leading to genetic suscep tib il ity  [91]. This may be correlated 
with the in t r in s ic  suscep tib il ity  of the cheetah macrophage to 
infection [139]. However, variation of the number of FCoV 
infected macrophages in in v i t ro  infection did not depend on 
the individual cat from which the macrophages were obtained 
[137]. A1ternatively, the monomorphism of the major 
h istocompatib ility complex (MHC) of cheetahs might be 
responsible fo r a poor immune response to v ira l epitopes 
involved in the induction of protective immunity [91].
Resistance of mice to MHV is genetically controlled. The 
expression of genetic resistance is manifested at the level of 
the mature macrophage and since these ce lls  are involved in 
primary v ira l rep lica tion, the ir  interaction with virus 
strongly determines the outcome of in fection [132, 139]. I t
has been proposed that FCoV virulence is determined by 
antigenic differences between isolates in the peplomer protein
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which mediates binding of virus to ce llu la r  receptors [30, 31]. 
However, attenuated FCoV strains ceased to replicate in 
macrophages 3-4 days p . i .  compared to v iru len t strains which 
were s t i l l  producing infectious virus 10-12 days p . i .  This 
finding suggests that additional c r i t ic a l  steps in CoV
infection of macrophages occur a fte r the virus has adsorbed and 
gained entry to the c e l l .  The avirulent and v iru len t FCoV 
strains grew to comparable t i t re s  in CRFK ce lls , therefore i t  
was concluded that the macrophages are in t r in s ic a l ly  more 
resistant to avirulent than v iru len t strains of FCoV [139].
Other evidence in favour o f  genetic predisposition is that 
several s iblings in a l i t t e r  and repeated l i t t e r s  from the same 
queen may succumb to FCoVV and then the queen may herself 
contract the disease [27, 98, 104, 106].
1 .3 .3  Age
FCoVV has been recognised in cats of a ll ages from s t i l lb o rn  
and newborn to aged animals over 14 years old [105, 106].
However, i t  is more usually a condition of younger cats [8 , 
104]. In one cattery which lost 59 cats the average age was 
5.8 months (range 2-11 months) [116]. In an American survey of 
cats which had died of FCoVV, 41 out of 153 were less than a 
year old; 47 were 1-2 years old; 24 were 2-3 years old; 20 were 
3-4 years old [101]. In the UK, 51 of 100 FCoVV cases were 
under a year old and 16 were 1-2 years old [140]. In both 
surveys, the prevalence declined a fte r 4 years of age and 
thereafter there was only sporadic occurrence of FCoVV.
In a survey of the presence of antibodies in cats, an inverse 
relationship was noted between age and mean FCoV antibody t i t r e  
[ 12].
1 .3 .4  Sex
In some early reports males were found to be affected s l ig h t ly  
more frequently than females [105, 116]. FCoVV [140] and FCoV 
antibodies [56] were more common in male cats than female but
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the difference was not s ign if ican t when compared to the sex 
incidence in the general population. In another report, no 
association was found between sex and the presence of 
antibodies or disease [ 12] and i t  is currently generally 
accepted that there is no s ign if ican t sex predisposition 
[104, 106].
1 .3 .5  Concurrent FeLV/FIV in fe c tio n
The immune component of FCoVV might lead one to speculate that 
concurrent infection with FeLV or FIV, which suppress the
immune response, would affect the outcome of infection with 
FCoV [114]. In two experimental colonies with no history of 
FCoVV, immune suppression by FeLV and methyl prednisolone [104, 
114] or cyclosporin A [76] caused outbreaks of FCoVV.
Early reports stated that about 50% of a ll cases of FCoVV had 
concurrent FeLV infection [43, 101, 153]. In a more recent
survey the frequency of FCoVV cases which were FeLV positive
was 19.3% and FCoVV was the th ird  most common disease condition 
associated with FeLV [117]. However, the prevalence of FeLV 
infection in the to ta l necropsy cat population was 16% in that 
survey, so the frequency was not s ign if ica n t ly  above average
[118].
In the UK, 3% of cases of FCoVV were found to be FeLV positive 
[140]. In another report, FCoVV was cited as the major cause of 
death in FeLV infected cats and no difference in incidence of 
FCoVV was noted between FeLV infected cats and those with 
concurrent FIV and FeLV infection [129].
In Japan no association was found between the incidence of FCoV 
antibodies and FIV infection. FCoVV was less common among FIV 
infected cats than would be expected in the population as a 
whole [69].
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1 .3 .6  Prevalence
In ordinary cats from pet households, the prevalence of FCoV 
antibodies is estimated to be between 10 and 40% of the 
population [94, 95, 102, 103, 109, 110, 111, 114, 153, 155].
In catteries antibodies are e ither completely absent or occur 
in 80-90% of the cats [9, 12, 57, 94, 102, 103, 109, 110, 111,
153, 155].
In most cases, the occurrence of FCoVV is sporadic and the 
disease can apparently disappear from a household of cats and 
then reappear months or years la te r  [106]. Although the 
infection rate is high among cats, less than 5% of cats 
infected with FCoV develop FCoVV [102, 104, 109]. Much higher 
rates have been seen in some isolated catteries. For example, 
a 3-49% yearly loss in kittens was observed in 1 cattery over a 
4 year period in an area where the cats were kept together in 
large numbers. By contrast, in another part of the same 
cattery where the cats were isolated from each other FCoVV 
m orta lity was very low (3 of 8000 cats) [116].
1.4 Pathogenesis
1 .4 .1  Virus transmission and source
The route by which FCoV is spread in nature is s t i l l  unknown 
[114] but i t  is l ik e ly  that in i t ia l  infection is probably oro- 
faecal or oral-oral [9, 48, 49, 111, 113, 140] and/or
by inhalation of virus into the trachea [9, 111, 141].
FCoV is a highly infectious virus infecting over 90% of cats in 
any cattery in which i t  is endemic. Sick cats cannot be the 
only source of virus because FCoVV is sporadic in occurrence 
and commonly many months or years pass between, the episodic 
appearance of cases of disease within catteries [ 111] .  
Besides, in experimental infections, by the time cats are 
c l in ic a l ly  i l l ,  they are no longer shedding virus [140, 141].
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The virus does not survive fo r long periods outside the host 
[ 100] ,  and ind irect transmission on l i t t e r  trays [ 111] and 
clothing [9, 103] has been shown to occur, however,
environmental virus is not thought l ik e ly  to be a major source 
of infection [64].
Transplacental transmission is possible but so fa r is unproven 
[9, 98, 99, 101]. The best evidence fo r th is  source was the
iso lation of FCoV from a 4 day old k itten [85, 114] and the 
recognition of FCoVV in s t i l lb o rn  and weak newborn kittens born 
to a queen that had FCoVV during the la t te r  stages of pregnancy 
[104].
An additional source of FIPV might be cats infected with FECV. 
Mutation of the la t te r  into the former has been postulated 
[104, 106, 108, 114].
Most instances of virus transmission are probably d irect [8]
and the most l ik e ly  source of FCoV is healthy ca rrie r cats
[104, 111, 114, 141]. I t  has been suggested that a fte r
transient URT signs, most cats recover and may become
persistently infected and shedders of virus [126]. The
existence of healthy carriers has been demonstrated by placing
tracer kittens with healthy seropositive cats [103, 111, 141].
Cats with higher antibody t i t re s  appeared to be more infectious
than cats with lower t i t re s  because the kittens seroconverted
in a shorter time [103, 111]. Latent FCoV infection was
demonstrated by infecting healthy FIPV immune cats with FeLV
and dosing with methyl prednisolone: 6 out of 8 died of FCoVV
r[114, 115]. This condition occurred 0-4 months a fte r FCoV
exposure but not 7-9 months la te r, suggesting that e ither virus 
is lost with time from the body, or that immunity is 
strengthened [107].
Whether transmission by haematophagous arthropods occurs is 
unknown [9] but is considered to be unlike ly [116].
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Experimentally, FCoV has been administered i / v  [87, 101], i /p  
[49, 87, 101, 109, 114], s/c [101], o ra l ly  [43, 49, 114],
in tra tracheally  [153], intranasally [114], and by aerosol [153, 
158]. In one experiment i /p  inoculation of NW1-FIPV produced 
seroconversion and effusive FCoVV in 100% of k ittens, 
intratracheal inoculation of the same dose caused FCoVV in 6 
of 10 kittens and seroconversion in one other, and oral 
inoculation of caused disease in 3 of 15 kittens and 
seroconversion of another 1 [110]. Route of infection
obviously has an important role in the outcome of the 
infection.
Abdominal exudate, organ extracts, whole blood, and urine from 
naturally infected cats have been used to transmit in fection 
[43] though urine was not found to be infectious in one study 
[ 101].
1 .4 .2  Virus shedding
FCoV is probably excreted into the environment in oral and 
respiratory secretions, faeces and possibly urine [8 , 9, 26,
48, 114, 153]. I t  is probably not shed in large amounts by
seemingly healthy cats [112]. Cats with persistently high FCoV 
antibody t i t re s  probably shed more virus than do cats with 
lower t i t r e s  [8 , 111] .
In experimental infections of cats which had been infected i /v  
or i /p ,  virus was detected in the oropharynx on the second day 
p . i .  and continued to be excreted fo r 9-10 days p . i .  Cessation 
of virus shedding seems to be associated with development of 
systemic IgG and both c ircu la ting and salivary IgA. A second 
short episode of virus shedding occurred around day 14 p . i . ,  
about the time of onset of c l in ica l signs. One cat in each of 
2 experiments did not show th is  la te r  shedding episode and did 
not go on to develop FCoVV. One possible reason fo r the 
d i f f i c u l t y  in iso lation of virus from f ie ld  cases may be that 
most cats stop shedding before any c l in ica l signs develop [82, 
141, 142, 143].
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In one experiment virus shedding in faeces began 2-7 days p . i .  
[48, 141] and continued to 10-14 days p . i .  There was no
secondary episode and an SPF cat which was placed in contact 
with a recovered experimental cat fo r 2 years fa iled  to 
seroconvert [141].
FCoV has been detected in the faeces of natura lly occurring 
cases of FCoVV [48] and FECV has been detected in the faeces of 
ca rr ie r cats [103, 111].
1 .4 .3  Virus dose
Increasing virus dose was shown to increase the proportion of 
cats infected with v iru len t NW1-UCD1-FIPV or avirulent FIPV- 
Black strains. Some cats which were given a small dose of 
virus became immune while others, given the same dose, fa iled  
to become infected or else became infected and died. The 
authors concluded that cats in the f ie ld  are exposed 
infrequently to re la t ive ly  small amounts of virus [ 112] .
Seronegative cats given low doses of FCoV developed a 
re la t ive ly  higher incidence of non-effusive FCoVV, while higher 
doses caused predominantly effusive FCoVV [104].
1 .4 .4  Primary s ite s  o f virus re p lic a tio n
The sites of primary virus replication are probably the 
ep ithe lia l ce lls  of the small intestine [42, 50, 104., 110, 113, 
126, 143, 160], possibly the tons ils  [113, 143] and the
oropharynx [ 110, 126].
FECV selectively infects the apical columnar epithelium of the 
in testina l v i l l i  from the caudal part of the duodenum to the 
caecum [111]. In a naturally occurring case, FECV antigen was 
observed only in the ep ithe lia l ce lls  of the caecum but no 
other tissue [111]. FECV also replicates to a lesser extent in 
the tons ils  and mesenteric lymph nodes [113]. I t  is claimed 
that the essential difference between FIPV and FECV is that the 
la t te r  does not spread any further than the in testina l
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epithelium and regional lymph nodes [104].
In experimental infections of cats, FCoV (FIPV) was detected by 
fluorescence in the jejunal enterocytes 12 hours p . i .  By day 5 
the whole SI was infected and infection persisted even to 12 
days p . i .  [48, 51]. The Wellcome stra in of FIPV was detected 
in the caecum 2-14 days p . i .  and in the lumen of the colon 3-14 
days p . i .  [143]. One author reported that in most cases 
antigen-containing ce lls  in the intestine decreased from day 7- 
8 p . i .  along with regeneration of the mucous membrane and onset 
of antibody production [48], while another showed that antigen 
was most obvious at 7-14 days p . i .  [143]. In natura lly 
occurring cases, v ira l antigen can be detected in epithelium of 
the duodenum, jejunum, caecum and colon even in the presence of 
high t i t re d  serum antibody [48].
In in testina l ring organ cultures, the UCD and Dahlberg strains 
of FIPV replicated in the cytoplasm of columnar ep ithe lia l 
ce lls  of v i l l i  [48, 62]. The changes observed were s im ilar to, 
though less severe than, those seen in infections by CoVs of 
other species which produce diarrhoea. In the absorptive 
ep ithe lia l ce lls  of the SI, m ic ro v i l l i  were shortened, blunt 
and decreased in number. Mitochondria assumed abnormal size 
and mprphology, the endoplasmic reticulum dilated and there 
were increased l ip id  droplets in the cytoplasm. FCoV secretion 
continued from day 1-43 in these cultures [62].
In a small proportion of cats infected with FCoV, the virus 
leaves the gut and becomes systemic. Two explanations have 
been offered fo r th is  progression. F irs t,  in these cats 
mucosal immunity is insu ff ic ien t to prevent the virus leaving 
the gut; and secondly v iru len t FCoVs are more able to in fect 
monocytic phagocytes in vivo so that v ira l replica tion is not 
restr ic ted to the in testina l epithelium [111, 139]. In these 
cats i t  is believed that the primary target cell fo r v ira l 
replication is the macrophage [49, 51, 73, 88, 100, 109, 113,
137, 139, 158]. Viral partic les have been observed by EM in
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cytoplasmic vacuoles and SER of degenerated macrophages in 
inflammatory lesions of experimentally infected cats [104, 158] 
and in the monocytic ce lls in the medullary sinuses of the 
mesenteric lymph nodes [111]. In natural, infections, CoV 
partic les can sometimes be detected by EM in peritoneal 
macrophages and mesothelial l in ing  ce lls  [45]. FCoVV could be 
transmitted using white blood ce lls  from infected cats but not 
plasma or white blood cell free erythrocyte suspensions [157]. 
In mice, the primary s ite  of coronavirus replica tion of mouse 
hepatit is  virus is in the macrophage. [132].
How the virus leaves the gut is s t i l l  a matter of speculation 
but may be via macrophages [19, 160] draining to the mesenteric 
lymph node or, in seropositive cats, via neutrophils which take 
up antigen-antibody complexes before infection of enterocytes 
or macrophages [51]. The virus is then transmitted throughout 
the body in the monocytes [126] or neutrophils [51] and enters 
the perivascular area of affected organs a fte r the monocytes 
attach to and migrate through the walls of the vessels. The 
resulting perivascu lit is  is the in i t ia l  lesion observed in 
histopathological sections of c l in ica l FCoVV [51,126].
In naturally occurring cases and o ra l ly  infected experimental 
cats, FIPV was detected by immunofluorescence (IF) in 
mesothelial ce lls , macrophages of the omentum and serosa of 
abdominal organs and spleen [45, 48]. Additionally, a fte r i /p  
in fection, FCoV antigen was found by IF in lesions in the 
spleen, l iv e r  and mesenteric lymph nodes [49]. At 5-12 days 
p . i .  some macrophages in the lamina propria of the S .I. and 
sinuses of the mesenteric lymph nodes showed v irus-spec if ic  
fluorescence [48]. In an experimental infection FCoV was 
detected in Peyer's patches 7-14 days p . i . ,  and s lig h t 
fluorescence was found around the portal areas of the l iv e r  14 
days p . i .  Virus was not. detected in any other organ [143].
Fluorescent antibody staining of tissue sections from cats with 
both forms of disease demonstrated the presence of FCoV in the
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lesions. In effusive FCoVV, a large amount of v ira l antigen 
was contained in the phagocytic ce lls  that make up the 
periphery of the pyogranulomatas, in Kuppfer ce lls  within and 
adjacent to hepatic sinusoids and in macrophages within 
parenchymatous lesions in the l iv e r .  There was less v ira l 
antigen in the lesions of non-effusive FCoVV and i t  was usually 
found within a few macrophages adjacent to vessels in the
centre of the lesions [106].
In tr in s ic  resistance, of fe line  peritoneal macrophages 
determines whether or not they w i l l  support FCoV rep lica tion . 
They are more resistant to avirulent laboratory strains than 
v iru len t strains which grow to comparable t i t re s  in CRFK ce lls  
[137, 139]. In v i t ro ,  macrophages produce virus fo r at least
6-8 days. Virus infection of macrophages is non-cytolytic which 
may indicate that FCoV-infected macrophages are important fo r  
persistence of infection and the carrie r state in vivo [137].
Secretion of IFN by ep ithe lia l ce lls  and macrophages may be
important early host factors in containment of primary mucosal 
infections. During v ira l infections, endogenous beta-IFN is 
generally released into the c ircu la tion within hours a fte r  
in i t ia l  v ira l rep lica tion. This c ircu la ting  IFN and also 
gamma-IFN from migrating virus-sensitised lymphocytes can
protect distant target organs from virus invasion. In v i t ro ,  
treatment of fe line  ce lls with homologous beta-IFN or human
alpha-IFN prevented or reduced subsequent v ira l rep lica tion in 
cultures challenge exposed to FCoV [160].
In kittens infected by aerosol, FCoV viraemia occurred 2 days 
p . i .  in seropositive kittens and 6 days p . i .  in seronegative 
k ittens and lasted at least 7 days in the former (sampling was
stopped at 9 days p . i . ) ,  13 days in the la t te r  [157, 158]. In
these kittens, in i t ia l  localisation and replication of virus 
occured in large mononuclear ce lls in regional lymphoreticular 
tissues and/or subepithelial tissues of the URT. This early 
v ira l replication was associated h is to log ica lly  with
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hyperplasia of reticuloendothelial and lymphoid ce lls  in T-cell 
dependent paracortical areas of regional lymph nodes [158].
Haematogenous spread of virus or virus-infected ce lls  a fte r 
local infection in lymphoreticular tissues may subsequently
result in infection of sinusoidal macrophages and 
reticuloendothelial ce lls  of target organs that contain 
extensive blood sinusoids ( i .e .  l iv e r  and spleen). Infection 
of specialised macrophages ( i .e .  pericytes) in the tunica 
adventitia of blood vessel walls or diapedesis of infected 
leukocytes from the c ircu la tion  might also result in early
vascular and perivascular infection in systemic tissues [158].
1 .4 .5  Nature o f the antibody response to FCoV
Spontaneous cases of FCoVV usually have markedly elevated serum 
anti-FCoV antibody t i t re s  [101, 156, 157].
Most cats infected with FCoV, whether diseased or healthy, 
produce VN and IF antibodies [114]. There is no correlation 
between the presence of fluorescent or VN antibodies and e ither 
the development of disease or immunity [112,114]. VN
antibodies in the sera of f ie ld  and experimental cases can have
t i t re s  of over 40,000 but have no protective value [57, 82].
IF and VN neutralising antibodies appear at the same time [112] 
but there is no correlation between the t i t re s  of each tes t.  
Antibodies detected by IF are probably against soluble antigens 
within infected ce lls and th e ir  persistence is often correlated 
with the persistence of the e l ic i t in g  agent [ 112] .
VN antibodies are believed to recognise the virus spike [31, 
112, 148]. These antibodies often persist fo r some time a fte r 
the virus is eliminated. In kittens IF antibody t i t r e s  peaked 
rapidly then dropped to undetectable levels in a month or so, 
whereas VN antibody t i t re s  remained high [112].
i n i t i a l l y
VN antibodies mayAbe IgM, because in a measurement of class- 
specific response, VN a c t iv i ty  was detected 5-7 days p . i . ,  as
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was the IgM response. The IgG response was not noted un ti l  5 
days la te r  [82].
VN antibodies prevent virus entering ce lls  in v i t ro .  However, 
two v iru len t isolates of FIPV and one isolate of FECV were able 
to spread from cell to cell in culture despite the presence of 
neutralising antibodies in the medium [31].
IF antibodies recognise M [59, 65, 163]. The in i t ia l  response 
of experimentally infected cats was to the M protein of the 
virus as measured by competitive ELISA (CELISA) [163]. Anti-N 
antibodies appeared 60 days p . i .  while there was no measurable 
anti-S response. Of 205 f ie ld  samples that were seropositive 
by CELISA, 98.5% had anti-M antibody, 58.5% had anti-N antibody 
and 4.8% had anti-S antibody. Only cats that developed 
antibodies to S had VN antibodies, although some succumbed to 
infection [163].
Cats which have confirmed FCoVV had antibodies to a 95K protein 
which may be a monomeric form of the spike [67].
IgM, IgG and IgA were produced to the same level against a ll 
v ira l proteins [82].
An tiv ira l antibodies may not be to ta l ly  responsible fo r  the 
hypergammaglobulinaemia seen in FCoVV [59, 68, 155]. IL -6,
which is produced by peritoneal exudate ce lls  in cases of 
FCoVV, regulates terminal d if fe ren tia t ion  of B ce lls  into 
antibody secreting ce lls [38, 52] and appears to be involved in 
the polyclonal B cell activation in several diseases such as 
rheumatoid a r th r i t is  [38]. Another theory is that v ira l 
antigen can non-specifically stimulate B cell p ro l ife ra t ion  in 
the absence of T helper ce lls . I f  some B cell clones happen to 
be autoreactive, autoantibodies w i l l  be produced [41].
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1 .4 .6  M aternally  derived antibody
Upon nursing, kittens acquire FCoV antibodies from the queen. 
Levels of these antibodies decline during the f i r s t  weeks of 
l i f e  with a ~t\ / 2  ° f  7 days, and by 4-6 weeks t i t r e s  are 
generally less than 16. In many kittens, antibody reappears in 
the serum around 8-14 weeks of age as the kittens become 
themselves infected while in others i t  remains at a low level 
[107, 111, 114].
IgG in colostrum and IgA in milk is protective because kittens 
are not usually infected un til between the f i f t h  and tenth 
weeks of l i f e  [103, 116]. In TGEV infection, immune pigs 
confer immunity on th e ir  pig lets through th e ir  colostrum and
milk [84]. Kittens born to FCoV immune mothers have a solid
immunity to FCoV on challenge between 8 and 12 weeks of age 
[107, 114]. Whether th is  was due to MDA or in a b i l i ty  to mount
an antibody response due to th e ir  youth was unknown. However,
i f  not infected un til 22 weeks of age some kittens w i l l  be 
immune and others develop enhanced disease [107,114].
1 .4 .7  Antibody dependent enhancement
Antibody dependent enhancement (ADE) is the name given to the 
phenomenon whereby cats with e ither natura lly or experimentally 
acquired serum anti-FCoV antibodies experience a more rapid 
fulminating FCoVV [9, 49, 82, 95, 109, 110, 111, 114, 139,
141, 154, 156, 157, 158] and/or e n te r it is  [51] following FCoV
exposure than do FCoV antibody negative cats receiving the same 
challenge dose. Seronegative kittens passively treated with 
immune serum or purified IgG develop disease with the same 
frequency, acuteness and severity as seropositive kittens [109, 
156]. This phenomenon has fo iled  many vaccine attempts with 
homologous virus [11, 138], CCV [82, 83, 138], TGEV [11], or 
recombinant vaccinia virus expressing the S protein [149].
The mechanism by which ADE occurs is poorly understood. I t  has 
been likened to dengue haemorrhagic fever (DHF) in man [109, 
139, 156] in which cases of disease occur as secondary
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infections in patients with pre-existing serum antibodies to 
dengue viruses. I t  is postulated that upon re infection with a 
heterologous serotype of dengue virus, the patient rapidly 
develops high t i t re s  of cross-reacting but non-neutralizing 
antibodies. The formation of large amounts of virus-antibody 
complexes leads to activation of complement and haemorrhagic 
shock syndrome [156]. Heterotypic immunity to d if fe ren t 
strains of FCoV may be involved in the pathogenesis of FCoVV
[113].
Several possible mechanisms of ADE have been considered. Non­
neutralis ing, opsonising antibodies may accelerate uptake of 
FCoV into target cell monocytes or macrophages [9, 49, 104,
113, 156, 158]. The exact mechanism is not understood, but i t  
is assumed that the Fc portions of the immunoglobulins bind to 
the mononuclear ce lls promoting attachment and uptake of virus 
[126]. Enhanced infection of fe line  macrophages in v i t ro  by
v iru len t FIPV isolates occurred when the viruses were incubated 
with anti-FCoV antibody before inoculation [137, 139].
Thymectomized kittens had more severe lesions and more 
prominent FCoV antigen positive macrophages than sham-operated 
kittens infected in the same way. This result suggested that
partia l depletion of T ce lls  due to thymectomy enhanced v ira l
growth or spread to macrophages [9, 50].
Surface expression of FCoV antigens on macrophages seen late in 
infection when virus progeny are already formed, could induce 
antibody-mediated lys is  of infected ce lls  and therefore promote 
increased dissemination of virus partic les. This could explain 
the decrease in complement levels in terminal FCoVV cases. A 
pronounced increase in T lymphocytes is also seen term inally in 
FCoVV cases which may be an indication of enhanced d irec t 
lymphocyte-mediated cy to tox ic ity  [73].
A th ird  mechanism might be promotion of widespread vascu lit is  
through immune complex (IC) deposition [9, 49, 158 ] .  Antibody
45
reacts with antigen and complement possibly resulting in a 
local Arthus-like response [109, 113].
However, the mere presence of FCoV antibody in the serum of a 
cat does not mean that FCoVV w i l l  ever develop in that cat, 
even a fte r repeated FCoV exposure. FCoVV is a re la t ive ly  
uncommon condition in nature and the majority of FCoV antibody 
positive cats w i l l  never develop the disease [9 ].
1 .4 .8  Timing o f the antibody response
At 3 days p . i .  no antibody response could be detected by IF, 
ELISA or VN. By 5-6 days p . i .  VNA were detected and by 9 days 
antibodies were detected by IF or ELISA [66, 82].
In experimental infections with FCoV, antibody was seen in the 
serum 4-14 days p . i .  [103, 114, 141] and continued to r ise 
un til death VN t i t re s  were higher and appeared sooner than IF 
antibodies [141]. Onset of c l in ica l signs coincides closely 
with the appearance of antibodies in the serum [156].
In an experiment which examined the class specific response, 
IgM was produced 3-7 days p . i . ,  peaked at 7-14 days, then 
decreased in cats which succumbed to FCoVV. In one cat which 
survived, the IgM response remained high. IgG production began
7-12 days p . i .  IgA response began 7-12 days p . i . ,  peaked at 
12-17 days then e ither remained constant (in a cat which died 
of FCoVV) or decreased to background levels (in a survivor). 
[82].
In natural infections, SPF kittens placed with healthy FCoV 
carriers seroconverted without developing fever, in 2-10 weeks 
[111, 114] and 2-3 weeks a fter exposure to an infected l i t t e r
tray [ 111] .
1 .4 .9  Immune complexes
There is a convincing case that FCoVV is an immune complex- 
mediated (IC) disease. Circulating ICs [70, 71, 82, 88, 139,
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141, 156] and glomerular IC deposition [71, 88, 109, 156] have 
been demonstrated. Complexes of IgG and C3 bound spec if ica lly  
to FCoV were demonstrated in the cytoplasm of infected 
macrophages [109, 158] and in lesions by IF [109, 156]. Pre­
existing antibody enhances the course of the disease and 
seronegative cats survive longer than seropositive cats [51, 
88, 109, 112, 156, 158]. The C3 component of serum complement 
a c t iv i ty  decreases several days before death [51, 71, 109, 141, 
156]. Passive antibody t i t re s  decrease more rapidly in FCoV- 
challenged kittens compared with unchallenged controls 
suggesting that antibodies are active ly consumed during the
course of disease in addition to spontaneous degradation [156].
Antibody reacting with c ircu la ting soluble antigen forms immune 
complexes the size, valency and s o lu b i l i ty  of which depend on
ratios and amounts of antigen and antibody and on the size of
the antigen. Such complexes are trapped in small blood 
vessels [25].
The nature of the antigen, ra tio  of antigen:antibody, class and 
subclass of antibody and interaction with the complement system 
and ce llu la r  elements such as macrophages, polymorphonuclear 
leukocytes play important roles in the fate and biologic
a c t iv i ty  of the IC [25].
Monovalent antigens such as haptens do not form la t t ice s ,  
therefore ICs remain in c ircu la tion fo r long periods without 
tissue deposition. However, multivalent antigens such as some 
proteins do combine with antibody to form la t t ice s  and ICs of 
varying composition depending on molar ra tio  of the reactants 
[25].
In large antigen excess small ICs are formed which do not f i x  
complement. In antibody excess the ICs can f i x  complement but 
are rapidly removed from the c ircu la tion by the lymphoreticular 
system [25, 121, 158]. Pathogenic ICs capable of in i t ia t in g  
inflammation when antigen excess is modest, form ICs
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intermediate in size and s o lu b i l i ty  and are capable of f ix ing  
complement but are not rapidly eliminated from the c ircu la tion  
by the reticuloendothelial system [25].
An Arthus-type reaction is a localised lesion of venules that 
results when antigen-antibody complexes, formed during periods 
of antibody excess, deposit in venules and f i x  complement. 
Furthermore, ICs formed in antibody excess are more e ffective  
activators of complement than are complexes formed at 
equivalence or antigen excess [158]. In FCoVV, as in Aleutian 
disease in mink, ICs form in antibody excess because cats with 
FCoVV usually have high FCoV serum antibody t i t re s  [156, 158].
The pathological consequencess of ICs are dependent on th e ir  
a b i l i t y  to activate the complement system [25]. I f  seropositive 
infected cats are decomplemented using cobra venom factor FCoVV 
does not ensue [71]. Complement is probably activated by the 
classical route in FCoVV (the alternative route is unlike ly 
because C3 and C4 levels are depleted simultaneously) [71].
Following deposition of the IC in the blood vessel wall, the Fc 
portion of IgG fixes C3a [88] .  C3a has chemotactic properties 
a ttracting neutrophils which invade the vessel walls [25, 57,
158]. C3a also has anaphylactic properties capable of 
tr iggering vasoactive amine release from p la te le ts , mast ce lls  
and th e ir  c ircu la ting counterpart, the basophil [71, 120]. The 
vasoactive amines released include histamine and 5- 
hydroxytryptamine [ 120] which cause endothelial cell re traction 
and thus increased vascular permeability [120, 156, 158].
Contraction of cap illa ry  endothelial ce lls  allows exudation of 
plasma proteins. Neutrophils pass through the gaps between the 
endothelial ce lls  and release lysosomal enzymes, pa rt icu la r ly  
collagenase and elastase, causing necrosis of the vessel wall. 
[25, 57]. The neutrophil is the characteristic  cell species
encountered in FCoVV granulomas [57, 71].
ICs also interact with p late lets through th e ir  Fc receptors
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causing aggregation and microthrombus formation [158] and 
release of more vasoactive amines. Several cases of 
disseminated intravascular coagulation (DIC) have been induced 
in FCoV antibody positive kittens experimentally infected with 
FCoV [113, 156]. Platelets w i l l  also clump at sites of
endothelial in ju ry  [156]. A lternative ly , there may be 
accelerated (antibody-mediated?) lys is  of p la te lets in 
sensitised kittens [156],
Immune complex deposition is most l ik e ly  where there is high 
blood pressure and turbulence. In glomerular cap il la r ies  blood 
pressure is four times that of any other cap il la r ies . Vessel 
bifurcations also cause turbulence and f i l t e r s  such as the 
choroid plexus or c i l ia r y  body of the eye are l ik e ly  sites fo r 
IC deposition [121]. FCoVV lesions are commonest in the 
peritoneum, kidney and uvea, a ll sites of high blood pressure 
and turbulence.
In effusive and enhanced FCoVV, the c l in ica l and pathological 
signs are attr ibutab le  to the vascular damage resulting from 
acute IC disease. The damage to the blood vessel walls allows 
the prote in-rich plasma to pass into the peritoneal or pleural 
cavities resulting in the characteristic  prote in-rich f lu id  of 
high specific  gravity seen in effusive FCoVV [126, 156].
1.4.10 Immunity 
(See also 1.4.6)
The development of FCoVV depends on two events: an in t r in s ic
suscep tib il i ty  of the alimentary or respiratory tra c t 
epithelium to infection and an immune response that is non- 
protective. In one experiment, a ll cats challenged by the i /p  
route, 6/10 challenged intratracheally  and 3/15 challenged 
o ra l ly  became infected [110]. The majority of cats exposed 
to FCoV by natural routes are resistant to infection [111, 
116].
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I f  primary infection of FCoV were lim ited to the URT or GIT, 
local immunity might in h ib it  systemic spread of virus [85,
153].
There are several reasons fo r believing that once FCoV has le f t  
the GIT, recovery is cell-mediated [27, 88, 159].
1. The humoral immune response is not protective. Transfer of 
hyperimmune serum from an immune individual to a susceptible 
cat results in enhanced disease in the recipient [104, 112, 
113, 114, 141].
2. Non-effusive FCoVV resembles tuberculosis and deep mycotic 
infections and the immunity to these infections involves mainly 
ce llu la r  mechanisms [104, 114].
3. The incidence of FCoVV can be increased by concurrent 
infection with FeLV. This effect may be due to suppression of 
cell mediated immunity and T cell mediated humoral immunity by 
FeLV [114]. FCoV reached peritoneal macrophages more commonly 
in thymectomized kittens compared with control kittens where i t  
was more commonly found in enterocytes suggesting that T ce lls  
have a role in local protection against FCoV. I t  has been 
suggested that FCoV impairs the function of T ce lls  [50]. 
Thus, following inoculation with FCoV the response of T ce lls  
to the mitogen concanavalin A was profoundly reduced and only 
recovered to pre-inoculation levels in cats which survived 
infection [141].
4. Healthy ca rr ie r cats carry FCoV as a latent or sequestered 
infection which can be reactivated by infection with FeLV. A 
carrie r state of th is  type is common in microbial infections 
where cell mediated immunity (CMI) is known to be the primary 
protective mechanism [114]. Immunity may depend on v ira l 
persistence in the body and be lost when virus is los t [107].
5. In aerosol infection with FCoV early v ira l rep lica tion was
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associated h is to log ica lly  with hyperplasia of the 
reticuloendothelial and lymphoid ce lls  in T-dependent areas of
regional lymph nodes. Pro life ration of mononuclear ce lls  in
these areas is consistent with early stimulation of CMI [158].
6 . Transfer of T ce lls  from suckling heterozygous mice (which 
are less susceptible to FIPV) to nude mice (which are very 
susceptible to FIPV) protected the la t te r  [145].
Experimentally, i t  has been d i f f i c u l t  to demonstrate CMI. In
one experiment only 4 of 8 immune cats showed delayed-type
hypersensitiv ity reactions when FCoV antigen was injected into 
the th ird  eyelid [114]. Weiss and Cox demonstrated strong 
delayed-type hypersensitiv ity response in the skin of a cat 
which was immune to FCoV and none in a cat which succumbed 
[159]. Only 2 cats which survived longest and 4 of 17 in
another experiment showed a specific lymphocyte blastogenesis 
to FCoV antigen [114, 141].
Persistent IgM production may protect cats from developing 
FCoVV. A suggested mechanism is that IgM competes with IgG fo r 
virus, since IgM does not opsonise antigen fo r macrophage 
uptake, less virus would be phagocytosed and therefore be able 
to replicate in macrophages [82].
1.5 C lin ic a l signs
The majority of FCoV infections are asymptomatic. Most cats 
natura lly exposed to FCoV develop antibodies without showing 
c l in ica l signs and less than 5% of infected animals succumb to 
the disease [57, 102, 105, 106, 111, 155, 156].
Pedersen has suggested that the form of FCoVV which follows
v ira l dissemination depends on the type of immunity which
develops: humoral immunity and strong CMI can lead to recovery
or la tent infection [113]. I f  cats with la tent in fection 
become immunosuppressed, reactivation of the virus occurs and 
effusive or non-effusive FCoVV ensues. Cats with humoral
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immunity and partia l CMI develop non-effusive FCoVV and cats 
with humoral immune response and no CMI develop effusive FCoVV. 
[104, 113].
1 .5 .1  Feline en te ric  coronavirus
FECV causes mild to moderately severe e n te r it is  lasting 2-5 
days [126] in SPF kittens 5-12 weeks old [103, 110, 111, 114].
I t  is rare ly fa ta l [96, 103, 114]. In SPF kittens 12 weeks of 
age FECV infection causes mild to inapparent signs and adult 
cats show no signs of infection [96, 103].
Pyrexia occurs 3-10 days p . i .  and lasts 2-5 days. Diarrhoea 
and vomiting occur jus t p r io r to fever. Vomiting precedes 
diarrhoea by 12-48 hours. The kitten becomes anorexic and dull 
during and a fte r the diarrhoea and there may be mucus and blood 
in the faeces. Diarrhoea lasts 48-96 hours. Some kittens 
become dehydrated [103, 111, 113].
In an adolescent cat with naturally occurring disease there was 
mesenteric lymphadenopathy, gross oedema of the bowel and 
mucus-laden diarrhoea [103].
Cats experimentally infected with FECV which eliminated the 
virus were observed fo r 3-24 months and did not develop FCoVV 
[103, 111].
Cats inoculated i /p  with a strain of FECV remained a febrile  and 
became seropositive 7 days p . i .  However, by the th ird  passage 
of th is  virus in vivo one of two kittens became very i l l  and 
fe b r i le  and virus was found in the mesenteric lymph node [114]. 
Cats inoculated with the Bristol stra in of FECV developed FCoVV 
[33].
1 .5 .2  C lin ic a l signs o f FCoVV
In most cases (over 75% [153]) the in i t ia l  infection is 
asymptomatic or signs are subclinical [9, 11, 102, 106, 114,
126, 153]. The primary signs of FCoV infection tend to be mild
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enteric [27, 28, 85, 110, 126, 140] or upper respiratory signs 
characterised by s ligh t ocular and or nasal discharge which 
persists fo r 1-4 weeks and occurs weeks to years before the 
onset of c l in ic a l signs of FCoVV [85, 110, 126, 153, 156, 157]. 
These signs occur throughout an affected cattery and not only 
in those cats which develop FCoVV [140].
The c l in ica l signs common to almost a l l  cases of FCoVV are 
chronic, fluctuating pyrexia [8 , 28, 29, 42, 57, 95, 97, 104,
106, 116, 126], anorexia [8 , 27, 28, 42, 95, 97, 104, 106,
116, 126], weakness or listlessness [28, 29, 42, 57, 95, 97,
104], and weight loss [27, 29, 42, 57, 71, 95, 104, 106, 116,
126]. Some cats are bright and with good appetite in the early 
stages of c l in ica l signs [78, 104].
In experimental infections pyrexia occurred at the same time 
as the appearance of antibodies, 7-10 days p . i .  when virus was 
inoculated i /p  [109, 110, 156] and 8-20 days a fte r
intratracheal inoculation. Following oral infection fever 
occurred 20-75 days a fter the f i r s t  dose of virus and FCoVV 
occurred 2-6 weeks la te r  [109, 110]. Antibody levels increased 
throughout the course of the disease [110, 111]. Seropositive 
kittens develop fever 24-48 hours p . i .  [109, 156].
Abdominal distension maybe present [27, 29, 104, 106, 156]
due to ascites [28, 57, 95, 97, 104, 126]. P leu r it is  occurs 
in about 40% of effusive cases leading to pleural effusions 
[106, 126] and dyspnoea [57, 104, 106].
Diarrhoea has been reported in cases of FCoVV [97]. FCoV was 
recovered from a 1.5 year old cat with fa ta l e n te r i t is  [85] and 
diarrhoea was observed in te rm itten tly  over a period of 10 
months in cheetahs which went on to die of FCoVV [27]. Certain 
FIPV isolates causing only diarrhoea have been reported [27, 
48].
In experimental in tragastr ic  infections, diarrhoea with blood
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was sometimes seen 2-3 days p . i .  [140]. Certain strains of 
FIPV are capable of producing FCoVV or e n te r it is  or both [9, 
48, 49, 50, 51, 67]. Vomiting sometimes occurs [77, 85, 97].
There is usually no pain on abdominal palpation [57, 97]. The 
mesenteric lymph nodes may be palpable [126] and the kidneys 
may feel irregu lar [104].
Clin ical signs in dry FCoVV depend on which organs are 
affected. Lesions are found in the peritoneal cavity of 50% 
of cats with non-effusive FCoVV and in the pleural cavity of 
10%. Unlike effusive FCoVV, there is a high incidence (33%) of 
ocular and CNS signs [106].
Ocular signs are common [57, 126] and include uveitis  [97, 
104, 106, 114]; precip ita tion of ce llu la r  debris in the
internal face of the cornea [97] causing punctate corneal 
opacities [28, 104] (in a case of wet FCoVV); hyphema [28,
104]; one pupil constricted more than the other [28]; 
haemorrhage on retina [28]; sheathing of the retina l blood 
vessels [104]; c h o r io re t in it is  [106] and nystagmus [78, 106].
CNS and cerebellar-vestibular signs have been reported in 35% 
of non-effusive and 10% of effusive cases [8 , 95, 126]. These 
include convulsive disorders [88, 104, 106]; inco-ordination
[78, 104, 106, 111, 116]; ataxia [116]; posterior paresis [8 ,
104, 106, 116]; head t i l t  [8 , 88, 106]; c irc l in g  [88, 106];
hyperaesthesia [104, 106, 116]; dementia, personality changes 
(rage, withdrawal) [88, 104, 106]; and brachial, trigeminal, 
facia l and sc ia tic  nerve palsies [104]. Hydrocephalus 
secondary to disease of choroid and ependyma has also been 
reported [8 , 78, 88, 104, 106].
Jaundice [95, 97, 104, 111, 116]; dehydration [97, 116];
o rch it is  [95, 104, 116]; and rough hair coat [126] have also 
been attributed to FCoVV.
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Six cases of colonic granulomatous FCoVV were reported which 
presented as weight loss, constipation, vomiting and palpable 
abdominal masses, la te r  shown to be colon. Contrast 
radiographs showed narrowing of the lumen of the intestine in 
the descending colon [147].
In cheetahs, erosions around the nos tr i ls  and l ip s ,  and 
depigmented areas above the incisors as a result of ulcerative 
g lo ss it is  were also reported [27].
1 .5 .3  Prognosis
In natural infections of the effusive kind, death ensues 
approximately 1-6 weeks a fte r the onset of c l in ic a l signs [29, 
97, 106, 116] but can occur up to and sometimes beyond three
months [28, 87, 95]. In non-effusive FCoVV, the course is 1-12 
weeks but can be more protracted on occasion [106].
In experimental infections death is often much more rapid, 
charac te r is t ica lly  15-20 days p . i .  [42, 109] especially i f  the 
cats are seropositive, when c l in ica l signs can appear 36-48 
hours p . i .  and death may ensue in 5-7 days [109].
In the l i te ra tu re ,  there are a few accounts of experimentally 
infected cats which developed c lin ica l signs and recovered [42, 
114].
1.6 Pathology
1 .6 .1  Gross pathology
There is no clear-cut d is t inc tion  between effusive and non- 
effusive forms of FCoVV. Parenchymal lesions can occur . in 
effusive FCoVV and a small quantity of f lu id  can occur in non- 
effusive FCoVV [57, 95]. For example, a laboratory k itten  
which showed CNS signs had fibrinous plaques on the surface of 
i ts  spleen and l iv e r  indicating that the cat had undergone an 
ea r l ie r  bout of p e r i to n it is  [ 111] .
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The characteristic lesions of effusive FCoVV are 0.5-3mm grey- 
white foci containing f ib r in .  Lesions may be found on the 
visceral and parietal peritoneum, pleura, pericardium, 
mesentery, omentum, on the diaphragm, and within lungs, thymus, 
l iv e r ,  germinal fo l l ic le s  of spleen, kidneys, pancreas, and 
abdominal and thoracic lymph nodes [42, 45, 49, 51, 57, 104,
116, 156, 158].
The characteristic lesion of non-effusive FCoVV usually 
consists of irregu lar so lita ry  or multiple granulomas, which 
are most commonly within the kidneys, but may occur in any 
organ [104, 106, 116].
Ascites
The ascites in effusive FCoVV is variously described as clear, 
yellowish, l ig h t  amber or straw coloured [9, 57, 104, 106, 116, 
126, 143, 156] and in quantities varying from a few ml [158]
to 500 ml in experimental cases [143] and less than 100ml to 
2,500ml in natural cases [42, 97, 116]. I t  is viscous [106] 
and characte ris t ica lly  clots on exposure to a ir  [42, 57, 97,
116, 128, 143]. Up to 20 mis of s im ilar f lu id  may occur in the 
thoracic cavity [116, 143] in 20% of cases [97].
There may be fibrinous adhesions between organs [95, 105]. The 
omentum is often thickened and oedematous [45, 106, 116].
Alimentary trac t
In experimental infections with FIPV, the SI and LI showed 
oedematous thickening of e ither anaemic or hyperaemic mucosa 
with watery or mucous content [48, 49]. In FECV, there was 
gross oedema of the bowel [103]. The colon and sometimes 
terminal ileum and caecum can be thickened, firm and f ib ro t ic  • 
due to granulomatous lesions of FCoVV. This condition can 
occur with or without FCoVV involvement of other organs [147].
Kidney
In the non-effusive form, lesions occur most frequently in the
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kidneys and consist of grey-white raised nodules 2mm-5cm in 
diameter, or opaque streaks scattered over the cortica l surface 
and extending into the cortex. In advanced cases, the nodules 
become confluent and replace large segments of the renal
parenchyma [28, 57, 87, 106, 116].
Brain
Grossly, lesions in the brain and spinal cord may be v i r tu a l ly  
absent in cats which show CNS signs. When found, lesions may 
be small (l-5mm) yellow-gray nodules and plaques most commonly 
on the ependyma and choroid plexus of the la te ra l and fourth 
ventric les, meninges and ventral surface of the spinal cord 
[78, 87, 116]. The aqueduct and fourth ventric le  may be f i l l e d  
with th ick, grey, opaque material. S light roughening and 
brownish discoloration approximately a mm deep of the 
ventricu lar surfaces may occur [8 , 78]. Hydrocephalus with 
d ila ta t ion  o f the la tera l ventric les, cerebral aqueduct and 
fourth ventric le  and th in cerebral cortex has been reported
[78, 116].
1 .6 .2  Histopathology
The characteristic lesion of FCoVV is a necrotising ph leb it is  
or perivascu lit is  of smaller veins, arteries and lymphatic 
vessels [45, 57, 87, 109, 126, 151, 155, 156]. The lesion is
characterised by a central focus of necrosis surrounded by a
perivascular in f i l t r a t io n  of mononuclear ce lls , p ro l ife ra t ing  
macrophages and lymphocytes, plasma ce lls  and neutrophils [28, 
45, 49, 156, 158]. Endothelial and subintimal mesenchymal
p ro l ife ra t ion  was also reported in a f ie ld  case [28]. Fibrin 
and prote in-rich f lu id  are deposited within and around the 
lesions [106]. Many of the vessels contain fibrinous thrombi 
[87, 156].
The lesions of non-effusive FCoVV are more granulomatous in 
nature. The outer zone is more fibrous and the numbers of 
plasma ce lls , lymphocytes and histiocytes are much greater. 
Oedema, hyperaemia and f ib r in  and protein exudation are not as
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pronounced as in effusive FCoVV [78, 87, 106, 113].
Serosae
The surface of the omentum, mesentery, peritoneum, abdominal 
organs and sometimes the pleura are covered with a greyish- 
white fibrinous deposit with a diffuse or focal in f i l t r a t io n  of 
lymphocytes, plasma ce lls , h istiocytes, macrophages, 
neutrophils and ce llu la r  debris [27, 42, 45, 97, 116, 143].
Sometimes the inflammatory lesion extends into underlying 
tissues along penetrating blood vessels [106].
In natura lly occurring FCoVV, EM of omentum and ce lls  spun out 
of asc it ic  f lu id  can occasionally reveal CoV partic les in the 
peritoneal macrophages and mesothelial l in ing  ce lls  [45].
Kidney
In the kidney, there is subcapsular d is tr ibu t ion  of nodular 
lesions and th e ir  orientation is around superfic ia l veins
[155]. IgG and C3 precipitated in the glomeruli cause
nephritis [47, 49, 70, 71].
Alimentary trac t
The enteric lesions of FIPV are degeneration, desquamation and 
hyperplasia of the ep ithe lia l ce lls and oedematous tunica
propria with some in f i l t r a t io n  of neutrophils and mononuclear
ce lls . Fusion of the ep ithe lia l ce lls  is frequent. In a few
cases, the deep mucosa and tunica muscularis of the SI and LI
had remarkable ce llu la r  in f i l t r a t io n  of lymphocytes, plasma
cells  and neutrophils [27, 48,. 51]. The v i l l i  of the SI are 
shortened and fused to one another [48, 143]. Peyer's patches 
are atrophied [48]. In the colonic form, granulomatous lesions 
originate in the deep layers of the colon, perhaps the serosa, 
and extend transmurally [147]. In natural infections of 
cheetahs, superficial gastric erosion was found in some animals 
[27].
In FECV infection, the target tissue is the mature apical
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columnar epithelium of the in testina l v i l l i  from the mid­
duodenum to terminal ileum and caecum. Fusion of adjacent 
ep ithe lia l ce lls  in the t ips  of the v i l l i ,  fusion of the v i l l i ,  
sloughing of the t ips  of the v i l l i  and v il lous  atrophy occur in 
severe cases [103, 111].
Lymphoid tissue
In experimental oropharyngeal in fection, the mandibular and 
mesenteric lymph nodes show diffuse and focal expansion of 
lymphoid tissue, congestion, oedema and in f i l t r a t io n  by 
inflammatory ce lls  [143]. In experimental aerosol infection of 
seronegative kittens, the in i t ia l  paracortical hyperplasia is 
followed by fo l l ic u la r  hyperplasia and formation of germinal 
centres which may indicate a specific primary humoral immune 
response. In seropositive k ittens, lymphoid depletion and 
severe necrosis develops rapidly in regional lymph nodes [158]. 
Fo ll icu la r  hyperplasia [147, 156] or depletion [156] have been 
noted by other authors. In natural infections, gross lymph 
node involvement is usually lim ited to the thoracic and 
abdominal lymph nodes [106].
The mesenteric lymph nodes showed sinus catarrh with 
accumulation of lymphocytes, plasma ce lls , polymorphonuclear 
neutrophils, ce llu la r  debris and histiocytes as well as nodular 
hyperplasia of macrophages, some of which contained 
erythrocytes [42, 48, 51, 87, 97, 156, 158]. In non-effusive 
FCoVV there may be nodular lesions in the mesenteric lymph 
nodes. Peyer's patches may be hypertrophied [28].
Splenic enlargement may be due to h is t io cy t ic  and plasmacytic 
in f i l t r a t io n  of the red pulp [51, 106], hyperplasia of the 
lymphoid elements of the white pulp [28, 87, 106, 156],
necrotising sp len it is  with f ib r in  deposition and neutrophil 
ce ll in f i l t r a te s  or by a more organised pyogranulomatous 
reaction [106, 156]. Other accounts found the fo l l ic le s  of the 
lymph nodes and spleen were atrophied [27, 48].
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Slight neutrophil ce ll in f i l t r a t io n  of tons ils  occurred 1-14 
days p . i .  Neutrophils and macrophages were present in the 
tons ils  and epithelium and in the surface exudate of 
inflammatory ce lls  and f ib r in .  By the time the cats showed 
c l in ica l signs, there were no longer histological changes 
present in the to n s i l ,  though there were s t i l l  changes in the 
mandibular lymph node [48, 143].
Eye
Lesions in the eyes [42] consist of focal to diffuse 
collections of macrophages, neutrophils and f ib r in  in the i r i s ,  
c i l ia r y  body, c i l ia r y  processes and anterior chamber [8 , 87,
116, 158]. Oedema and small aggregates of ce lls  were present 
in the retina. The anterior chamber may contain clumps of 
ce lls , some adhering to the corneal endothelium and forming 
keratic precipitates [28, 116]. Corneal oedema may occur [116]. 
Focal and diffuse pyogranulomatous inflammation of meninges and 
optic nerve have been recorded [8 , 87].
Brain
As many as 63% of spontaneous cases of FCoVV have 
neuropathological lesions though fewer present with 
neurological signs [8] .
The pattern of inflammation of the brain characteristic  fo r  
FCoVV is also seen in the encephalitides of equine infectious 
anaemia and visna in sheep. Since a ll three disorders are 
believed to be immunologically-mediated, th e ir  common patterns 
probably re f lec t zones of the CNS prone to IC and/or ce ll 
mediated in ju ry  [8] .  Another possible cause of neurological 
signs in FCoVV is ischaemic encephalopathy secondary to the 
vascu lit is  [88] .
In the choroid plexus, ependyma of the fourth ventric le  and 
meninges of the brain stem, leptomeninges, eighth cranial 
nerve, medulla oblongata, cerebellar peduncles and cerebellar 
white matter and pons there may be perivascular cuffing by
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mononuclear ce lls , neutrophils, f ib r in  and necrotic debris [8 , 
28, 42, 78, 155, 158]. Reactive astrocytes with enlarged
vesicular nuclei occur under the region of mononuclear cell 
in f i l t r a t io n  [8] .
The fourth ventric le  contains eosinophilic, proteinaceous 
exudate with a few macrophages, neutrophils, lymphocytes, 
plasma ce lls  and ce llu la r  debris. Blockage of the normal flow 
of CSF may result in secondary hydrocephalus [8 , 78, 88] .
Bone marrow
Bone marrow showed an increased number of megakaryocytes and 
immature myeloid elements but decreased erythropoeitic ce lls  
[28, 85, 87].
1.7 Biochemistry
Biochemical tests are useful anc illa ry  tools in the diagnosis 
of FCoVV. The most useful parameter is the serum 
albumin.-globulin (A:G) ra tio  which is usually low in cases of 
FCoVV (<0.6) [28, 42, 155].
CSF and aqueous humour in cats with CNS signs show a s im ila r 
increase in protein as in the serum, unless the disease is 
localised in the subependymal area [78, 88, 104, 106, 116,
155]. Creatinine phosphokinase does not normally cross the 
blood-brain barrier; so i ts  presence in the CSF re flec ts  e ither 
vascular leakage or destruction of CNS tissue, in one case of 
FCoVV i t  was 46 SU/ml, (normal is less than 1 SU/ml) [78].
Urine may be changed in cases of FCoVV. For example, protein 
may be present, depending on urinary tra c t lesions. However 
these changes are not consistent enough to aid diagnosis [28, 
79, 104, 116].
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1 .7 .1  Serum
Measurement of serum proteins in FCoVV is a useful adjunct to 
diagnosis. However caution must be advised in in terpreting 
serum proteins of the cat because there is a wide variation in 
normal values [42] depending on age, sex, d ie t, stress and 
method of analysis. With age, albumin levels decrease whereas 
globulin concentration increases [92].
In FCoVV to ta l proteins are raised to over 78 g/1 in 55% of 
effusive cases and 70% non-effusive [8 , 57, 78, 79, 95, 96,
104, 106, 126, 155, 156]. This is caused by a variable
increase in gamma-1 (IgGl) gamma-2 (IgG2) [9, 155] alpha-2,
beta and gamma globulins [ 8 , 42, 104, 106, 155] but not IgA or 
IgM [42]. (Alpha-2 globulins are fibrinogen or haptoglobin and 
beta-1 globulin is trans fe rr in ) .  Haptoglobin increases in
intravascular haemolysis, non-specific in ju ry  and inflammation 
and is raised in the serum of cats with FCoVV [44].
A polyclonal hypergammaglobulinaemia is frequently reported in 
c l in ica l cases of FCoVV [12, 28, 42, 79, 95, 97, 116, 156] with 
globulin levels of over 46g/l [155]. I t  is not known i f  th is  
polyclonal gammopathy is specific fo r FCoV [57, 155],
In experimental infections, gamma globulins showed a smooth
polyclonal increase over the period of testing [142].
Cats with experimental FCoV infection exhib it a biphasic acute 
phase protein response. Orosomucoid, haptoglobin and a beta-2 
protein which may be transferrin  rose s l ig h t ly  the day a fte r 
inoculation with FIPV then showed a large negative response 
before gradually returning to normal levels term inally. Two 
other bands in the alpha-2 region showed a sim ilar biphasic 
response, these corresponded to ceruloplasmin and alpha-2
macroglobulin of humans, although these proteins are not yet
iden tif ied  in the cat [142].
These acute phase proteins are not associated with immune
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complex deposition. However, in experimental FCoVV C3 shows a 
small r ise i n i t i a l l y ,  followed by a drop which rose again about 
7 days before death, when there was a further fa l l  [71] which 
mirrors the acute phase protein response [142].
Acute phase proteins are largely induced by the action of 
macrophage-derived cytokines (IL-1, TNF, possibly IFNs) on 
hepatocytes and the pro files  seen may result from the 
involvement of the macrophage in the pathogenesis of FCoVV. 
The in i t ia l  increase may result from cytokine release by v irus- 
infected ce lls  and the negative response may be due to 
depletion of functional phagocytic ce lls  as demonstrated by 
suppression of clearance of ^ I - l a b e l le d  polyvinyl pyrollidone 
in FCoV infected cats. The terminal r ise may also be 
associated with inflammation seen in la te r  stages of disease or 
DIC [142]. However, i t  has been shown that FIPV triggers 
release of IL-1 from peritoneal exudate ce lls  [36, 40] and
alveolar macrophages [37]. A lternative ly , the cytokine 
involved may be IL -6 which induces positive and negative phase 
protein responses [52]. IL -6 is found in the sera and ascites 
of cats with naturally occurring FCoVV but not in healthy cat 
sera [38].
I t  has been suggested that a biphasic acute phase protein 
response is unique to FCoV infection but i t  has no practical 
application because changes occur before s ign if ican t c l in ic a l 
signs appear and a surviving cat showed a s im ilar response to 
those which succumbed to FCoVV [142].
Bleeding time, prothrombin time and partia l thromboplastin 
times are a l l  increased where there is DIC [81, 104, 106, 154,
155]. Also, depression of coagulation factors 7, 8 , 9, 11 and 
12, elevated fib r in -f ib r inogen  degradation products, and 
thrombocytopaenia are associated with DIC in infected cats 
[154, 155]. Serum fibrinogen is raised [81, 95, 104] in 45% of 
cases [155]. Fibrinogen rises as early as 8 days p . i .  in serum 
and plasma [42].
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In experimental infections C3 levels became elevated, reaching 
peak values 7 days before death, then decreased as levels of 
c ircu la ting  ICs and anti-FCoV antibodies increased [71, 95,
156].
Liver damage due to FCoVV lesions may result in raised l iv e r  
enzymes, serum glutamic-pyruvic transaminase; serum glutamic- 
oxaloacetic transaminase and sorbitol dehydrogenase and in 
raised b i l i ru b in  [57, 81, 95, 104, 126, 155, 156].
Renal damage may result in raised blood urea or creatinine [28, 
81, 95, 155].
Lesions may involve the pancreas causing a pancreatitis , 
increased serum lipase and possibly amylase. Diabetes mellitus 
secondary to FCoVV has been reported [155].
1 .7 .2  Ascites
The ascites in cases of FCoVV is an exudate, not a transudate. 
I t  is l ig h t  amber or straw coloured [57, 106, 126] and often 
contains f ib r in  tags [42, 57, 95]. The coagulation on exposure 
to a ir  operates in 2 stages: the f i r s t  is fibrinogen to f ib r in  
and the second is slower, independent of the action of the 
usual anticoagulants and depends on factors destroyed a fte r a 
period of 16 hours at 56°C. Differences in the extent of 
coagulation of ascites depends on the temperature at which i t  
is stored: those frozen to -20°C were to ta l ly  coagulated, those 
stored at 4°C contained a large c lo t,  at 20-37°C there were 
small clots and at 56°C ascites was cloudy without coagulation 
[42].
Proteins in ascites are raised though less [42] or more [116] 
in quantity than those of serum. Protein measurement of 
pleural or peritoneal effusions from cats is useful in 
establishing or ru ling out a diagnosis of FCoVV. Effusions 
from a series of 12 cases of FCoVV were compared with 47
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effusions due to other diseases. I f  gamma globulins 
represented over 32% of to ta l protein then the animal was 
l ik e ly  to be suffering from FCoVV. I f  gamma globulins were 
less than 32%, or i f  albumin was over 48%, or the A:G ra tio  was 
over 0.81, then the animal was unlikely to have FCoVV [128].
Ascites or pleural effusions from FCoVV cases typ ica l ly  have 
high to ta l protein, in the range 45-80g/l [28, 57, 79, 81, 95,
104, 106, 116, 128, 155] due to i ts  high gamma globulin content 
[28, 79, 95, 116]. This property (along with cytology and
serology) serves to distinguish FCoVV from CCF, hepatic disease 
or neoplasia [79] though does not help to distinguish i t  from 
lymphocytic cholangitis.
IL -6 is produced by peritoneal exudate ce lls  in natura lly 
occurring cases of FCoVV. More IL-6 is found in ascites than 
sera. No IL -6 was found in healthy cat sera. Asc itic  IL -6 was 
inversely correlated to serum albumin:globulin ra tio  [38]. IL- 
6 regulates the acute phase response of the l iv e r  [38, 52].
IL -6 in ascites may leak into the systemic c ircu la tion  and be 
linked to systemic alterations such as pyrexia, enhanced 
synthesis of immunoglobulin and acute phase proteins [38].
Ascites in cases of FCoVV has high specific gravity (1.017- 
1.047g/l) [9, 28, 57, 81, 95, 155] and is always s te r i le  [28,
79, 155].
Haptoglobin values are less in ascites than in serum and 
therefore are not useful in diagnosis [44].
1.8  Cytology
1 .8 .1  Haematology
Haematological changes are variable and not diagnostic of FCoVV 
in themselves [155]. Leucocytosis is the most commonly 
reported change [42, 57, 78, 79, 81, 95, 96, 97, 104, 106, 116, 
155] and occurs shortly a fter the onset of fever [42].
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Occasionally, a leukopaenia has been reported [57, 79]
especially in experimental cats [155]. In kittens
experimentally infected with a strain of FECV white blood cell 
counts dropped to less than 50% of normal at the onset of fever 
and diarrhoea, due to a fa l l  in neutrophil count [103, 111].
The neutropaenia persisted fo r the period that diarrhoea was
present.
Neutrophilia [42, 81, 85, 97, 104, 106, 116, 155] of up to 90% 
[42, 79] or over [97] occurs, with a s h i f t . to  the le f t  [57, 78, 
79, 155]. Inclusion bodies have been seen in the c ircu la ting
neutrophils of some cats with FCoVV which may be immune
complexes [106] or Dohle bodies [28].
Lymphopaenia [42, 81, 85, 96, 97, 104, 106, 116, 155] and
eosinopaenia [42, 57, 97] may occur.
Red blood cell counts are variable. Mild anaemia may occur
[28, . 42, 79, 81, 97, 106, 116, 155] and is normocytic and
normochromic [57, 95]. A lternative ly, the red blood cell count 
may remain unchanged [42, 79]. Thrombocytopaenia is associated 
with DIC [154, 155, 156].
1 .8 .2  Ascites
Ascites contains a high number of wbc (1,600 - 25,000 wbc per 
m icro litre ) [104, 106] consisting of neutrophils [79, 96, 116, 
155], lymphocytes [116], macrophages, plasma ce lls , f ib rob lasts 
[79] and mesothelial ce lls [28, 106, 155]. I t  may also contain 
erythrocytes [28]. Cats in the acute stage of FCoVV have a 
high ra tio  of neutrophils to mononuclear ce lls , whereas more 
chronic cases have increased numbers of macrophages, 
lymphocytes, plasma ce lls  and mesothelial ce lls  [155]. 
Cytology of abdominal or thoracic f lu ids  shows an inflammatory 
disease process which can be useful in eliminating d if fe re n t ia l  
diagnoses of abdominal tumour [24].
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1 .8 .3  CSF
CSF and aqueous humour in cats that show CNS signs or ocular 
signs contain 90-9250 ce lls , mostly neutrophils, per m ic ro litre  
[78, 88, 104, 106, 116, 155].
1.9 Diagnosis
D efin it ive  diagnosis of FCoVV can only be made by 
histopathology of a biopsy or post mortem sample [9, 78, 126,
155]. Most c l in ica l diagnoses at present re ly  on evaluation of 
h istory, presenting signs and results of serology, biochemical 
and haematological tests [9 ].
FCoV i t s e l f  is notoriously d i f f i c u l t  to isolate from f ie ld  
cases [26, 96, 114].
1 .9 .1  In d ire c t immunofluorescent assay
FCoV-infected cell culture or tissue sections from cats with
FCoVV are reacted with d iffe ren t d ilu tions of test serum or
ascites. A fter incubation and washing, an a n t i- fe l in e  IgG 
conjugated to fluorescein isothiocyanate (FITC) is applied [5, 
10, 26, 66, 67, 102, 114, 141, 155, 157]. Tissue sections
used are # commonly l iv e r  [80, 102, 109] or FCoV infected
suckling mouse brain [50].
Occasionally TGEV [5, 26, 56, 57, 66, 94, 155] or CCV [27, 85,
155] is used instead of FCoV. Antibody t i t re s  obtained from 
heterologous IFA may be lower than with homologous virus [26, 
66, 94]. Reactions with H229E are generally weak and not
acceptable fo r diagnostic purposes [5 ].
IF has also been used to locate v ira l antigen in s itu  [106, 
156, 158] using rabbit anti-FIPV or canine anti-CCV sera [85].
1 .9 .2  ELISA
Purified FIPV, FECV, or TGEV is attached to a 96 well plate, 
the serum to be tested is added, then anti-cat IgG conjugated
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to an enzyme is added to each well [ 66, 67, 82].
Kinetics-based ELISA (KELA) d if fe rs  from conventional ELISA by 
giving values which can be converted to an antibody t i t r e  [ 12] .
A competition ELISA fo r the detection of immune complexes has 
recently been developed by SmithKline Beecham but is reported 
not to compare well with IF [124].
1 .9 .3  Virus n e u tra liza tio n
VN is determined by a plaque reduction test. Dilutions of test 
sera are mixed with virus suspension fo r one hour at 37°C then 
are inoculated onto confluent cell culture. FCoV is usually 
used but TGEV may be employed [94, 119]. An agar overlay is 
applied a fte r a period of adsorption and the plates are 
incubated un ti l  plaque formation occurs. Titres are expressed 
as the serum d ilu t ion  which inh ib its  a proportion of plaques 
[4, 66, 85, 141, 164]. T itres as high as over 40,000 have been 
reported in f ie ld  cases [57].
VN may be more sensitive than IFA or ELISA [82] fo r detection 
of an early response to FCoV infection. However, 17/89 serum 
samples positive by ELISA and IF fo r anti-FCoV antibodies were 
negative by VN. Most of the antibody a c t iv i ty  of these samples 
was directed against M and N rather than S [ 66].
1 .9 .4  Uses o f serological tests
There are several ways in which serological tests are useful in 
FCoV in fection.
1. As an aid to diagnosis: presence of anti-FCoV antibodies 
w i l l  not diagnose FCoVV, but a negative test w i l l  usually rule 
i t  out [9, 12, 104, 153, 155]. Cats with FCoVV generally have 
high IFA antibody t i t re s ,  even over 25,000 [8 , 9, 12, 26, 27,
57, 67, 94, 102, 106, 153, 155, 158]. Cats with effusive FCoVV 
had t i t re s  of 1:400-1:25,600, cats with non-effusive FCoVV had 
t i t re s  of 1:1,600-1:25,600 [102]. I t  has been claimed that
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t i t re s  of over 1:1600 are uncommon in cats infected with FECV 
but common in FIP [104, 111]. However, cats with FIP have been 
reported to have lower t i t re s  [134].
2. Screening of catteries fo r exposure to FCoV [9, 153, 155].
3. Screening new cats fo r entry into seronegative catteries 
[9, 153]. Cats should be isolated and retested 2 weeks la te r  
[153].
4. Prognosis: serology can be used to monitor exposure to FCoV 
. and a prognosis can be made depending on how elevated the
antibody t i t r e  becomes [27]. A precipitous rise in t i t r e  may 
mean a poor prognosis fo r the cat [153]. The antibody levels 
of 2 cats with non-effusive FCoVV monitored over a 14 week 
period rose 30-100 fold [102]. However, there may be a 
decrease in antibody t i t r e ,  especially in the terminal stages 
of disease [126]. Prolonged elevated t i t r e  suggests possible 
v ira l persistence in ca rrie r animals [ 12] though some animals 
which go on to die have persistently high t i t re s  fo r a long 
time before developing il lness.
5. Monitoring treatment [155].
1 .9 .5  L im itations o f serological tes ts
I t  should be appreciated that there are several l im ita t ions  in 
the use of serological tests.
1. The in a b i l i ty  to distinguish v iru len t, vasculitis-causing 
infections from asymptomatic or enteritis-causing FCoVs, CCV or 
TGEV infection [9, 11, 23, 66, 82, 96, 104, 105, 111, 126,
133]. Antibody to TGE could be detected by IF only a fte r
parenteral hyperimmunisation [56]. Cross-reactivity with HCV 
229E is not a problem [11].
2. The presence of antibodies in both diseased and healthy
animals renders diagnosis of FIP and prediction of prognosis
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d i f f i c u l t  [3, 7, 9, 11, 12, 80, 95, 96, 101, 103, 105, 106,
133, 153, 155].
3. FCoVV cases may have low antibody or no detectable antibody 
[9, 104, 126].
Five explanations have been offered fo r th is :
a. the cat is moribund. Antibody sometimes disappears from 
the c ircu la tion  during the terminal stages of disease 
[9, 94, 102]
b. extensive immune complexing means there is l i t t l e  free, 
unbound antibody available to be detected [9, 126]
c. peracute disease process where there is a sluggish 
antibody response (e.g. in young kittens) which is harder 
to detect, especially i f  the test uses heterologous 
virus [9, 94, 155]
d. wrong diagnosis [155]
e. more than one serotype of FCoV [126]. In examining 
fe line  f ie ld  sera against FCoV and CCV, those cats which 
were positive against one isolate and negative against 
another were the cats with lower t i t re s  [82].
4. Cats with other diseases which may appear l ik e  a 
manifestation of FCoVV may coincidentally have FCoV antibodies 
[9, 11, 155].
5. The presence of antibody does not indicate immune status 
because the cats which develop FCoVV are also seropositive [9 ].
6 . There is a lack of correlation between presence of 
antibodies with virus excretion though i t  is possible that 
cats with lower antibody t i t re s  excrete less virus than those 
with higher t i t re s  [110, 153]. The tests should never be used 
in a test and removal programme [9].
7. Non-specific reactions: cats may develop antibody against 
bovine serum components that may be present in vaccine 
preparations. Bovine serum is used in cell cultures as a
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nutrient fo r  growing both vaccine virus and the antigen used in 
serological tests [ 6 , 9, 10, 12, 29, 126]. As many as 6% of 
a l l  sera tested in one laboratory had increased background [ 10, 
12]. This re a c t iv i ty  usually lasts up to 3 months [ 6, 10, 12]
but can be persistent in some cats with no history of recent 
vaccination. This finding suggests that persistent antigen 
stimulates antibody-producing ce lls , perhaps by frequent 
comsumption of bovine products, milk or beef [ 10] .
1.10 Treatment
By the time c l in ica l signs appear, treatment is generally of 
l i t t l e  value and the course of the disease is almost invariably 
fa ta l [104, 116, 126, 138, 155]. Treatment is aimed at
modifying the immune response. Use of immunosuppressive and 
antineoplastic drugs such as cyclophosphamide, phenylalanine 
mustard and azathioprine have produced only temporary remission 
and have had unpleasant side effects [104, 153]. Large doses 
of corticosteroids, usually prednisolone, are the treatment of 
choice [116, 126, 138, 155]. Recently, studies of an
immunomodulating drug, Promodulin, indicated 40% of cats 
treated showed remission of anorexia, pyrexia and serosal 
effusion [162].
Antib io tics fo r control of secondary infection are also given. 
Although certain a n t i-v ira l agents such as human alpha-IFN and 
fe line  beta-IFN have been shown, in v i t ro ,  to in h ib i t  
replication of FCoV, they would only be of use during early 
virus exposure [160],
Transfusion of immune sera fa i ls  to protect and in fact 
enhances disease [ 112] .
In cats which are showing CNS signs, the c l in ic ian  must 
remember that many immunosuppressive agents do not cross the 
blood brain barrier. I f  seizures are present, cats can be 
treated with l.lmg/kg/day of phenobarbital divided into 2 doses
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[88].
I t  has been reported that cats with only ocular signs may 
recover with local corticosteroid treatment and that antibodies 
to FCoV w i l l  eventually decrease [104, 126].
1.11 Vaccine stateg ies
To be t ru ly  e ffective , a vaccine must evoke long-lasting CMI, 
therefore i t  is unlike ly that a k i l le d  virus vaccine would 
work. The ideal vaccine would be a modified l ive  product that
w i l l  persist long enough to evoke CMI [107, 114].
One problem is stra in variation. Cats that appear so lid ly  
immune to one or more stra in of FCoV can develop FCoVV when 
inoculated with another stra in [114]. Protective immunity may 
not be inducible in some cats [112, 113].
1 .11.1  Homologous virus
Some cats can be immunised using sublethal doses of v iru len t
FCoV. However, where some cats became immune, others given the 
same dose by the same route would develop FCoVV. Furthermore, 
the same dose of virus that would e ither k i l l  or immunise some 
cats fa iled  to in fect others [19, 112, 113]. When FECV was 
used to inoculate cats, there was some protection in some cats 
but enhanced disease in others [110, 111]. Obviously these
results are too inconsistent to advocate the use of v iru len t 
virus or FECV as a vaccine [19, 112, 113].
There are various reports of unsuccessful vaccine attempts
using FCoV strains:
Cats inoculated with FIPV-UCD2 were resistant to re infection 
with the homologous virus but were susceptible to infection 
with FIPV-UCD1 and FIPV-79-1146 and showed ADE [114].
FIPV-UCD3 given oronasally. evokes solid immunity without 
causing FCoVV. The problem is that the cats become immune
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carriers of the virus and may develop disease i f  th e ir  immunity 
is depressed [114].
Cats inoculated with low v iru len t strains w i l l  e ither develop 
FCoVV or seroconvert without i l lness . I f  the la t te r  group is 
challenged with more v iru len t virus, some w i l l  be immune and 
some develop accelerated effusive FCoVV [107].
Cats inoculated with avirulent strains oronasally produced IF 
and VN antibodies. They were not protected against oronasal 
challenge and some developed enhanced disease. There may be a 
factor present in v iru len t virus that is absent in avirulent 
virus but is necessary fo r protection [ 112] .
1 .11 .2  Heterologous virus vaccines
Attempts to vaccinate cats with TGEV fa iled  to protect against 
subsequent challenge with FCoV [19, 26, 66, 112, 113, 138,
139].
Vaccination with an unattenuated f ie ld  isolate of CCV by 
aerosol or s/c fa iled  to protect or enhance [19, 138]. In
another experiment, CCV caused enhancement to FCoV and further 
inoculation induced pathological lesions characteristic of 
effusive FCoVV [82].
Attempts to vaccinate cats with HCV 229E caused an homologous 
antibody response but neither protection nor sensitisation was 
observed [11, 19].
1.11 .3  Recombinant vaccinia-FCoV vaccine
Recombinant vaccinia viruses expressing S, N, and M have been 
used to vaccinate cats. The spike-expressing recombinant 
evoked enhanced disease. Immunisation with the N protein 
recombinant had no apparent effect on the outcome of challenge. 
Three of 8 k ittens immunised with the M protein recombinant 
survived challenge with v iru len t virus compared with one of 8 
control k ittens [149, 151] suggesting that an anti-M response
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is important in recovery.
1 .11 .4  Tem perature-sensitive mutant vaccine
The most hopeful vaccine candidate to date is a temperature- 
sensitive mutant of FCoV which replicates at 31°C but not at 
39°C. This mutant could be recovered from the URT, cervical 
and mandibular lymph nodes and to n s il ,  but from nowhere else in 
the cat. Mucosal immunity may be important in stopping the 
primary infection of FCoV [19, 34, 35].
74
CHAPTER 2
MATERIALS AND METHODS
MATERIALS
2.1 Media
Dulbecco's Minimal Essential Medium (MEM) was purchased from 
Gibco and was supplemented with 200mM L-glutamine, lOOmM sodium 
pyruvate and 3.75% sodium bicarbonate. Foetal bovine serum 
(FBS) was used at 10% fo r cell growth and 1% fo r virus growth.
For storage of ce lls  in l iq u id  nitrogen, 10% FBS and 10% 
dimethyl sulphoxide (DMSO) were added to the above.
2.2  Cell cu ltu re
Feline embryonic f ib rob last ce lls of the FEA line  [74] were 
used between passages 20-45. The ce lls  were routinely grown 
in 250ml p las tic  flasks (Nunclon) and 2.51 glass ro l le r  
bottles. The ce lls  were routinely sub-cultured 1:4 twice a 
week.
2 .3  Feline coronavirus (FCoV)
The Wellcome stra in of FIP virus was used [93]. Virus was 
cloned three times by picking plaques under agar and stock was 
prepared as described in 2 . 2. 2.
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Table 2.1 Stock solutions and buffers fo r  SDS-PAGE
Acrylamide stock
acrylamide 30%
bis-acrylamide 0 .8%
made up in d is t i l le d  water (DW).
Ammonium persulphate (AMPS)
10% in DW.
Coomassie blue sta in in g  so lution
Coomassie Blue 0.05%
methanol 30%
glac ia l acetic acid 10%
Destaining solution
acetic acid glacial 7%
made up in DW
Reducing sample b u ffer (RSB)
tris/HCl pH 6.8 0.0625M
SDS 2%
2-mercaptoethanol 5%
glycerol 10%
Bromophenol blue in DW 1%
In non-reducing sample buffer the 2-mercaptoethanol 
omitted.
SDS-PAGE running bu ffer
glycine 192mM
t r i s  base pH 8.6 25mM
SDS 0.1%
SDS-PAGE running gel
acrylamide 10%
bis-acrylamide 0.33%
Tris pH 8.6 0.4M
SDS 0.1%
TEMED 0.07%
DW
AMPS 0.025%
SDS-PAGE stacking gel
acrylamide 5%
bis-acrylamide 0.17%
Tris pH 6.8 0.12M
SDS 0.1%
TEMED 0.07%
DW
AMPS 0.075%
was
Table 2 .2  Stock solutions and buffers fo r  immunoblots
A lka lin e  Phosphatase (AP) b u ffer  
NaCl 
MgCl?
dietnanolamine pH 9.5
BCIP
BCIP (disodium sa lt) 
dimethylformamide
EDTA
EDTA 
in DW
Immunoblotting b u ffer
glycine
t r i s  base pH 8:6 
SDS
methanol
NBT
NBT
dimethylformamide
PBS/Tween
Tween 20
in phosphate buffered saline (PBS)
Solution A
non-fat milk powder 
in TBS
T ris -b u ffe red  sa line  (TBS)
NaCl
t r i s
pH 8.0 with HC1
lOOmM
5mM
lOOmM
5%
100%
500mM
192mM
25mM
0 . 01%
20%
5%
70%
0.05%
1%
144mM
25mM
METHODS
2.4  Cell growth and sub-culture
Cells were grown in 25 cm ,^ 80 cm^  or 175 cnr* p las tic  flasks or
2.5 l i t r e  glass ro l le r  bottles. To make sub-cultures of FEA 
ce lls  growing in monolayers, the old medium was removed and the 
monolayer was washed with 10 or 20 ml trysin-versene prepared
by adding 20ml trypsin-EDTA (Gibco) to 180ml PBS. The washing
was repeated and the flask or ro l le r  bottle  was incubated at 
37°C fo r 5 minutes. Then the detached ce lls  were suspended in 
medium, were carefu lly  dispersed and one quarter of the ce lls
i
was seeded in 25 or 100ml medium. A mixture of 5% CO2! in a ir  
was added and the culture was incubated at 37°C. Sub-cultures 
were made twice a week.
2.5  Preparation o f FCoV
Confluent FEA monolayers were infected with FCoV at a ra tio  of
10 pfu FCoV/cell. After 2 hours at 37°C the inoculum was
removed and 5 or 20ml medium containing 1% FBS was added. The 
virus was harvested 24 hours la te r, spun at 10K fo r 10 mins and 
frozen to -70°C. Stock prepared in th is  way had a t i t r e  of 2 x 
107 pfu/ml. Before using to inoculate new ce lls  i t  was
f i l te re d  using a 450nm Micropore f i l t e r  (Flow).
2 .6  Assay o f FCoV
Six-well plates (35mm diameter) were seeded with 5 x 10  ^ FEA 
per well. Twenty-four hours la te r  each well was inoculated 
with 1.0ml of a virus d ilu t io n  in medium with 1% FBS. The 
plates were agitated every twenty minutes fo r 2 hours then the 
inoculum was removed. A volume of 3ml 1% Noble agar (Difco) 
in medium with 1% FBS was added to each well. The plates were
incubated at 37°C fo r 1-3 days according to when the plaques
were iden tif iab le , then stained with 10% crystal v io le t (BDH) 
in 10% formalin, 5% methanol. After 4 hours the agar overlay 
was washed o f f  and the plaques were counted.
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2.7  Concentration o f FCoV
Equal volumes of FCoV stock and cold, neutralised saturated 
ammonium sulphate (SAS) were mixed and incubated overnight at 
4°C. The suspension was then spun at 10,000 rpm fo r 10 mins. 
The SN was discarded and the p recip ita te  was resuspended in PBS 
to about 5% of the o rig ina l volume. This suspension was then 
layered onto a SW41 centrifuge tube containing 1.0ml 20%
sucrose in PBS on top of 1ml 60% sucrose in PBS. The tube was 
spun at 35K fo r 1.5 hrs. The band obtained at the interface of 
the two sucrose layers was resuspended in 5ml PBS then 
ca re fu lly  layered onto a gradient o f 2ml 60% sucrose, 2ml 40% 
sucrose, and 2ml 20% sucrose in PBS which had been standing 
overnight in an SW41 tube. This was then spun fo r 2 hrs at 
35K. The band of virus which formed at a density of 1.15 
gm.cnf^ was collected through a hole punctured in the bottom of 
the tube and was e ither frozen at -70°C or resuspended in PBS 
and pe lle tted  by spinning fo r 2 hrs at 35K, depending on its  
intended use.
2 .8  Protein measurement o f  FCoV
FCoV protein was quantified by comparison with known 
concentrations of ovalbumin on PAGE as shown in f ig  2.1. 
Lanes 1-8 show twofold d ilu tions  of ovalbumin, s ta rting  at 500 
micrograms/ml, the FCoV sample to be measured was neat in lane 
10, then d ilu ted twofold (lanes 10-14). The N protein in the 
la s t d ilu tio n  was s im ila r in in tens ity  to the th ird  lane of 
ovalbumin. Since FCoV at 1:16 was comparable to 125 
micrograms/ml of ovalbumin, the concentration of N in th is  
sample was approximately 2.0mg/ml. Sim ilar calculations were 
made fo r M and S protein (when v is ib le ) .
2 .9  In d ire c t immunofluorescence assay (IFA)
FEA ce lls  were inoculated in suspension with an appropriate 
concentration of the Wellcome stra in  of FCoV [93] to in fec t 
about 50% of the ce lls . A fte r incubation at 37°C fo r 4 hours 
in s tirre d  suspension, the ce lls  were seeded onto 96 well glass 
plates (C.A. Hendley (Essex) Ltd.) A fte r a fu rthe r incubation
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Fig. 2.1
M e a s u r e m e n t  o f  p r o t e in  c o n t e n t  o f  F C o V  b y  c o m p a r is o n  w i t h  
k n o w n  c o n c e n t r a t io n s  o f  o v a lb u m in .
L a n e s  1 - 8  D o u b l i n g  d i lu t io n s  o f  o v a l b u m i n  s t a r t in g  a t  
5 0 0  m ic r o g r a m s / m l
L a n e  9  M o l e c u la r  w e i g h t  m a r k e r s
L a n e s  1 0 - 1 4  F C o V  u n d i lu t e d ,  a n d  t h e r e a f t e r  in  t w o f o ld  
d i lu t io n s
of 6-8 hours the attached ce lls  were washed in PBS, then fixed, 
and subsequently stored, in methanol at -20°C. Before use, 
the plates were washed in PBS.
Test serum was d ilu ted  1:10 and thereafter in doubling 
d ilu tio n s  up to 1:1280 in PBS.
The d ilu ted  serum was inoculated on to the wells o f the 96 well 
plate and incubated fo r 60 mins at 37°C. The plates were then 
washed twice in PBS. Twenty-five ul o f fluorescein 
isothiocyanate conjugated goat an ti-ca t IgG was incubated on
the ce lls  fo r a period of 60 minutes at 37°C. A fte r fu rthe r
washing in PBS the ce lls  were examined fo r fluorescence in a
microscope using u ltra -v io le t l ig h t .  The antibody t i t r e  was
taken as the la s t d ilu tio n  of serum which showed fluorescence.
2.10 Polyacrylamide gel electrophoresis
Gels were made using the Mini-protean I I  dual slab ce ll 
(BioRad). The solutions used are lis te d  in table 2.1
For a 5ml gel, the follow ing were mixed from prepared stocks
1.7ml 30% acrylamide: 0.8% bis-acrylamide; 1.25ml 1.5M t r is  pH 
8 .6 ; 2.0ml DW; 50ul 10% SDS and 6.5uT TEMED. Seventeen
m icro litres  of fresh ly prepared 10% AMPS was added immediately 
before pouring the gel. An overlay of water saturated butanol 
was applied and the gel was le f t  to set fo r approximately 20 
mins. The water saturated butanol was poured o ff ,  the gel was 
rinsed with d is t i l le d  water and dried with b lo tting  paper, and 
the stacking gel was poured on.
The stacking gel consisted of 600ul o f 30% acrylamide:0.8% bis- 
acrylamide; 750ul 0.75M t r is  ph 6 .8 ; 1.75ml DW; 7.5ul TEMED;
31ul 10% SDS and 15ul 10% AMPS added la s t. The comb was added
and the gel was le f t  to set at 4°C.
Samples were boiled fo r 3 minutes in one-third volume RSB or 
non-reducing sample buffer. A mixture of 2.5ul Amersham
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rainbow markers + and 1.3ul RSB was boiled fo r 1 minute.
Gel running buffer was added between the plates to a level mid­
way between the tops of the two glass plates and to the tank. 
Any trapped a ir  bubbles were removed with a pasteur p ipette . 
The comb was removed and the samples and markers were added.
The mini-gel was run at 200V, 35mA constant current, fo r 
approximately 45 mins.
2.11 Immunoblot preparation and development
The proteins were transferred from the gel to n itroce llu lose  in 
immunoblotting buffer (see table 2.2) fo r lh r  at 100V using a 
Mini Trans Blot (Biorad). The remaining binding sites were 
blocked with 0.5% non-fat m ilk powder in TBS fo r 3 hrs or 
overnight. The b lo t was dried and stored at -20°C in parafilm .
The b lo t was cut in to s trips  and each was incubated with the 
serum to be tested at a d ilu tio n  of 1:10 in solution A (see 
table 2.2) fo r 2 hrs or overnight. The s tr ip  was washed 3 
times in PBS/Tween, then 0.004% b io tiny la ted protein A (Sigma) 
in solution A was added fo r 1 hr. The s tr ip  was washed 3 times 
in PBS/Tween then 0.001% streptavid in a lkaline phosphatase 
(Southern Biotechnology Associates, Inc.) in solution A was 
added fo r 1 hr. A fte r washing 3 times in PBS/Tween, the s tr ip  
was developed in darkness in 0.0033% BCIP (Sigma) and 0.0066% 
NBT (Sigma) in AP buffer u n til bands appeared (usually 10-20 
mins).
2.12 FeLV te s t
Samples were screened fo r FeLV antigen using an ELISA (FeLV 
Petcheck, Idexx) to detect p27 antigen and positive  results 
were confirmed by virus iso la tion  [75].
2.13 FIV te s t
A commercial ELISA, FIV Antibody Test K it (FIV Petcheck, Idexx) 
was used to screen samples fo r FIV antibodies.
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2.14 Histopathology
Samples fo r histopathology were fixed in 10% neutral buffered 
formalin and embedded in polywax before sectioning. Sections 
were stained with haematoxylin and eosin. Histopathological 
examination was kindly performed by Dr Sarah Toth.
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CHAPTER 3
THE PREVALENCE OF ANTI-FCoV ANTIBODIES 
IN SELECTED CAT POPULATIONS
3.1  INTRODUCTION
In the absence of a re lia b le  method of iso la ting  FCoV from cats 
in the f ie ld  [45, 102, 110, 164] serology is  widely used fo r 
diagnostic purposes. However, as discussed in chapter 1, one 
of the d if f ic u lt ie s  in in te rpre ting  FCoV antibody t it re s  is  the 
presence o f antibodies not only in diseased but also in healthy 
cats [3, 7, 9, 56, 80, 96, 102, 103, 104, 105, 155].
In order to in te rp re t the significance of an antibody t i t r e  in 
a given cat, the background prevalence of antibodies had to be 
established fo r comparison. To th is  end, information was 
gathered about cats which had died of FCoVV and a survey was 
conducted to study the prevalence of FCoV antibodies in the 
U.K.
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3 .2  MATERIALS AND METHODS
PM material from cats with FCoVV was sent to the FVU by 
veterinary practitioners in the UK fo r diagnosis by 
histopathology. Some cases were referred to the small animal 
medicine department o f the University o f Glasgow fo r diagnosis 
and, eventually, PM.
FeLV, FIV and FCoV IFA tests were performed as described in 
Chapter 2. Serum d ilu tions  were made to 1:1280 and therefore 
th is  t i t r e  represents a ll t i t re s  equal to and over 1280.
Plasma samples from 127 healthy domestic cats were obtained by 
veterinary surgeons in general practice from cats submitted fo r 
neutering or orthopaedic operations [63]. Other sera used were 
those submitted to the FVU fo r routine or diagnostic serology 
or virus iso la tion . Sera from 100 sick and healthy pedigree 
cats, 100 sick domestic cats, 88 domestic cats from single cat 
households (SCH), 100 from domestic cats in m ulticat households 
(MCH) were examined by IF fo r evidence of anti-FCoV antibody. 
E ighty-six o f the healthy pedigree cats were from MCH and the 
housing of 14 was unknown. Unfortunately there were 
in su ffic ie n t pedigree cats from SCH fo r comparison with other 
groups.
S ta tis tic a l analysis was kindly performed by Dr Chris Robertson 
(Strathclyde University).
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3.3  RESULTS
3 .3 .1  Pathology
FCoVV cases were c lass ified  as effusive i f  over 5 ml o f a sc itic  
f lu id  was present. Five ml was an a rb itra ry  choice, since some 
leakage into the peritoneal cavity is to be expected at PM i f  
the animal has been dead fo r more than a few hours. The 
appearance of a classical case of effusive FCoVV is illu s tra te d  
in f ig .s  3.1 and 3.2. On the omentum of the cat in f ig .  3.2 
pyogranulomata l-2mm across are v is ib le . The typ ica l 
appearance of non-effusive FCoVV granulomata is  shown in f ig .
3.3.
Atypical pathology was noted with moderate frequency: no
macroscopically v is ib le  pyogranulomata ( f ig .  3 .4), thickening 
of the colon not unlike alimentary lymphosarcoma ( f ig .  3 .5), 
tumour-like lesions on the surface of the in testine  and in the
mesenteric lymph node ( f ig .  3.6) and m ilia ry  tumour-like
appearance in the lungs ( f ig .  3.7).
3 .3 .2  Breed
Fig. 3.8 shows the breed d is tr ib u tio n  in 38 effusive and 23 
non-effusive cases of FCoVV. S ixty-three percent of effusive 
cases were in pedigree cats of which 10 cats (26%) were 
Persians. Forty-eight percent of non-effusive cases were
pedigree cats of which 4 (17%) were Burmese.
The results of the FCoV antibody survey are presented in table 
3.1. FCoV antibody was most prevalent in healthy pedigree 
cats (53%) and least prevalent in healthy domestic cats (14%).
3 .3 .3  Age
The ages of the animals which died of FCoVV are presented in 
f ig .  3.9. F ifty - f iv e  percent of the cats were under a year of 
age and a fu rthe r 14% were 12-18 months old. A fte r 18 months 
o f age the incidence was sporadic.
83
Fig. 3.1
T h e  c la s s ic a l  a p p e a r a n c e  o f  e f f u s iv e  F C o W  s h o w in g  t h e  
t y p ic a l  s t r a w - c o lo u r e d  e f f u s io n  a n d  a d h e s i o n s  in  t h e  t h o r a c i c  
c a v ity .  T h o r a c ic  e f f u s io n s  o c c u r  in  a r o u n d  2 0 %  o f  F C o W
c a s e s .
Fig.
T y p ic a l  p y o g r a n u l o m a t a  1 - 2 m m  in  d i a m e t e r  a r e  s e e n  o n  t h e  
o m e n t u m  o f  a  c a t  w i t h  e f f u s iv e  F C o W .
Fig. 3.3
P y o g r a n u l o m a t a  in  n o n - e f f u s iv e  F C o V V  o n  t h e  s u r f a c e  o f  t h e  
k id n e y s .
Fig. 3.4
A t y p ic a l  p r e s e n t a t io n  o f  F C o V V :  n o  m a c r o s c o p ic a l ly  v is ib le  
p y o g r a n u l o m a t a  o r  f lu id  in  a  c o n f i r m e d  c a s e  o f  F C o W .
Fig. 3.5
T h ic k e n i n g  o f  t h e  c o lo n  d u e  t o  F C o V V ,  a  le s io n  w h ic h  c o u ld  
e a s i ly  b e  m is t a k e n  f o r  a l im e n t a r y  l y m p h o s a r c o m a .
Fig. 3.6
T u m o u r - l i k e  F C o V V  le s io n s  o n  t h e  s u r f a c e  o f  t h e  in t e s t in e  
a n d  m e s e n t e r ic  ly m p h  n o d e s .
Fig. 3.7
M il ia r y  a p p e a r a n c e  o f  F C o W  p y o g r a n u l o m a t a  in  t h e  lu n g s .
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Table 3.1 Survey o f FCoV antibodies in 
selected groups o f cats
Healthy pedigree 
Healthy domestic 
Sick pedigree 
Sick domestic 
SCH domestics 
MCH domestics
Proportion
seropositive
53/100* 
18/127 (14%) 
24/100 
20/100  
14/88 (16%)
28/100
Key:
*  number of seropositive cats
over to ta l number o f cats tested 
SCH single cat household
MCH m ulticat household
Table 3.2 The sex d is tr ib u tio n  o f cases o f FCoVV 
and presence o f antibodies to FCoV
Female Female Male Male
neuter neuter
a.
Effusive 16 2 13 7
Non-effusive 7 5 6 5
b.
100 s ick ped 10/29 (34) 1/10 (10) 8/40 (20) 5/19 (26)
100 s ick dom 8/28 (28) 1/10 ( 10) 5/27 (18) 6/34 (18)
100 healthy ped 28/52 (54) 2/5 (40) 16/32 (50) 3/7 (43)
127 healthy dom 12/68 (18) 0/5 (0 ) 6/50 (12) 0/4 (0 )
88 SCH dom 7/37 (19) 1/11 (9 ) 4/30 (13) 2/8 (25)
100 MCH dom 13/55 (24) 0/5 (0 ) 14/35 (40) 0/4 (0 )
Total 78/269(29) 5/46 (11) 53/214(25) 16/76(21)
Key:
a. cats with FCoVV
b. no. o f seropositive cats from the survey against the to ta l fo r 
that sex in each group. Percentage in brackets.
ped pedigree 
dom domestic
SCH single cat household 
MCH multi cat household
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Cats' ages were available fo r 85 domestic cats from SCH: 119
healthy domestic cats and 93'domestic cats in MCH. No ages 
were available fo r the sick domestic or healthy or sick 
pedigree cats. The results are presented in f ig .  3.10. Forty- 
three of 228 (19%) cats under 3 years old were seropositive 
compared with 7/69 (10%) of cats over 3 years old.
3 .3 .4  Sex
The sex of cases of FCoVV is presented in table 3.2 a. 
Overall, there were 30 females and 31 males. Four more cases, 
where the type of FCoVV was unknown, were male. There was no 
difference in sex d is tr ib u tio n  between effusive and non- 
effusive forms.
In table 3.2 b. the sex d is tr ib u tio n  o f seropositive and 
seronegative cats is recorded. In to ta l,  26% of female and 24% 
of male cats tested were seropositive.
3 .3 .5  FeLV/FIV
The prevalence of FeLV and FIV in cases of FCoVV is  presented 
in table 3.3.
In table 3.4, the prevalence of FeLV and FIV in fection in the 6 
d iffe re n t categories is given along with the number of 
seropositive cats in brackets. Numbers were too low to be very 
meaningful but the proportion o f FCoV seropositive cats with 
FeLV/FIV was the same as in the general population.
3 .3 .6  Antibody leve ls
The antibody t it re s  of cases of effusive and non-effusive FCoVV 
cases are presented in f ig .  3.11 and in d iffe re n t categories of 
cats are presented in f ig .  3.12. I t  can read ily  be seen that 
t i t re s  are generally lower in healthy domestic compared to 
healthy pedigree cats and in SCH as opposed to MCH.
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Table 3.3 The incidence o f FeLV and FIV in h is to - 
pathologically confirmed cases o f FCoVV
Effusive Non-effusive
Total No. % Total No. %
no. cats pos. no. cats pos.
3 11.5 22 4 18
2 8 19 2 10.5
Table 3.4 The prevalence o f FeLV and FIV in the 
selected populations in the serosurvey
FeLV+ FIV+
Healthy pedigree* 2 ( 1) 8 (5)
Healthy domestic 4 (2) 3 (0)
Sick pedigree* 8 (2) 9 (3)
Sick domestic** 15 (6) 26 (5)
SCH domestics 4 (0) 5 (2)
MCH domestics 2 ( 1) 5 (0)
Key:
FeLV+ Feline leukaemia virus positive
FIV+ Feline immunodeficiency virus positive
() number seropositive
SCH single cat household
MCH m ulticat household
*  1 had both FeLV and FIV
FeLV 26
FIV 24
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G iv e n  a s  a  p e r c e n t a g e  w h e n  n e c e s s a r y .
K e y :
■ 100healthy pedigree ■ 127 healthy domestic
100sick pedigree ■ 88 domestic from SCH
□ 100 sick domestic ■ 100 domestic from MCH
3 .3 .7  Housing
Information on the housing of the cats which died of FCoVV was 
only available fo r 40 animals, 36 were from MCH and 4 from 2- 
cat households.
In the FCoV antibody prevalence survey, 114 healthy domestic 
cats were free-ranging, 6 were kept indoors and the status o f 
the others was unknown. Eight SCH domestic cats were kept 
indoors and 77 were free-ranging. Of the MCH domestic cats, 3 
were kept indoors and 95 were free-ranging. This information 
was unobtainable fo r the other three categories. There were 
in su ffic ie n t indoor cats in these categories to establish i f  
being free-range or indoor made a difference to the ca t's  
chance of being seropositive.
Domestic cats were more lik e ly  to be seropositive i f  from MCH 
than SCH but i t  was not s ig n ifican t (P = 0.6). Pedigree cats 
were 3 times as lik e ly  to have antibodies in a MCH than in a 
SCH.
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3 .4  DISCUSSION
3 .4 .1  Pathology
There were su ffic ie n t numbers of FCoVV cases with atypical 
gross pathology to ju s t i fy  the assertion that a ll cases should 
be confirmed by histopathology. Resemblance to lymphosarcoma 
associated with FeLV has been noticed previously [87, 101]. The 
colonic form of FCoVV has been reported before and can ex is t on 
its  own or in association with more typ ica l signs of FCoVV 
[147].
3 .4 .2  Breed and housing
Previous surveys of cats which had died of FCoVV or of cats 
which had antibodies against FCoV have given co n flic tin g  
opinions about breed pred ilection.
I t  was in teresting to note that the non-effusive form was found 
predominantly in domestic cats, while the effusive form was 
encountered more frequently in pedigree cats. The predominance 
in pedigree cats could be due e ither to genetic predisposition 
or the fac t that they are more often kept in large groups [ 2 , 
105]. The higher incidence in Persians, together with the 
predominance of the effusive form in that breed may indicate a 
genetic su sce p tib ility . Higher incidence in Persians has been 
noticed before [12] as has higher incidence in Burmese [140] 
which was the second commonest pedigree breed in th is  survey.
From th is  survey, i t  was clear that both cases of FCoVV and 
FCoV antibodies were more prevalent in MCH. Ninety percent of 
FCoVV cases, where housing status was known, had come from MCH. 
Increased prevalence in MCH has been noted before [2, 12, 80,
102].
Healthy pedigree cats were twice as lik e ly  as any other group 
to have FCoV antibodies. E ighty-six were known to be from MCH 
and 46 of these (53%) were seropositive. Only 28% of domestic 
cats from MCH were seropositive. I t  is  un like ly  that being
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pedigree or not a lte rs  the predisposition of a cat to 
seroconvert in response to an antigen, though inbreeding may 
a lte r the immune response. Possibly pedigree cats are more 
prone to becoming FCoV carrie rs .
In th is  survey i t  was established that young cats are more 
lik e ly  to be seropositive than older cats. Perhaps pedigree 
cats in MCH are in general younger since they tend to be kept 
fo r breeding. However, i t  is l ik e ly  that l i fe - s ty le  of the 
pedigree cat, going to shows and exchange of cats between 
households fo r mating, increases both the frequency o f exposure 
to FCoV and the virus dose. This might explain why sick 
pedigree cats had a lower prevalence o f antibodies than did 
healthy pedigrees: possibly these a c tiv it ie s  are suspended fo r 
a while i f  the animal is  a ilin g . A lte rna tive ly , the nature of 
the cats' illness  may depress the immune response or the 
antibody may be consumed in the pathological process. The 
housing o f these sick cats was unknown. Perhaps many were from 
SCH and therefore not exposed so often to FCoV.
The levels of antibody were higher in pedigree compared to 
domestic cats which may represent current or recent exposure to 
virus or an anamnestic response to repeated exposure. I t  has 
been suggested that cats with higher t it re s  are more lik e ly  to 
be FCoV excretors [111]. This question w il l  be addressed in 
Chapter 5.
3 .4 .3  Age
In th is  survey, 58% of effusive and 43% of non-effusive cases 
of FCoVV were under one year o f age. The s lig h t ly  la te r peak 
of non-effusive FCoVV cases could be a re flec tio n  of the more 
developed immune system of older cats because the non-effusive 
form is thought to be an intermediate stage between the 
effusive form and immunity. A lte rna tive ly , i t  may only re fle c t 
the longer incubation period of th is  form. In th is  survey, 
there was an abrupt decline o f FCoVV incidence a fte r 1.5 years
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of age, which was e a rlie r  than in previous surveys [102, 140].
I t  is  tempting to assume that FCoVV occurs more frequently in 
younger cats because th e ir  immunity is less mature, but how 
much m ulticat housing and the stress of rehoming influences 
th is  is  unknown. Clearly the fate o f older seropositive cats 
in MCH needs to be examined, increased su sce p tib ility  to FCoVV 
in experimental cats with pre-existing antibody has been
reported [49, 109, 112, 156, 157, 158]. I f  th is  were also true
in the f ie ld ,  one would expect a higher incidence in older cats
which had been exposed to FCoV more than once. Surpris ingly, 
in th is  survey, cats under 3 years of age were twice as l ik e ly  
to be seropositive as those over 3 years old.
3 .4 .4  Sex
No sex predilection was noted in e ither those cats which had 
died o f FCoVV or had seroconverted.
3 .4 .5  FeLV/FIV
In th is  survey of cases of FCoVV, the prevalence of FeLV was
14.6% which was not s ig n ifica n tly  d iffe re n t from the prevalence 
of FeLV in sick cats in the U.K. [63]. This resu lt agrees with 
more recent surveys which showed that the incidence of FeLV in 
cases of FCoVV is much the same as in the rest of the fe lin e  
population [118, 140].
The prevalence of FIV was 9% which was s ig n ific a n tly  less than 
the prevalence of 19% in sick cats in the UK [63]. This find ing 
agrees with that of a previous survey [69]. One explanation 
could be the d iffe r in g  epidemiological patterns between the two 
in fections: FCoVV was found to a ffect young pedigree cats
whereas FIV increases in prevalence as age increases and is 
less l ik e ly  to be found in pedigree cats [63]. None of the FIV 
positive cats in th is  survey was pedigree.
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3 .4 .6  Antibody leve ls  in FCoVV cases
Most cats which die of FCoVV have antibody t i t re s  equal to or 
over 1280. Some effusive cases had lower t i t re s .  FCoVV cases 
with no detectable FCoV antibodies have been reported and were 
also found in th is  study. Several explanations were reviewed 
in 1.9.5.
Recovery of virus from cases of FCoVV is  extremely d i f f ic u l t  
[45]. Even in experimental infections with a laboratory s tra in  
of FCoV, virus could only be detected fo r 2-16 days p . i .  
[140,141]. For antibody production to continue, antigen must 
continue to be present.
There is  good evidence that FCoVV is an immune complex mediated 
disease [57, 60, 70, 71, 102, 109, 154, 156, 157]. Immune
complex formation depends on a pa rticu la r balance of antigen 
and antibody, neither being in excess, therefore i t  is not the 
magnitude of the antibody response that is  important but the 
antibody:antigen ra tio . This might be the reason why in the 
more rap id ly developing, effusive, manifestation of th is  
disease antibody levels were sometimes quite low.
The va scu litis  resulting from immune complex deposition in 
blood vessels causes the c lin ic a l signs we associate with 
FCoVV. Even i f  immune complexes are present fo r only a short 
time before the onset of c lin ic a l signs they could cause such 
severe damage to the animal's vascular system that i t  cannot 
recover. This subject w il l be addressed again in Chapters 4 
and 6 .
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CHAPTER 4
THE RELEVANCE OF ANTI-FCoV ANTIBODIES TO THE FATE OF 
CATS NATURALLY EXPOSED TO THE VIRUS.
4.1 INTRODUCTION
The fate of cats with antibodies to FCoV is o f major concern to 
cat owners, p a rticu la r ly  breeders, and th e ir  veterinary 
surgeons. Of p a rticu la r importance is the significance of the 
presence of antibodies in healthy cats exposed to a case of 
FCoVV.
The IFA tes t has been used as an aid to diagnosing FCoVV and as 
a screen to determine i f  a household is  infected w ith, or has 
been exposed to FCoV [3, 9, 155]. However, once a household 
has been found to have FCoV antibodies, many more questions 
arise:
1. Does the presence of FCoV antibodies indicate FIPV or FECV 
infection?
2. How many more cats can be expected to die from FCoVV?
3. Is any pa rticu la r antibody t i t r e  or pattern o f t i t re s  
ind ica tive  of th is  fate?
4. What period elapses between seroconversion and death and 
at what stage, i f  ever, can one assume that a seropositive 
cat is  immune?
5. W ill a seropositive cat suffer enhanced disease i f  
reinfected?
6 . W ill the ca t's  antibodies ever disappear? I f  so, in what 
time scale?
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7. What factors, i f  any, determine whether cats become sero­
negative, stay seropositive or develop FCoVV?
8 . Can cats which have become seronegative begin to excrete 
virus again?
9. Is a cat which is FIV or FeLV positive  more lik e ly  to 
succumb to FCoVV?
In th is  chapter, a survey is described in which seropositive 
cats and th e ir  seronegative in-contacts were followed fo r 
periods of up to 3 years. Households were chosen with 
d iffe re n t c lin ic a l h is to ries so that hopefully stra ins o f FCoV 
of varying pathogenicity could be examined. I t  was found that 
there were cases of FCoVV in cats from households with a ll 
types of c lin ic a l h is tory indicating that the assumption tha t a 
household has a FECV or non-pathogenic FCoV in fection  on 
grounds of c lin ic a l h istory is unwise.
Death rates from FCoVV appeared to be higher (around 12%) in 
index infections than in households which had been seropositive 
fo r some time (around 3-4%). Repeat IFA t it re s  were o f l i t t l e
value in predicting a ca t's  fate since even some cats which
appeared to have recovered from in fection and became 
seronegative la te r died of vascular lesions sustained during 
the time of active in fection . These lesions were mainly in the 
kidneys. By contrast, there were no cases of FCoVV in cats 
which did not seroconvert throughout the survey. I t  w il l  s t i l l  
be some time before the true m orta lity  rate of FCoV in fection  
can be assessed. I t  may be that FCoV in fection  is responsible 
fo r some of the presently unexplained kidney disease of the 
older cat.
I some
The in fection  was eliminated fromAhouseholds and a ll o f the 
cats became seronegative. On re in fection , these cats and cats 
whose antibody t it re s  had fa lle n  considerably and rose again
appeared not to show ADE because the m orta lity  rate was s t i l l
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very low. Households where cats were kept in groups of 3 or
less were more lik e ly  to elim inate the in fection than those
which maintained cats in larger groups.
In households that became seronegative, when re in fection  
occurred the source of virus could always be traced to contact 
with a cat which was seropositive or o f unknown FCoV antibody 
status. There was no evidence to suggest that seronegative 
cats could be carriers of FCoV.
Seven households had concurrent FeLV in fection  and 6 had
concurrent FIV in fection (o f which, one household had both).
The incidence of FCoVV was no higher in FeLV infected 
households than in non-infected households. The presence of 
FIV in a group of cats s lig h t ly  increased thechance of a death 
due to FCoVV.
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4 .2  MATERIALS AND METHODS
4 .2 .1  Seropositive household survey
In 1988, a survey was begun to monitor the antibody status of 
cats in FCoV seropositive households. Seventy-two cat owners 
partic ipated, with over 700 cats. Household size ranged from 
1-42 cats.
In table 4.1, the reasons fo r household partic ipa tion  are 
presented. Diagnosis of FCoVV was confirmed by 
histopathological examination where possible. Presumptive 
diagnosis of FECV in fection was made according to c lin ic a l 
h istory as described by Dr Niels Pedersen: the presence of non- 
responsive diarrhoea prim arily  in k ittens 5-12 weeks o f age 
[103, 110, 111, 114]. FECV was given as a histopathological
diagnosis by Dr Irene McCandlish in one household (1598) due to 
stunting and fusion of the SI v i l l i  s im ila r to TGEV in fection  
in p ig le ts .
Most cats were bled and necropsied by th e ir  veterinary 
surgeons. The cats in households 1598, 1786, 1801 and 2863 
were bled and necropsied by the author.
The health of cats in a ll of the households except 1688 were 
checked by telephone in September 1990.
A computer database was constructed to record the sequential 
blood samples from each cat. The data comprised concurrent 
FeLV and FIV resu lts , age, health status, whether free-ranging 
or kept indoors, and from MCH or SCH. I f  from the former, the 
number of in-contact cats and the highest antibody t i t r e  o f in ­
contact cats where known, were recorded.
4 .2 .2  I  FA
Antibody measurement was performed by I FA as described in 2.9. 
Since consecutive tests on any cat were performed at varying 
in terva ls over the three year period, i t  was important to 
assess whether fluctuations in antibody t i t r e  arose because of
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Table 4.1 Reasons fo r  pa rtic ipa tion  o f households in the survey 
and FeLV and FIV te s t resu lts .
FIV
+
N/D
N/D
N/D
N/D
N/D
N/D
+
N/D
N/D
N/D
N/D
N/D
N/D
N/D
N/D
+
N/D
N/D
N/D
N/D
N/D
N/D
N/D
N/D
N/D
N/D
+
Owner Reason 1st No. Dead FeLV
re f sampled FCoVV other
Cats died o f FCoVV on premises
216 1 SA 0 0 -
1594 1 S 1 SK 0 -
1596 1 CA 0 0 N/D
1613 4 SA 0 2 -
1615 1 S 2 CA 0 +
1627 2 SA 0 0 N/D
1673 2 S 0 2 +
1674 1 s 0 0 -
1677 1 SK ISA 3 CA 9 +
1678 1 S 0 1 -
1680 1 CA 0 1 -
1682 1 S 0 1 N/D
1683 1 CA 0 3 N/D
1690 1 CA 0 0 -
1692 1 S 0 0 -
1693 1 SA 0 1 -
1694 1 SA 1 SA 0 +
1768 2 SA 1SK 1 CA 1CK 1SK 1 N/D
1769 1 SA 0 1 -
1770 1 SA 1 S 1 N/D
1773 1 S 0 1 N/D
1777 1 S 1 CA 1SK 3 -
1778 1 SA 1SK 0 0 -
1781 1 CA 1 CA 1 -
1784 2 SA 0 3 +
1785 1 SA 0 0 N/D
1790 1 SA 1 SA 0 -
2097 1 SA 0 0 -
3122 1 CA 0 1 N/D
3123 1 CA 0 2 N/D
3124 1 C 2S 0 0 **
Sold kittens died o f FCoVV
1672 SK 2 SA 1 N/D
1675 2 SK 0 0 N/D
1684 1 SK 1 CA 1 -
1686 2 SK 0 0 N/D
1691 SK 0 1 N/D
1771 1 CK 1 CA 1 -
1775 1 SK 0 1 -
1776 1 CK 2SK 1 CA 1 -
1779 1 SK 0 0 -
1789 SK 2 CA ISA 3 -
1801 2 CK 0 0 N/D
3117 2 SK 0 3 -
3121 1 CK 0 0 -
3125 1 CK 0 0 N/D
N/D
N/D
contd.
Table 4.1 contd.
Owner Reason 1st No. Dead FeLV FIV
r e f sampled FCoVV other
C lin ic a l signs suspi cious o f FCoV in fe c tio n
54 S clin.case 0 0 - N/D
1685 R ( flu ) 1C IS 11 - +
1772 R (E) 0 0 N/D N/D
3095 S (preg) 1 CK 0 - -
C lin ic a l h is to ry  in d ic a tiv e  o f FECV in fe c tio n
1598 E C 3 CA 2CK 0 - -
1612 E 0 0 N/D N/D
1676 E 1 CK 1 - -
1780 E 0 4 N/D N/D
In contact w ith real or suspected FCoV excretor
1614 IC S 0 1 N/D N/D
1681 IC S 0 1 N/D N/D
1687 IC KS 0 0 N/D N/D
1689 IC S 1 1 - N/D
1774 IC S 0 •1 - -
1788 IC S 0 3 N/D N/D
2439 IC 0 0 N/D N/D
2863 IC C 0 0 N/D N/D
No h is to ry  in d ic a tiv e  o f FCoV in fec tio n
1595 R 0 2 - ■ -
1679 R 0 2 N/D N/D
1695 R 1 CA 0 - N/D
1782 R 0 0 -
1786 R 0 0 - -
3119 R 0 0 - N/D
3120 R 0 1 + N/D
Reason fo r  f i r s t  sampling unknown
3 0 1 N/D +
1688 0 0 N/D N/D
1783 0 1 + -
1787 1 s 0 N/D N/D
S = suspected o f FCoVV
C = histopathologica lly confirmed
A = adult
K = k itten
IC = in contact with a case
E = e n te r it is , FECV suspected
R = routine, e.g. fo r mating, no cases FCoVV. 
N/D = not done 
+ = positive
= negative
genuine differences in the ca t's  antibody level or re flected 
experimental va ria tion . To th is  end 45 samples from 10 cats 
were retested and the plates were read by the 3 persons who 
usually performed the tests (Mrs J. Simpson, Mr M. Golder and 
the author). The results are presented in table 4.2. The new 
results were compared with the o rig ina l resu lts . S ta tis tic a l 
analysis, kindly performed by Dr Chris Robertson o f Strathclyde 
University, showed that there was no evidence of any 
s ig n ifica n t difference among the three readers. Variation 
between t i t re s  was random. Once differences among the samples 
and cats had been taken into account, the standard deviation of 
the log (base 10) values was 0.48. This resu lt showed that 
varia tion  in IFA t it re s  reflected real fluctuations in antibody 
levels in the cat.
At the beginning of the survey, testing was monthly. However, 
th is  frequency met with cat owner resistance and since l i t t l e  
change was noticed in IFA t it re s  from month to month, testing 
thereafter was at in terva ls of 3-6 months or whenever the owner 
would permit.
4 .2 .3  FeLV/FIV
The adult cats in 43 households were screened fo r FeLV and in 
29 households were tested fo r FIV using the tests described in 
2.12 and 2.13.
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Table 4 .2  Comparison o f three readings o f sequential IFA t i t r e s  
from 10 cats
The o rig ina l IFA t i t r e  is given f i r s t  and the rechecks are below.
The orig ina l might have been read by Mrs Simpson, Mr Golder or the
author. The f i r s t  recheck was by the author and the second by Mr
Golder. The two recheck readings are on the same plate.
5678*
P2405C** P5527C
40
160
160
80
320
320
P7621C
320
320
320
P9385C
80
160
160
5542
P954C
80
640
320
P3548C
320
320
320
P8340C
40
40
20
P3580D
320
160
160
5691
PI131C P1617C P2495C P5702C P7125C P8926C P1995D
640 1280 640 320 160 1280 640
320 1280 640 640 20 160 320
320 1280 640 320 40 160 320
5692
P1134C P2492C P4051C P5701C P7128C P8931C P1999D
160 320 320 80 20 1280 160
40 320 320 160 20 640 160
40 320 320 80 20 160 80
5732
P4002C
40
160
40
P5976C
320
160
160
P9113C
80
640
640
5733
P4011C
0
80
20
P5974C
40
20
20
P9111C
0
80
40
* Cat's reference number 
**  Sample reference number
Table 4 .2  contd.
5734
P4007C P5979C P9105C
20 160 0
20 160 0
20 80 40
5011
P7997B
0
0
0
P1650C
80
0
0
P5902C
0
0
0
5187
P225C
40
40
40
P2712C
40
20
40
P7334C
320
0
40
5361
P7744B
320
160
320
P8336B
160
80
160
P168C
160
320
320
P9437C
320
20
0
P35D
40
40
80
P2996C P5898C P8489C
320 80 640
80 80 20
320 160 320
* Cat's reference number
** Sample reference number
4.3  RESULTS
4 .3 .1  The prevalence o f FCoVV in households w ith d if fe re n t  
c lin ic a l h is to rie s
The reasons fo r f i r s t  sampling cats fo r FCoV antibodies are 
presented in table 4.1. Households broadly fe l l  in to  5 
categories: those which had a case of FCoVV on th e ir  premises,
or in a k itte n  which was bred in the household and had been
sold to another owner; those which suspected FECV in fec tion ; 
those which suspected contact with an excretor of FCoV; and
those with no h istory of contact or illn e ss .
I t  can read ily  be appreciated from table 4.1 that deaths due 
to FCoVV occurred in cats from a ll categories. There were 7 
fu rthe r deaths in the 31 households which had had a death 
w ith in th e ir  household; 4 fu rther deaths in the 14 households 
which had had a sold k itten  die; 5 confirmed cases of FCoVV in 
household 1598 which had the h is to log ica l report o f FECV and 
one in another household with a c lin ic a l h is to ry suggestive of 
FECV. There were 2 deaths in cats from households which had 
been tested because cats had symptoms which might have 
indicated FCoV in fec tion ; one death from the 8 households which 
had no h istory of FCoVV or FECV; and one from the 4 households 
where the reason fo r f i r s t  sampling was unknown.
Thus i t  was concluded that under no circumstances can the 
presence o f FCoV in a household be judged to be non-pathogenic 
on the basis of c lin ic a l h istory or even histopathological 
evidence that the in fection produced enteric lesions.
4 .3 .2  The m o rta lity  ra te  in FCoV in fected  cats
In an attempt to calculate the m orta lity  rate of a FCoV 
in fection  newly introduced into a household, the proportion of 
cats which died o f FCoVV was obtained by d iv id ing the number of 
cats which died of FCoVV in i t ia l ly  (39) by the to ta l number of 
cats in those households which presented fo r testing because of 
a FCoVV death w ith in the household (331): th is  gives a
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proportion o f 12%. I f  seropositive cats alone are counted 
(39/224) a m orta lity  rate of 16% is found. In Chapter 6 i t  
w il l be shown that cats with an IFA t i t r e  of 0 may have anti-N 
antibody which can be demonstrated by immunoblotting, therefore 
the true number of infected cats is  impossible to determine by 
IF alone. The reason the other groups were excluded from th is  
calculation is  because they may have had FCoV in th e ir  
household fo r some time. Of course, some of the group included 
may have had FCoV in fection  fo r some time but in the absence of 
a serological h istory there was no way of discovering th is .
There were 11 subsequent deaths in th is  group: 2 in households 
which subsequently became mainly seronegative, and one in a 
house which became mostly seronegative then seropositive again. 
Hence, 11 divided by the to ta l number of cats at the s ta rt of 
the survey plus the new cats (and excluding those which had 
died of FCoVV at the s ta rt of the survey) (325) gives a figure  
of 3% fo r fu rther m orta lity .
To obtain the m orta lity  rate amongst seropositive cats, the 
to ta l number of subsequent FCoVV deaths in adults from a ll 
groups was divided by the to ta l number o f seropositive cats at 
the beginning of the survey (not counting the adult cats which 
died of FCoVV at the s ta r t) .  The proportion obtained was 
26/599 (4%).
Eighty cats (13%) died from other causes. Since histology was 
available fo r only 14 (2%) of which 2 were inconclusive, i t  was 
only in 2% that there was no sign of FCoVV. These results are 
presented in table 4.3.
Ninety-seven cats were los t to the survey because they were 
re-homed.
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Table 4 .3  The causes o f death in 80 survey cats which died fo r  
reasons other than FCoVV
No. Cause o f death 
cats
10 kidney fa ilu re
Number which were examined 
h is to lo g ic a lly
(focal in te rs t i t ia l  nephritis  
nephritis  and cholangitis) 
(histopathology inconclusive) 
(myeloid leukaemia)
(thymoma
squamous ce ll carcinoma)
7 road accident
6 FeLV
5 FIV
1 FeLV and FIV
4 mammary tumours
3 k ille d  by dogs
2 FUS
2 cardiomyopathy
2 euthanased because of loss
2 euthanased because seroposi
lungworm 
cirrhos is  
pneumonia
fe lin e  ca lic iv iru s  
shot
toxaemic m astitis 
anaesthetic death 
g in g iv it is
ruptured gall bladder 
heart fa ilu re  
eczema
euthanased because aborted 
masses in kidney and alimentary tra c t 
23 unknown 1 (histopathology inconclusive)
1 (p ro !ite ra tiv e  cholangitis
and mesenteric lymphadenitis)
2 (cardiomyopathy) 
o f house tra in ing
t i  ve
1 (lungworm)
1 (c irrhos is)
1 (pneumonia)
4 .3 .3  Sequential IFA t i t r e s  in cats which developed FCoVV
T h irty - fiv e  cats and kittens died o f FCoVV during the course of 
the survey (excluding index cases) and the IFA records o f 21 of 
these are presented in table 4.4. In the other 14 cases e ithe r 
only one or no samples were available. From th is  table i t  can 
be seen that there is no consistent pattern of IFA response 
which could be considered characte ris tic  o f development of 
FCoVV. Cats 5040, 5153, 5164 and 5508 which became
seronegative were thought to have recovered from the in fec tion , 
but histopathology revealed lesions consistent with FCoVV in 
the kidneys of a ll four and also in the eyes and meninges of 
cat 5508. These lesions resulted in the death of these animals 
due to kidney fa ilu re  in cats 5040 and 5164, and neurological 
deficiencies in cat 5508. Cat 5153 had a squamous ce ll 
carcinoma in the mouth and anaemia as well as FCoVV lesions. 
Cat 5164 was FIV positive and the others were FeLV and FIV 
negative. On the basis of c lin ic a l and IFA t i t r e  h istory i t  is 
therefore impossible to d istinguish recovered cats from those 
which w il l  succumb.
i
j
The case records of household 1598, which lo s t most cats to 
FCoVV, are presented as an example in table 4.5 to show that 
the records of the cats which are s t i l l  well in October 1991 
are s im ila r to the records o f those which died.
4 .3 .4  The time course from in fec tio n  to death
I t  can also be seen from table 4.4 that the time course from 
seroconversion to onset of c lin ic a l signs is very variable. 
Eleven cats had been seropositive fo r over a year before they 
developed c lin ic a l signs resulting from the FCoV in fec tion . 
Cats 5149, 5038, 5047 and 5684 were seropositive fo r around
three years before they died. Cat 5040 had been seronegative 
fo r 15 months before he died of the kidney lesions sustained 
during active FCoV in fection . Another 10 cats died o f kidney 
fa ilu re . Histopathology was only available fo r two and they 
had no FCoVV lesions. Other survey cats have been reported to 
have had c lin ic a l signs o f kidney disease which have resolved
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Table 4.4 IFA t i t r e  records o f cats which died o f FCoVV
Cat
re f.
House
hold
Date
T itre
Date 
T i tre
Date
T itre
Date
T itre
Date
T itre
Date 
T i tre
Date
T itre
5038 1598
Apr 88 
320
Sep 90 
1280
Oct 88 
160
Nov 90 
1280
Jun 89 
320
died Nov
Oct 89 
320
90
Feb 90 
1280
Jun 90 
>1280
5040 1598
Apr 88 Oct 88 
40 20 
died Sep 90
Jun 89 
10
Oct 89 
0
Feb 90 
10
Jun 90 
0
Sep 90 
0
5047 1598
Apr 88 
320
Apr 91 
1280
Oct 88 
160
Jun 91 
1280
Jun 89 
160
died Jun
Oct 89 
320
91
Jan 90 
80
Jun 90 
20
Nov 90 
1280
5769 1598
Jun 89 
640
died Mar
Jul 89 
1280 
90
Aug 89 
1280
Oct 89 
640
Jan 90 
320
Jan 90 
1280
Feb 90 
640
5080 1615
Jan 88 
160
Mar 88 
640
May 88 
1280 died Jan 89
5097 1615
Mar 88 
1280
Apr 88 
>1280
Feb 89 
1280
Mar 89 
1280 died Mar 89
5149 1677
Jul 88 
40
died Jun
Oct 88 
20 
91
Apr 89 
80
Sep 89 
80
Mar 90 
320
Sep 90 
320
Jun 91 
1280
5153 1677
Jul 88 
40
Oct 88 
0
Apr 89
0 died Jun 89
5164 1677
Jul 88 
10
Oct 88 
80
Apr 89 
20
Sep 89 
0 died Nov 89
5376 1685
Feb 88 
320
May 88 
1280
Aug 88 
1280 died Aug 88
5377 1685
Feb 88 
1280
May 88
1280 died May 88
»
Table 4 .4  contd.
Cat
re f.
House
hold
Date
T itre
Date
T itre
Date
T itre
Date
T itre
Date
T itre
Date
T itre
Date
T itre
5225 1684
Oct 86 
1280
Jan 87 
1280
Feb 87 
1280 died Feb 87
5508 1689
Apr 88 
320
Jul 88 
80
Oct 88 
160
Apr 89 
80
Dec 89
0 died Apr 90
5340 1768
Mar 88 
40
Jun 88 
320
Jul 88 
40
May 89 
320
Aug 89
160 died Aug 89
5412 1770
Mar 88 
640
May 88 
1280 died Jun 88
5684 1771
Sep 88 
320
Oct 91 
>1280
Jan 89 
320
died Oct
Apr 89 
1280
. 91
Sep 89 
640
Mar 90 
1280
Oct 90 
1280
Apr 91 
640
5466 1776
Jul 88 
20
Oct 88 
1280 died Oct 88
5481 1777
Apr 88 Jun 88 
80 320 
died Mar 89
Aug 88 
320
Oct 88 
1280
Dec 88 
1280
Feb 89 
1280
Nov 90 Jan 91 
Brandy 1781 1280 320 died Jan 91
Jan 88 Mar 88 Jun 88 Oct 88 Feb 89 
5611 1789 640 320 320 80 1280 died Feb 89
5660 1789
Nov 87 Feb 89 
80 1280 died Feb 89
Table 4.5 Sequential IFA tests on cats in household 1598 
showing that IFA sequences are indistinguishable between 
cats which survive FCoV infection and those which succumb.
Cat ref. no.
5038
5039
5040
5041
5042
5043
5044
5045
5046
5047
5049
5050
5051
5052
5053
5767
5768
5049/3/2*
5046/4/1*
Apr
88
320
160
40
160
160
40
160
1280
40
320
40
160
160
40
40
Jun
640
Oct
88
160
40
20
160
40
80
80
160
40
160
40
80
80
80
0
40
Jul 
1280
40
Jun
89
320
20
10
80
20
80
640
1280
80
160
160
1280
80
10
20
160
160 
Aug 
1280
80
Oct
89
320
80
0
80
0
160
320
640
160
320
80
80
20
0
0
40
10
<Dct80
640
10
Feb
90
1280
80
10
160
160
160
640
320
160
80
80
20
10
20
10
160
|80
Jan
320
ie
Jun
90
>
1280
640
0
80
20
40
640
320
640
20
rlehom
320
40
40
80
640
1280
Jan
1280
Sep
90
1280 
1280 
0 
320
sd
640
ebS
640
640
Nov
90
1280
160 
cJiedS 
160 
640 
160 
320 
1280 
640 
1280
10
40
20
40
640
20
Apr
91
died
0
sp 90j FCo\
40 
40 
20
320 ^an avfay Aijig 91 
320 
1280
1280
no
0
10
10
10
640
40
died Mar9C 
Jul Nov9P 
640 I 320
Jun 
91
Nov $0 effilisive FfCoVty
Vies
non-
1280 died 
n-effusive
effusi 
Way ^ 1 
160
ons in
Jun 9 
FCoW
/e FCoW
kid nay
* These are kittens. The ref. no. refers to the queen's ref., the no. of litter 
then the no. of kitten within the litter. These kittens were sold, the new 
owner kindly allowed testing to continue.
Except where otherwise stated, these cats were well in Oct 91.
successfully with treatment.
4 .3 .5  Re-exposure o f the seropositive cat to  FCoV
Forty-seven cats were selected whose antibody level fe l l  by 4 
two-fold d ilu tions  ( i f  over 320 to begin with) or 3 two-fold 
d ilu tio n s  ( i f  160 or 80) and then rose again abruptly. Cats 
whose antibodies disappeared were not included because the 
intention was to examine seropositive animals which had been 
re-exposed to FCoV e ither from without or by recrudescence of 
la ten t virus in th e ir  own bodies. No doubt, other cats with 
more even levels of antibodies throughout the survey were also 
re-exposed to v irus, but since there was no way of detecting 
these cats, they could not be counted. Only one of the 47 cats 
(cat 5047) succumbed to FCoVV. Thus i t  appears that ADE is  not 
a major problem in na tura lly  occurring FCoV in fection .
4 .3 .6  Reinfection o f seronegative households
Cats in 9 o f 24 households which had become predominantly 
seronegative seroconverted again. The reason could be traced 
to the introduction of a new cat (houses 1682, 1693, 1779,
1782, 1790 and 3117), as an example, household 1790 is
illu s tra te d  in table 4.6. Two of the cats from household 1775 
had gone to an untested stud; in household 1690, there was a 
free-ranging pet cat (5267) which alone remained seropositive 
when the rest of the household was seronegative and whose t i t r e  
rose shortly before the other cats seroconverted again. 
Household 1690 is shown in table 4.7. The seronegative cats in 
household 1774 were allowed to mix with the three remaining 
seropositive cats and two new seropositive cats were 
introduced. In household 1779, a cat, which had not d ire c tly  
contacted the new a rr iv a l, seroconverted, showing ind irec t 
transmission.
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Table 4.6 Sequential IFA tests on cats in household 1790 
in which FCoV was re-introduced by purchase of an infected 
kitten.
Cat ref. no. Oct87
Nov
87
Dec
87
Jan
88
Mar
88
Jun
88
Oct
88
Apr
89
Feb
90
5624 320 320 1280 40 0 0 20 320
5625 320 160 320 20 20 0 0 40
5626 160 160 1280 80 0 320
5627 160 160 320 80 160 80 10 80
5628 80 40 80 20 80 0 0 40 10
5629 40 40 20 20 20 20 0 160
5630 80 40 160 20 preg. ) o 0
5631 80 20 160 20 80 0 0 320
5632 0 0 0 0 0 ipreg. I 0 320
5633 0 0 0 0 0 320
5634 128C' 1281) diec I Nov 37, oculars gns
5635 20 0 20 0 0 0 0 320
5636 0 0 20 0 40 0 0 0
5637 0 0 0 0 0 0 0
I
20
5705/1/1 Furchesed Jan 89, test 3d 80 returnedt<) breeder
Except where otherwise stated, these cats were well in Sep 90.
Table 4.7 Sequential IFA tests on cats in household 1690 
in which FCoV was re-introduced by cat 5267 which was the 
only free-ranging cat.
Cat ref. no. May88
Jul
88
Oct
88
Jun
89
Mov
89
Feb
90
May
90
Jun
90
Sep
90
Feb
91
Oct
91
>
5267 320 80 80 160 40 160 20 40 0 0 1280
5266 320 40 20 0 1280 40 1280
5270 10 10 0 0 640 80 0
5263 0 10 0 0 320 160 80 20
5265 640 80 0 1280 640 10 160
5268 80 20 0 0 1280 80 1280
5262 20 20 0 0 160 80
5264 160 40 0 0 0 80 320 128C 20 320
5269 320 40 0 0 1280 640 0 0
5113
acqui ed Dcic88
0 0 1280 1280 0
5271 died Apr 8 3 FCcWcc nfirm<;d
5073 acquired Jun 89 0 640 80 0 80
Except where otherwise stated, these cats were well in Oct 91.
4.3.7 Loss o f FCoV antibodies
In 24 households 50% or more of the cats became seronegative by 
June 1991. The survey households are presented in table 4.8. 
In 9 o f these households cats subsequently became seropositive 
again. Therefore at the end of the survey, in 57 households 
over 50% of cats were seropositive. Antibody loss occurred in 
periods ranging from 3months (households 1594 and 1690) to 
35months (1684).
In the 24 households, in i t ia l ly  37 cats were seronegative and 
145 (80%) seropositive. At the end, 132 were seronegative and 
44 (25%) seropositive. To check whether th is  was because the
seronegative households had been followed fo r longer and 
therefore had more time to lose th e ir  antibodies, the in terva ls 
in months between the f i r s t  and la s t tests were added together 
fo r each of the groups and divided by the number of households. 
In seronegative households: 357m divided by 24 households = 
14.9m (range 3-35m.) In seropositive households 995m divided 
by 53 households = 18.7m (range 5-41m). Thus, the seropositive 
households had, on average, been followed fo r s lig h t ly  longer 
than the seronegative households but the difference was not 
s ig n ifica n t.
To determine i f  the number of cats in the households affected 
the outcome, the average number of cats in the households in 
the 2 groups was calculated. I t  has to be borne in mind that 
not a ll o f the cats in a household might be tested fo r reasons 
such as age of cat or pregnancy. However these factors were 
s im ila r fo r both groups. In the households in which cats 
became seronegative there were 290 cats, giving 12.1 cats per 
house. In the households where cats remained seropositive 
there were 538 cats, giving 10.1 cats per house. There were 
more cats, on average, in the households which became 
seronegative, though not s ig n ifica n tly  more. However, as is  
shown below, the grouping of the cats w ith in  these households 
was an important factor in the outcome.
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Table 4 .8  The outcome o f the survey households.
The households are grouped under the reason fo r f i r s t  presenting fo r 
FCoV testing . In 24 households, over 50% of cats became seronegative. 
The time from f i r s t  testing to most being seronegative is given along 
with the time the household was surveyed. The bracketed households 
became negative then IFA t it re s  rose again.
Owner s ta r t No. end In te r Time No. Re­ De
r e f + - new + - -val to ta l FCoVV home ot
cats
Cats died o f FCoVV on premises
216 8 0 - 4 4 4m 7m 0 0 0
1594 6 1 1 2 5 3m 3m 0 1 0
1596 10 0 - 6 3xU ? 8m 0 0 0
1613 6 0 2 1 3 24m 36m 0 0 2
1615 22 1 1 18 2 17m 2CA 4 0
1627 3 2 - 3 1 5m 0 0 0
1673 5 3 - 2 5 5m 5m 0 0 0
1674 6 3 - 0 8 11m 23m 0 0 0
1677 24 1 1 20 4 26m 2CA 0 6
1678 10 0 2 8 3 20m 0 0 1
1680 6 0 6 11 0 31m 0 0 1
1682 } 6 0 1 1 4 14m 0 0 0
} 4 2 39m 0 0 0
1683 11 2 - 11 2 5m 0 0 0
1690 } 9 2 - 1 10 3m 0 1 0
} 2 11 1 29m 0 0 0
1692 5 3 - 2(2x 10)6 8m 0 0 0
1693 6 7 2 0 12 9m 30m 0 2 0
1694 2 1 - 0 2 9m 9m ISA 0 0
1768 14 0 - 12 0 14m 1CA 1CK 1SK 0 1
1769 2 0 1 1 2 30m 30m 0 0 1
1770 14 0 - 13 0 4m IS 0 1
1773 4 5 - 9 0 11m 0 0 1
1777 16 4 4 5 9 9m 3 1
4 13 4 41m 1 9 3
1778 8 1 - 2 7 14m 14m 0 0 0
1781 8 1 3 8 0 12m ISA 1 1
-1784 4 0 - 1 3 6m 6m 0 0 0
1785 4 0 - 3 1 32m 0 0 0
1790 } 10 4 2 2 12 8m ISA 0 0
} 12 3 19m
2097 1 0 - 1 0 28m 0 0 0
3122 21 3 3 16 5 6m 0 6 0
3123 8 4 1 6 2 9m 0 2 2
3124 4 0 1 3 2 19m 0 0 0
Sold k itten s died o f FCoVV
1672 6 0 1 3 0 17m 2SA 2 0
1675 6 0 - 4 2 25m 0 0 0
1684 3 1 2 2 3 35m 35m 1CA 0 1
1686 5 0 - 3 2 5m 0 0 0
1691 7 0 - 6 0 9m 0 1 1
1771 5 0 1 3 3 26m 26m 0 0 0
1775 } 2 1 - 0 4 4m
} 1 4 0 34m 0 0 1
1776 5 0 3 6 0 34m 1CA 1 0
Table 4 .8  contd.
Owner s ta rt No. end In te r Time No. Reh Dead
re f + - new + - -val to ta l FCoVV ome other
cats
1779 3 0 2 0 5 15m 28m 0 0 0
1789 24 1 6 29 2 26m 2CA ISA 0 2
1801 22 1 - 15 3 17m 0 3 0
3117 } 10 5 1 6 6 5m 1
} 3 9 2 21m 0 5 2
3121 8 1 - 7 1 24m 0 3 0
3125 5 0 - 4 0 16m 0 0 0
C lin ica l signs suspicious o f FCoV in fection
54 7 0 1 4 0 14m 0 4 0
1685 41 1 3 31 6 31m 1C IS 5 10
1772 5 0 - 2 3 25m 25m 0 0 0
3095 6 1 1 7 1 14m 1 CK 0 0
C lin ica l h is to ry  ind ica tive  o f FECV in fection
1598 17 0 4 19 1 31m 2C 2 1
1612 2 0 - 2 0 6m 0 0 0
1676 14 0 1 14 1 29m 1CK 1 1
1780 4 0 - 3 1 12m 0 0 4
In contact with real or suspected FCoV excretor
1614 9 0 - 9 0 5m 0 0 0
1681 8 0 - 4 0 8m 8m 0 6 1
1687 13 0 - 11 0 30m 0 2 0
1689 10 0 - 7 3 26m 1 0 1
1774 } 10 2 2 4 10 11m
} 5 5 9 29m 0 4 1
1788 13 2 8 (2U) 3 24m 0 2 3
2439 1 0 - 1 0 9m 0 0 0
2863 7 0 1 5 2 24m 0 1 0
No h is to ry ind ica tive  o f FCoV in fection
1595 7 3 1 10 0 37m 0 1 2
1679 6 3 - 3 5 22m 40m 0 1 2
1695 10 0 10 0 7m 1CA 0 0
1782 } 8 0 - 4(3x10) 4 16m 0 0 0
} 3 11 1 32m 0 0 0
1786 4 1 - 2 3 26m 37m 0 0 0
3119 1 2 - 3 0 21m 0 0 0
3120 6 3 1 7 1 28m 0 2 1
Reason
3
fo r
2
f i r s t
2xU
sampling unknown 
4 0 7m 0 0 1
1688 2 2 3 1 10m 0 0 0
1783 19 0 19 0 12m 0 6 1
1787 9 3 11 1 24m IS 0 0
S = suspected of FCoVV + = positive
C = h istopathologica lly confirmed - = negative
A = adult
K = k itten
The next factor to be examined was the antibody t i t re s  in each 
of the households. Presumably, cats which mount a high 
antibody response take longer to become seronegative than those 
which have less antibodies. In 22 households the highest t i t r e  
reached was less than or equal to 640, while in a ll o f the 
other 50 households one or more cats had had an IFA t i t r e  o f 
1280. Eleven of these 22 households went on to become mostly 
seronegative, which is obviously a greater proportion than in 
those households which remained seropositive.
In the households which became seronegative at the end, 37 cats 
were seronegative at the beginning and 145 were seropositive. 
In those households which remained seropositive throughout the 
survey, 473 were seropositive at the s ta rt and 45 were 
seronegative. This is a very s ig n ifica n t difference by chi - 
squared analysis (p < 0.001). Therefore the proportion of 
seronegative cats at the end is influenced by the proportion of 
seronegative cats at the s ta rt. This may seem obvious, but i t  
should be noted that i t  was not necessarily the same cats which 
remained seronegative throughout the survey (as can be seen in 
table 4.7): many o f those which began the survey seronegative 
became seropositive and vice versa.
A computer programme was devised to select cats whose IFA 
t it re s  had fa llen  from 320 or over to 20 or less, and those 
whose t it re s  had risen from less than 20 to 320 or over by June 
1990. The IFA t it re s  of 71 cats had risen, o f which one had 
died of FCoVV. The antibody t it re s  of 96 cats had fa lle n , and 
one of these cats had died o f FCoVV.
The groupings of the cats were classifed as 'sm a ll' i f  up to 3 
cats, 'medium' i f  4-10 cats and 'la rg e ' i f  over 10 were 
present. Where the groupings of the cat altered, the 
predominant grouping around the time of the t i t r e  change of 
in te rest was taken. The t it re s  of some cats rose and f e l l .  Of 
those whose t it re s  had fa lle n , 20 were housed in small groups, 
30 in medium and 18 in large and 3 were unknown. Of those
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whose t i t re s  had risen, 44 were in small groups, 25 in medium, 
20 in large and 7 unknown. Group size was found to
p
s ig n if ic a n tly  a ffec t whether a ca t's  t i t r e  rose or fe l l  (Chi^ = 
6 .88, p < 0.05 at 2 degrees of freedom). Neither the ca t's  age 
nor whether pedigree or domestic affected the t i t r e .
A s im ila r programme selected cats whose antibody t i t r e s  
remained at less than or equal to 20 fo r 3 or more tests. One 
hundred and fo rty -fo u r cats had mainly low t i t re s  fo r an 
average of 66.2 weeks (and 3 fo r an unknown tim e): of these 55 
were in small groups, 48 in medium groups, 29 in large groups 
and the group size of 14 was unknown. One cat o f 144 died of 
FCoVV.
F ifty  cats had IFA t i t re s  equal to and over 640 fo r at least 3 
tests and there were 4 deaths to FCoVV in th is  group. Of these, 
16 cats were in small groups, 22 in medium groups, 8 in large 
groups and the group size of 4 was unknown. Chi^ was 2.73 
which is  s ign ifica n t (p < 0.25) at 2 degrees of freedom.
4 .3 .8  FCoVV in  FeLV and FIV in fected households
Seven out o f 43 households had endemic FeLV in fection  and 6 of 
29 households had FIV positive cats. Three cats from FeLV 
positive  households and 14 from FeLV negative households 
developed FCoVV. Comparison of cat m orta lity  due to FCoVV in 
houses which had FeLV and those which did not, showed that 
there was no s ig n ific a n tly  greater m orta lity  rate in houses in 
which FeLV is  endemic. Cats from 4 FIV positive  and 8 FIV 
negative households died of FCoVV which is  s ig n ifica n t (p < 
0.25).
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4 .4  DISCUSSION
4 .4 .1  FECV or FIPV?
In the lite ra tu re , much has been made of the range of 
pathogenicity o f FCoV which can be found in cats inoculated
with laboratory stra ins [9, 11, 23, 66, 96, 104, 111, 113,
133, 126]. Veterinarians have been led to believe that the
presence of FCoV antibodies in a cattery may not necessarily 
indicate the presence o f a virus capable o f causing FCoVV. In
th is  survey, there were FCoVV deaths in a ll the groups of
seropositive households, regardless o f the f i r s t  reason fo r
presentation. Therefore an important find ing in th is  study was
that no d is tin c tio n  can be made between stra ins of FCoV in the 
f ie ld  on the basis of c lin ic a l and serological h is to ry. A ll 
FCoV in fections should be regarded as p o te n tia lly  pathogenic.
4 .4 .2  The m o rta lity  ra te  in seropositive households
The m orta lity  rate was highest (12%) at the s ta rt of the survey 
in those households which were included because they had had a 
death from FCoVV. With time, the m orta lity  rate fe l l  in th is  
group to the same level as found in seropositive cats in a ll 
the other groups (3-4%). This finding agrees with previous 
authors who reported that morbidity due to FCoVV rare ly exceeds 
30% in cattery reared cats and in most cases is less than 5% 
[102, 105]. An explanation fo r th is  finding may be that the
cats in households which presented fo r FCoVV death were meeting 
the in fection  fo r the f i r s t  time and therefore had no immunity 
to i t .
Whether or not the outcome of FCoV in fection in any p a rticu la r 
cat depends on the stra in  of the FCoV or on the ca t's  immune 
response to the in fection remains to be seen. Certainly, no 
household sustained large losses from which one might 
extrapolate that there was no p a rticu la r ly  v iru le n t s tra in  of 
FCoV at large in these households. Death rates fe l l  a fte r what 
is presumed to be the primary in fection ind icating that some 
degree o f immunity or resistance to in fection existed in most
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of the cats.
The figure  o f 3-4% m orta lity  may well rise  as the remaining 
cats are followed over the next few years because deaths from 
seemingly unrelated causes (kidney fa ilu re  and neurological 
signs) were shown to have th e ir  o rig in  in FCoV in fec tion . 
Since cats 5038, 5047, 5149 and 5684 had incubation periods of 
3 years or more, i t  is  also l ik e ly  that there w il l  be more 
losses due to classical FCoVV as we continue to observe the 
cats. Presently there is no way of d istinguishing an immune 
cat from one which w ill succumb to FCoVV.
4.4.3 IFA t i t r e s  in cats which developed FCoVV
In experimental in fections of cats with FCoV, the antibody 
t i t r e  rose rapid ly and consistently and th is  was assumed to be 
the pattern which would be found in the f ie ld  [49, 71, 102,
112, 140]. The results of th is  survey show that th is  is not
the case. While 9 cats which developed FCoVV did have steadily
climbing IFA t i t re s  and 4 had consistently high IFA t i t r e s ,  in 
5 other cats, IFA t it re s  actually f e l l .  In cats 5040, 5153,
5164, 5340 and 5508 the IFA t it re s  never rose above 320, or
indeed 40 in the case of cat 5040. One explanation of th is  
find ing is that i t  is not the t i t r e  o f antibodies that is 
important, but whether the balance o f antibody and virus is
such that ICs can be formed. Thus a cat which has a low
antibody response to FCoV w il l  s t i l l  be in danger i f  the amount 
of virus in i ts  blood is such that ICs can be formed and
vascular damage ensue.
In te res ting ly , none of the 48 cats which remained IFA negative 
throughout the survey developed FCoVV although, as is  shown in 
6.3.5, many had anti-N antibody and must have been exposed to 
v irus.
Cat 5569 was seropositive from March 1988 to April 1991 and her 
IFA t i t r e  was 320 fo r two years fa llin g  to 40 la t te r ly .  She
did not shed virus because, f i r s t ,  a ll 12 k ittens born in to
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the household were in contact with her and were seronegative 
and, secondly, a ll antibody t it re s  of a ll the other adults 
fe l l  to zero.
4 .4 .4  ADE in the f ie ld
ADE of FCoV in fection  is a commonly reported phenomenon which 
has fo ile d  many vaccine attempts [51, 83, 107, 110, 111, 112,
114, 149]. In th is  survey, previously exposed ( i.e .
seropositive) cats in the f ie ld  did not appear to be more 
susceptible to FCoVV. Indeed, the m orta lity  rate in households 
which had already lo s t a cat to FCoVV appeared to be less than 
at the time of index case presentation.
An explanation of the discrepancy between laboratory results 
and f ie ld  observations may be tha t, in the former conditions, 
virus dose is possibly much greater than in nature. 
Experimentally, sublethal amounts o f v iru le n t virus have been 
shown to be protective but very high doses were almost always 
lethal [112]. Secondly, many experimenters administer the 
virus parenterally, bypassing the mucosae which are the ca t's  
f i r s t  lin e  o f defence against th is  in fection . D if f ic u lty  in 
in fecting  cats with FCoV o ra lly  has been reported [49, 71].
In an experimental attempt to mimic natural in fec tion , up to 6 
virus exposures and f in a lly  subcutaneous inoculation were
needed to induce seroconversion and disease in a group of cats
[71].
I t  is possible that in the m ajority of FCoV infections the
virus remains in the alimentary tra c t and never becomes 
systemic. Like TGEV and CCV, i t  is p rim arily  an in tes tina l
pathogen.
4 .4 .5  Loss o f FCoV antibodies
One th ird  o f the survey households became mainly seronegative 
and seemed to have eliminated the in fection . Fall o f IFA 
t it re s  from over 320 to 20 or less was found to be 
s ig n ific a n tly  associated with keeping the cats in groups of 3
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or less. In Chapter 5 i t  w il l be shown that approximately one 
in 3 seropositive cats excretes v irus, therefore i t  seems 
lik e ly  that th is  management system simply reduces exposure to 
v irus. Cats which were kept in larger groups remained 
seropositive in d e fin ite ly . Cats could remain seropositive fo r 
a long time (37 months or over) without exposure to external 
virus as was shown by cat 5569 which was in a household in to  
which several l i t t e r s  of seronegative k ittens were born. Her 
IFA t i t r e  remained about 320 fo r over 2 years then gradually 
fe l l  to 40 while the other adults in the household became 
seronegative.
A study of sequential IFA t it re s  in na tura lly  occurring FCoV 
in fection  has only been recorded once before in a colony o f 32 
cheetahs, o f which some s t i l l  had antibodies a fte r 4 years 
[16].
4 .4 .6  Reinfection o f seronegative households
No cat which became seronegative seroconverted again without a 
h is tory of exposure to a possible external source of v irus. 
Therefore seronegative cats do not appear to harbour la ten t 
virus which can recrudesce.
'4 .4 .7  Conclusion
The question facing veterinarians when FCoV is endemic in a 
household is  whether or not IFA testing is  worthwhile. The 
answer to th is  question w ill depend on the reason why testing 
is being considered. I f  i t  is to try  to establish the virus 
excreting status or prognosis of a pa rticu la r cat w ith in  the 
household, then testing the adults w ill not be useful. Neither 
w ill a one-off test o f a colony be p a rticu la r ly  helpful unless 
i t  is to establish whether or not FCoV is endemic w ith in  the 
colony. However, repeated testing w ill determine whether or 
not the household is the one in three which w ill become 
seronegative and therefore the virus excreting status of the 
whole household w il l  be determined.
Repeat testing is useful fo r cat owners who are w illin g  to keep
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seropositive and seronegative cats apart in small groups in 
order to help th e ir  household to become seronegative. However, 
as is shown in Chapter 5, the cat with an antibody t i t r e  o f 40 
is ju s t as l ik e ly  to excrete virus as one with a t i t r e  of 1280 
so grouping the seropositives according to t i t r e  is probably 
not usefu l.
Testing is  best performed every 3-6 months in the f ie ld ,  as 
s ig n ifica n t change in IFA t i t r e  in less than 3 months is 
uncommon.
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CHAPTER 5
A STUDY OF KITTENS FROM QUEENS NATURALLY EXPOSED TO FCoV
5.1 INTRODUCTION
5 .1 .1  Source o f in fe c tio n
In the UK, the highest incidence of FCoVV is in pedigree cats 
up to eighteen months of age ( f ig .s  3.8, 3.9) [140]. Given the 
lack o f a h istory of contact with other cats in th e ir  new 
homes, i t  seemed reasonable to assume that most of these cats 
became infected in the cattery o f o rig in  rather than by meeting 
the virus a fte r sale [114]. As stated in Chapter 4, many of 
the survey households only became aware o f the presence of FCoV 
in th e ir  establishments when a k itten  which they had sold went 
on to die of FCoVV (table 4.1).
In th is  study, we were interested to discover what happened to 
k ittens born into seropositive households. The serology of 
these kittens was investigated in conjunction with other 
factors such as age, breed of queen and management of k ittens . 
The serology of na tura lly  infected kittens has previously only 
been examined in one household [ 110] .
FCoV appears to be spread mainly from ca rrie r queens to th e ir  
k ittens w ith in the f i r s t  few weeks of l i f e  [114]. Virus is 
probably ingested a fte r b irth  [106] although there is evidence 
of transplacental [85, 106] and ind irec t transmission [110]. 
However, the source of in fection has remained speculative [9 ]. 
Since the virus cannot survive fo r long periods outside the 
host, ind irec t transmission is un like ly to be a major source 
[100]. Most cats which develop FCoVV have no h istory of being 
in contact with a c lin ic a l case of FCoVV. I t  has been 
postulated that FIPV could be a v iru le n t mutant of a chronic, 
asymptomatic FECV in fection [110, 108]. The most l ik e ly  source 
of FCoV is healthy, ca rrie r cats [106].
107
The existence o f healthy seropositive carrie rs has been 
demonstrated by placing 12 week old SPF kittens with healthy 
seropositive cats. Seroconversion of the k ittens occurred 
a fte r 2 - 1 0  weeks [ 110] .
Many questions remain about FCoV ca rrie r cats. For example, i t  
is  not known i f  ca rrie r cats go on to develop FCoVV; how long 
they excrete v irus; whether seronegative cats excrete v irus ; i f  
any pa rticu la r antibody t i t r e  is associated with virus 
excretion; or what proportion of seropositive cats are carrie rs  
[9 ]. Those questions were addressed in th is  study.
Another question which was considered was at what age should 
kittens be tested to gain an accurate idea of whether or not 
they had been infected.
5 .1 .2  Health o f the k itten s
Given the long incubation period o f FCoV from time of in fection  
to development o f c lin ic a l signs, health was monitored before 
and a fte r sale of the kittens as fa r as possible.
Circumstantial evidence suggests that in i t ia l  in fection  with 
FCoV is accompanied by mild URT signs [5, 132, 140] or
diarrhoea [132,140]. There are many possible causes of 
diarrhoea in kittens apart from FCoV: d ie tary, p a ras itic ,
bacterial and v ira l.  Therefore the prevalence of antibodies to 
FCoV was examined in kittens with and without diarrhoea. 
Kittens in both groups were from the same households so that 
other environmental factors would be the same as fa r as 
possible. FECV is alleged to cause inapparent to m ild ly  severe 
e n te r it is  in k ittens between 5-12 wks of age [103,-110, 111].
E n te ritis  has also been reported in f ie ld  cases of FIP [48].
In experimental in fections, pre-existing antibody enhances the 
disease [109, 110, 112, 156]. I t  has also been suggested that 
fewer cats develop FIP a fte r FIPV ingestion i f  they had been
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previously infected with FECV but that in those which do 
develop the disease i t  is enhanced [111]. However, MDA may 
confer some degree of immunity; eight k ittens born to immune
queens were protected from challenge at 8-10 weeks of age
[114]. In the present study, the health of the k ittens a fte r
they le f t  th e ir  breeding establishments was monitored to t ry  to 
determine i f  seropositive k ittens were more of less l ik e ly  to 
develop FCoVV.
5 .1 .3  K itten  M o rta lity  Complex (KMC)
KMC is defined as reproductive fa ilu re  ( fa ilu re  to concieve; 
foetal resorption; abortion; s t i l lb ir th s ;  congenital b ir th  
defects)- k itten  m orta lity  (fading k ittens ; acute congestive 
cardiomyopathy: FIP) [125]. FCoV has been implicated in the
KMC [57, 85, 89, 99, 125, 153].
While there is no doubt that there is a high incidence of FCoV 
se ropos itiv ity  in many catteries which have th is  complex, i t  is 
also true that i t  has been observed in seronegative ca tte ries 
and that there are seropositive catteries in which i t  does not 
exist [104, 114].
In th is  survey, the incidence o f the various signs which make 
up th is  complex was examined.
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5.2  MATERIALS AND METHODS
5 .2 .1  Source o f in fec tio n
Kittens from the survey described in Chapter 4 were bled one to 
three times before they were sold. Only k ittens over 7 weeks 
and under 16 weeks of age are included in table 5.1. Their 
antibody t i t r e  was measured by IFA as described in Chapter 2. 
Low antibody t i t re s  are d i f f ic u l t  to in te rp re t, so whenever 
there was a k itten  with a t i t r e  of 10 the serology of its  
litte rm ates was taken in to consideration. When several o f a 
l i t t e r  were seronegative but one k itten  had a t i t r e  of 10, that 
l i t t e r  and k itten  were considered to be seronegative.
Four hundred kittens from 98 queens f i t t in g  the c r ite r ia  above 
were sampled. Fifteen queens had more than one l i t t e r .  The 
cats were from 41 households, 19 of which had cases of FCoVV in 
adults and 12 had cases in kittens which had been sold out of 
the house. Four had been in d irec t contact with cats in 
households which had had a case o f FCoVV. In 2 households 
testing was in it ia te d  because the cats had chronic diarrhoea. 
FECV had been diagnosed h is to lo g ica lly  in one and was suspected 
in the other. In 4 households there was no h istory o f FCoVV or 
diarrhoea.
Kittens were c lass ified  according to th e ir  environment at the 
time o f the f i r s t  blood sampling. These were: 'normal' (N) i f  
the k ittens were allowed to mix with the rest o f the household, 
'mother' (M) i f  the k ittens were isolated with th e ir  mother and 
'iso la te d ' ( I)  i f  the kittens were isolated from a ll adult 
cats, including th e ir  mother, from 2 - 6  weeks of age. Choice 
of k itten  environment was e n tire ly  at the breeder's d iscre tion .
The reference numbers of the k ittens re fe r f i r s t  to the queen's 
reference number, the number o f the l i t t e r  (which is an 
indication of how many l i t t e r s  that queen had had) then the 
number of the k itten  w ith in that l i t t e r .
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Table 5.1 Effect o f environment on FCoV in fection  o f k ittens 
from seropositive households
Total no. o f l i t t e r s  
Total no. o f k ittens
L itte rs  becoming seropositive
No. o f l i t t e r s  
Total no. o f k ittens 
No. seropositive k ittens 
No. developing FCoVV 
No. seronegative k ittens 
No. developing FCoVV
Environment 
Normal Mother Isolated
81
238
39
114
12
46
50 11
134 39
124 (52%)* 35 (30%) 
5 * *  j * * *
10 (4%)**** 4 (4%)
0 0
L itte rs  becoming seronegative
No. o f l i t t e r s
No. seronegative k ittens
No. developing FCoVV
31 28 12
104 (44%) 75 (66%) 46 (100%)
0 0 0 .
Key:
No. = number
FCoVV = fe lin e  coronavirus-associated vascu litis
*  percentage of to ta l no. of k ittens in that environment
* *  2 diagnosed by c lin ic a l signs and t i t r e ,  3 confirmed by
histopathology.
* * *  confirmed by histology
* * * *  In one of the l i t t e r s  a ll o f the k ittens were seronegative 
at 9 weeks and one k itten  seroconverted at 16 weeks. The 
t i t r e  o f the other two kittens was not available so these 
two are counted neither positive nor negative.
5 .2 .2  Health o f the k itten s
Breeders were requested to report on the k itte n 's  health p rio r 
to sale. They were asked i f  there had been any diarrhoea; 
fa ilu re  to gain weight as normal; sneezing; ocular discharge; 
or other signs. The breeders were contacted regu larly to ask 
i f  they had heard how the kittens were doing in th e ir  new 
homes. Unfortunately, few of the people who bought the k ittens 
allowed sampling a fte r the k ittens had le f t  the breeding 
establishment. Some kittens were kept by th e ir  breeders and 
became part of the general survey.
I am gratefu l to Dr Chris Robertson fo r s ta t is t ic a l analysis of 
the k itte n s ' health data.
5 .2 .3  K itten  M o rta lity  Complex
Post mortem material was sp e c ifica lly  requested from abortions, 
s t i l lb ir th s ,  fading or deformed kittens from seropositive 
households fo r histopathology. Because se ropos itiv ity  does not 
necessarily re fle c t in fe c t iv ity ,  the incidence of these 
abnormalities was examined in l i t t e r s  where presence or 
absence of FCoV antibodies in litte rm ates was known.
I l l
5.3  RESULTS
5 .3 .1  Waning o f MDA and seroconversion o f k itte n s
I t  was assumed that maternal antibody to FCoV disappeared by 7- 
8 weeks of age [111, 114] and that any antibody t i t re s  found in 
older k ittens thereafter t ru ly  re flected exposure of the 
kittens to coronavirus. This assumption seemed reasonable since 
five  queens with high t it re s  (1280) in M and I environments 
produced 15 kittens which had no detectable antibodies at 
e ight, nine, ten and twelve weeks respectively at the time of 
f i r s t  tes ting . L it te r  5691/2 had antibodies at 6 weeks which 
had gone by 9 weeks.
Sequential weekly testing of kittens from b irth  has only been 
reported once [111] where MDA was found to wane by 4-6 weeks of 
age. Antibody reappeared around 8-14 wks of age as the k ittens 
became infected. In th is  survey, p lo ttin g  the t i t r e  o f the 
k itten  against that of the queen supported th is  time scale 
since k itten  antibody levels equal to , or greater than, those 
of the queens started to appear from 8 wks (Fig. 5.1).
Fig. 5.2 shows the proportion of seropositive and seronegative 
k ittens aged from 1 to 12 weeks. The percentage of 
seronegative k ittens fa lls  between 5 and 10 weeks and the 
percentage of seropositive kittens rises. A fte r ten weeks the 
levels remain around 50%. I t  appears that not a ll infected 
k ittens are able to seroconvert before 10 weeks of age.
In only a few l i t t e r s  were 3 blood samples available fo r more 
than one member of the l i t t e r .  In l i t t e r  5717/1 two out of 
three kittens were, seronegative at 8 weeks, but a ll 3 had 
become seropositive by 12 weeks. L it te r  5043/1 was 
seronegative at 10 weeks and seropositive at 14 weeks. Three 
o f 4 k ittens of l i t t e r  5760/1 were seropositive at 8 weeks and 
a ll were seropositive by 11 weeks. L it te r  5476/2 was 
seronegative at 9 wks though 5476/2/2 was seropositive at 15 
and went on to die of FCoVV. In the same household only 2 o f 6
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in l i t t e r  5473/1 were seropositive at 12 weeks.
The k ittens of l i t t e r  5340/2 were a ll seropositive at 9 weeks 
with t i t re s  o f 20, 20, 80, 40 and 10 respectively. Kittens 
5340/2/1, 4 and 5 were seronegative by 13 weeks and 5340/2/2
and 3, whose t i t re s  were 20 and 80 at 9 weeks, had t i t re s  o f 20 
and 40 by 13 weeks. K itten 5340/2/3 went on to die of FCoVV. 
The queen's t i t r e  at the k itte n 's  b ir th  was 40 and had risen to 
320 when the kittens were tested at 9 weeks of age.
5 .3 .2  Influence o f environment
The resu lt of the e ffec t of environment on in fection  of k ittens 
is  shown in Table 5.1. Clearly the management of the 
seropositive queen and her k ittens strongly influenced the 
prevalence o f exposure to FCoV. The differences in proportion 
of seropositive kittens in each environment were highly 
s ig n ifica n t by Chi-squared analysis (p <0.05).
Table 5.2 shows the seroconversion and environment of l i t t e r s  
from queens which had more than one l i t t e r .  This confirms that 
k ittens kept in a N environment were more lik e ly  to 
seroconvert. Queens which had had a seronegative l i t t e r  in I 
or M environment had a seropositive l i t t e r  in the N environment 
(queens 5047, 5265, 5444, 5633, 5695 and 5698) despite th e ir  
own t i t re s  being zero or fa ll in g .
Figs 5.3, 5.4 and 5.5 show that the age, breed and antibody
t i t r e  of the queens were evenly d is tribu ted  throughout the 
three environments.
5 .3 .3  Virus excretion by queens
Twenty-seven kittens in 10 l i t t e r s  from 10 seronegative queens 
in the M environment were seronegative at 7,8,9,10,12 and 14 
weeks. Five l i t t e r s  were born at a time when the antibody 
levels in the households had fa llen  or were fa llin g  to zero. 
One l i t t e r  o f 8 k ittens from a seronegative queen were a ll 
seronegative at 6 weeks of age and two which were retested
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Table 5 .2  Seroconversion o f successive l i t t e r s  
from the same queen
Queen
re f.
L it te r
no.
Envir. K ittens
seropos/neg
Queen's
t i t r e
5015 2 M + 160
5015 3 N + 1280
5043 1 M + 160
5043 2 N + 40
5047 1 M - 80
5047 2 N + 20
5111 1 N + 80
5111 2 M + 320
5144 3 N + 160
5144 4 M - 1280
5265 3 I - 80
5265 4 M + 1280
5268 2 M - 80
5268 3 I - 20
5340 2 N + 320
5340 3 M + 320
5444 7 I - 40
5444 8 M - 0
5444 9 N - 0
5444 10 N + 40
5460 2 N - 40
5460 3 I - 1280
5476 2 N + 0
5476 3 I - 0
5633 2 M - • 0
5633 3 N + 0
5695 1 M - 0
5695 2 N + 0
5696 1 N + 0
5696 2 M - 40
5698 1 M - 0
5698 2 N + 1280
5698 3 M - 320
Key:
+ = seropositive 
- = seronegative
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remained seronegative at 15 weeks. There were no seropositive 
kittens from seronegative queens in the M environment.
Serial blood samples and information on the health of the 
queens in the M environment were available fo r 10 out o f 11 
queens which had had a l i t t e r  o f seropositive k ittens . These 
are presented in table 5.3. Eight queens were s t i l l  well on 
average 16.5 months a fte r giving b ir th  to the seropositive 
l i t t e r  (range 2-30 months.) One died of h istopatho log ica lly 
confirmed effusive FCoVV 5 months la te r; one was put to sleep 
because she had had a seropositive l i t t e r .
5.3.4. Health o f the k ittens
Table 5.4 shows the h isto ry of those kittens which died of 
FCoVV. There are more k ittens recorded in th is  table than 
shown in table 4.1 because th is  table includes those cats which 
were excluded previously because of age or lack of known 
antibody status. From table 5.4 i t  can be seen that no 
p a rticu la r antibody t i t r e ,  nor any pattern of t i t r e s ,  can be 
said to be predictive of the development of FCoVV.
The range of ages of death due to FCoVV was 1.8-53.2 weeks, 
though most deaths occurred before 35 weeks of age. I t  seems 
reasonable to suppose, therefore, that the m ajority o f k ittens 
which are s t i l l  well a year a fte r f i r s t  being tested w il l  
remain w ell.
Table 5.5 shows the fate of k ittens in the three d iffe re n t 
environments. No kittens which were seronegative went on to 
die of FCoVV.
Of the seropositive kittens in the N environment which were 
retested a fte r 16 weeks, 1 was seronegative by 19 weeks; the 2 
litte rm ates of one which died of FCoVV were s t i l l  seropositive 
at 18 and 25 weeks and s t i l l  well at 55.4 weeks of age; 1 was 
s t i l l  seropositive at 17 and 24 weeks; another at 19 and 26 
weeks; 1 at 20 and 27 weeks; 1 s t i l l  seropositive at 20 weeks
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Table 5.3 Antibody t i t re s  and fa te  o f virus excreting queens 
in the Mother environment
Queen's re f.  Queen's fa te
Oct Mar Jan+ Jun Oct Jun Aug
5015 87 88 89 89 89 90 90
0 0 160 10 0 1280 Fine
Apr Oct Jun Oct Jan Jun Sep
5043 88 88 89 89 90 90 90
40 80 80 160 160 40 Fine
Feb Mar Jul Sep Mar May Oct Sep
5111 88 88 88 88 89 89 89 90
40 20 40 40 80 80 320 Fine
May Jul Nov Jun Aug Jul
5265 88 88 89 90 90 90
640 80 0 1280 640 Fine
Mar Jun Jun May Aug Aug
5340 88 88 88 89 89 89
40 320 40 320 160 Wet FCoVV confirmed*
Aug Oct Jan Apr Sep Apr Oct Oct
5419 88 88 89 89 89 90 90 90
320 80 160 160 320 20 0 Fine
Apr Jun Mar Sep
5587 88 88 89 90
80 80 0 Fine
Feb Jun Oct Feb Oct
5717 89 89 89 90 90
160 40 20 0 Fine
Feb May Oct Jan Oct
5718 89 89 89 90 90
160 40 320 320 Fine
Oct Jan Mar
5746 88 89 89
80 80 euthanased at owner's request
+ Dates in bold are tests nearest the time of the l i t t e r  in the M.
environment
* 5340/1 was three s tillb o rn  k ittens.
5340/2 were 5 k ittens in N environment, one of which went on to die
of wet FCoVV
5340/3 were 5 k ittens in M environment, 1 x 10, 3 x 20, 1 x 40,
ris in g  to 2 x 80, 2 x 160 at 16 weeks (no fo llow  up fo r the
k itten  t i t r e  10) born Mar 89, s t i l l  fine  66 weeks a fte r
th e ir  f i r s t  tes t at 12 weeks.
Table 5 .4  Antibody t i t r e s  o f k itten s  which died o f FCoVV
Ref. Env. Age T itre Age T itre Age T itre Age died C/S Wet/
dry
7001/1/1 M 8 160 8.5 20 8.5 C Wet
5049/3/1 N 17 1280 17.1 C Dry
5049/3/2 N 18 640 22 1280 26 1280 53.2 c Dry
5145/2/1 N 13 10 20 80 30 160 30.5 c Wet
5340/2/3 N 9 80 13 40 17 640 28.2 c Wet
5343/2/2 N 10 20 14 10 13.5 s
5476/2/2 N 9 0 15 80 26 640 32.0 s
5686/1/1 N 13.8 s
5692/1/1 N 1 80 1.8 s -
5762/2/1 N 11 1280 11.2 c Wet
5762/2/4 9.8 s Wet
Key:
Ref. = the k itte n 's  reference number
Age = in weeks
Env. = environment
C = confirmed by histopathology
S = suspected of FCoVV on gross PM alone
Table 5.5 Fate o f the kittens
A live Dead Unknown
Env. Sero No. No. weeks observed FIP other Sold Unknown
pos/neg • Mean in wks (range)
N + 80 53.5 (12.4-135.1) 5 (3xC) 4 (1 diarrhoea) 10 25
N 64 44.4 (16.2-110.7) 0 1 (RTA) 11 28
M + 29 50.0 (6.1-71.1) 1 (C) 0 0 5
M 54 65.3 (13.8-147.2) 0 1 (CCF) 3 22
I 30 49.9 (14.5-87.8) 0 1 (RTA) 6 9
Key:
Env.
+
C
RTA
CCF
environment
seropositive
seronegative
confirmed by histopathology 
road t r a f f ic  accident 
congestive cardiac fa ilu re
was s t i l l  well at 50 weeks; 1 was s t i l l  seropositive 5 weeks 
a fte r being sold and its  antibody t i t r e  had fa lle n  from 160 to 
40; 5 were s t i l l  seropositive at 22 weeks; 2 at 23 weeks; 1 at 
24 weeks; 1 at 45 weeks. In one which was s t i l l  seropositive 
at 25 weeks and showing neurological signs, FCoVV was suspected 
but PM revealed a porto-systemic shunt.
In the N environment, o f the seronegative k ittens which were 
retested a fte r 16 weeks, 3 were s t i l l  seronegative at 27, 33,
44 weeks of age. Six had become seropositive by 17 (th is  cat 
s t i l l  seropositive at 21), 20, 33, 42, 42 ( s t i l l  seropositive 
at 57), and 45 weeks.
The fate o f 5 seropositive k ittens in the M environment was 
unknown. One was a litte rm a te  of the one which died and had an 
antibody t i t r e  of 10 at 10 weeks and zero at 13 weeks. Of the 
seropositive k ittens which were retested a fte r 16 weeks, 3 were 
s t i l l  seropositive at 19 weeks; 1 at 21 weeks; 1 at 34 weeks; 2 
of a l i t t e r  o f 3 were s t i l l  seropositive at 17 weeks and the 
th ird  was seronegative; 2 of 5 were s t i l l  seropositive at 19 
weeks, the other 3 were seronegative; one became seronegative 
by 30 weeks, remaining so at 48 weeks.
In the M environment, 5 of the seronegative k ittens were s t i l l  
seronegative at 22; 23 and 27; 27; 37; and 39 weeks of age. 
Three k ittens were sold 5.8 weeks a fte r testing and no fu rthe r 
data were available from them. Two became seropositive at 25 
weeks; one was seropositive at 26 and 38 weeks and was s t i l l  
well at 70 weeks of age. One seronegative k itten  (5144/4/1) 
died o f congestive cardiac fa ilu re  at a year old, its  tissues 
showed no sign of FCoVV.
Of the 46 k ittens in the I environment, one was k ille d  on the 
road 32.4 weeks a fte r testing ; 4 were sold 2.7, 2.7, 9.5 and
10.1 weeks a fte r testing and 2 were sold at an unknown time. 
Among those tested a fte r 16 weeks, 3 were s t i l l  seronegative at 
25; 1 at 31 and 1 at 60 weeks of age.
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Details o f the health of the k ittens, where available, is 
presented in table 5.6. Forty-one kittens fa ile d  to put on 
weight as normal, 33 of these were seropositive, 8 
seronegative. Thirty-two had diarrhoea and 8 had not. Of the 
seropositive k ittens , 28 had diarrhoea, 4 did not, and the 
status of 1 was unknown. Fifty-seven percent o f k ittens with 
diarrhoea were seropositive compared with 32% of k ittens which 
had no diarrhoea. S ta tis tica l analysis revealed a causal 
re la tionship between diarrhoea and the presence of FCoV 
antibodies. This is s ig n ifica n t by Chi-squared analysis 
(p<0.5).
Twenty-one o f 26 kittens with URT signs or sneezing were sero­
positive  and 2 went on to die of FCoVV. C a lic iv irus  was 
isolated from 3 seronegative k ittens. C a lic iv irus  a r th r it is  
occurred in 3 seropositive k ittens.
5.3.5 K itten M orta lity  Complex
The prevalence of the main signs which make up the KMC are 
shown in Fig. 5.6. There is no difference between the 
proportion of seropositive queens which fa ile d  to conceive, 
aborted or resorbed, had s tillb o rn  or fading kittens and those 
which had none of these problems.
Eleven breeders reported fa ilu re  to conceive in 13 queens. Four 
cats fa ile d  to conceive on more than one occasion. One of 
these was FeLV positive . Two cats were both seropositive and 
seronegative at d iffe re n t times of fa ilu re  to conceive.
Abortion or resorption occurred in 12 cats belonging to 11 
breeders and 2 cats were affected in more than one l i t t e r .  
Eighteen breeders reported s t illb o rn  k ittens from 24 queens. 
Thirty-one queens had fading kittens according to th e ir  21 
breeders. T h irty -five  breeders reported 89 l i t t e r s  which had 
none of these problems.
In table 5.7 the antibody status of litte rm ates of premature,
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Table 5 .6  Health status o f the k itten s
Condition
Completely healthy 
No diarrhoea
Seropositive
35 (21%) 
73 (32%)
No.
FCoVV
0
4
Seronegative
134 (79%) 
155 (68%)
No.
FCoVV
0
0
Diarrhoea 59 (57%)
Ocular discharge 4 (40%)
URT signs/sneezing 21 (81%)
Pneumonia
Ataxia 2
Ascites 2
44 (43%)
6 (60%) 
5 (19%)
3 
1
Poor growth 
Normal growth
No. No. No. No.
d ia r. FCoVV. d id r. FCoVV
33 (80%) 28 1 8 (20%) 4 0
83 (32%) 26 0 180 (68%) 30 0
Key:
No. = number
d ia r. = diarrhoea
FCoVV = fe lin e  coronaviral-associated vascu litis
() = the percentage of the to ta l with the given condition
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Table 5.7 Incidence o f seroconversion o f litte rm ates in KMC
Ref no. Queen's
breed
Queen
t i t r e
's  Littermates 
seropos/neg
Premature
5692/2/2
5692/2/3
5692/2/4
5692/2/5
5 days premature 
5 days premature 
5 days premature 
5 days premature
Persian 40
S tillb o rn
5043/1/4 Foreign 160 +
5184/4/1 Burmese 0 -
5199/1/2 Siamese 0 -
5447/4/2* Abyssinian 80 +
5469/4/2
5469/4/3
5469/4/4
5469/4/5
Russian Blue 160
5476/2/3 Abyssinian 0 -
5595/2/2 Persian 160 -
5626/3/1 Birman 80 -
5682/1/2
5682/1/3
5682/1/4
Persian 320 1 other in l i t t e r  
t i t r e  10 at 6 wks
5703/1/3 Persian 80 +
5718/1/6
5718/1/7
Siamese 160 +
Fading k ittens
5045/2/5
5045/2/6
Burmese 320 +
Key:
The queen's reference number consists of the survey number o f the queen, 
the number of the l i t t e r s  she has had to date and the number o f the 
k itten  w ith in that l i t t e r .
+ = seropositive 
- = seronegative
Table 5.7 contd.
Ref no. Queen's
breed
Queen's
t i t r e
Littermates
seropos/neg
5127/1/2
5127/1/3
5127/1/4
11 wks imperf. anus
23d
23d
Chinchilla 0 “
5062/1/1 erythemic myelosis B ritish  Blue 20 +
5198/1/2 Siamese 20 1 other - at 5wks
5351/1/3
5351/1/4
5351/1/5
Foreign 80 “
5444/9/1 pneumonia Abyssinian 1 -
5447/ 4/ 3* Abyssinian 80 +
5591/4/4 Persian 80 - (6wks)
5593/2/4
5593/2/5
1 day old c le ft  palate Persian 
1 day old
320 - (6 wks)
5596/3/2 Persian 20 -
5692/1/1 13 days, ? FCoVV Oriental 320 + at 2wks - at 12
5696/1/1 12.5 wks Persian 0 +
5698/2/5 Persian 1280 +
5740/1/3
5740/1/4
Persian 320 +
Key:
The queen's reference number consists o f the survey number of the queen, 
the number of the l i t t e r s  she has had to date and the number of the 
k itten  w ith in that l i t t e r .
+ = seropositive 
- = seronegative
deformed, s t illb o rn  and faded k ittens: antibody t i t r e  and breed 
of queen are presented. Histopathology was available fo r only 
a few of these k ittens. Nine out of 23 l i t t e r s  seroconverted, 
showing presence of FCoV in the environment. L it te r  5682/1 had 
one survivor which had t i t r e  10 at 6 weeks, which is  probably a 
t a i l - o f f  o f MDA (the queen had a t i t r e  of 320).
We received one aborted, 5 s tillb o rn  and 31 faded kittens from 
17 households fo r histopathology and the results are presented 
in table 5.8. Histopathological evidence of FCoVV was found in 
only 1 of 31 faded k ittens.
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Table 5.8 
Ref. Age
1801
2863
1788
1686
1785
1679
1681
1615
1782
1777
1686
1676
1695
Histopathology o f k ittens from seropositive households
Breed
12h 
4 w
14d
6 w 
4 w
1790 3 d
1596 1 d
1594
Hart 2 w
Hughes 4 w
Persian
Persian
Persian
Ragdoll
Russian Blue 
Burmese
Siamese
Persian
Birman
Condition
aborted ND* 
s tillb o rn  ND 
s tillb o rn  ND
s tillb o rn  Spina b ifid a , malfor­
mation o f vertebrae, 
myelodysplasia 
s t illb o rn  ND
s tillb o rn  ND but thymus poorly 
developed
p ro life ra tive  pneumonia
ND
FIE
ND
non-specific enteropathy and leukocytosis 
erythemic myelosis
thymic atrophy, depletion of Ragdoll
lymphoid organs
1 d lordosis Ragdoll
ND Persian
bacterial p e r ito n it is  Somali
acute exudative bronchopneumonia 
acute exudative bronchopneumonia 
acute exudative bronchopneumonia
ND Birman
ND Devon Rex
ND Colourpoint
ND Colourpoint
FCoVV Devon Rex
ND Siamese
Key:
*ND No evidence of any infectious disease including FCoVV 
d = days 
h = hours 
w = weeks
Table 5 .8  contd.
Ref. Age Condition Breed
1598 4 d ND Siamese
4 d ND Siamese
1690 1 d ND Persian
1 d ND Persian
1 d ND Persian
1 d ND Persian
1774 5 w thymic atrophy, c a lic iv iru s  in f 'n Abyssinian
5 d smothering Abyssinian
1 d lordosis Abyssinian
5 d ND Abyssinian
2 w exudative bronchopneumonia Abyssinian
3 w exudative bronchopneumonia Abyssinian
pneumonia Abyssinian
2 w exudative bronchopneumonia Abyssinian
2 w exudative bronchopneumonia Abyssinian
Key:
*ND No evidence of any infectious disease including FCoVV. 
d = days 
h = hours 
w = weeks
DISCUSSION
5 .4 .1  Waning o f MDA and seroconversion o f k itten s
In those k ittens which were seronegative at 8,9, and 10 weeks 
and seropositive a few weeks la te r, i t  was impossible to 
ascertain whether th is  reflected la te r in fection  or delayed 
seroconversion.
In l i t t e r  5340/2, 5 k ittens were seropositive at 9 weeks and 3 
became seronegative by 13 weeks. One of the two which remained 
seropositive went on to die of FCoVV. Since the queen's 
antibody t i t r e  around the time of b ir th  o f these k ittens was 
40, i t  is  un like ly  that the k itte n s ' antibody was maternally 
derived. (T l/2  ° f  MDA in FCoV in fection is 7 days [111].) I t  
would appear, therefore, that a ll o f the l i t t e r  were exposed to 
la te r FCoV in fection and seroconverted, but most of them 
recovered and soon became seronegative. A previous report of 
FCoV in fection  in k ittens noted that IFA t i t re s  peaked rapid ly 
then dropped to undetectable levels in a month or so while 
virus neutra lis ing antibody t it re s  remained high [ 112] .
The serological pattern of l i t t e r  5340/2 is  consistent with 
experimental findings in which sublethal doses of FIPV were 
given to cats so that some animals recovered, while others 
succumbed. M orta lity  did not increase with increasing dose 
in a predictable way, suggesting that host su sce p tib ility  is  as 
important as virus dose in the development o f the disease. 
[112].
Queen 5340 went on herself to die of FCoVV. In previous 
surveys i t  was noted that when several cats from the same 
colony were affected they tended to e ither be litte rm ates or 
successive l i t t e r s  from the same queen [101, 116, 140]. One
explanation fo r th is  could be that there may be genetic 
predisposition to the disease.
The kittens in l i t t e r  5476/2 were seronegative at 9 weeks
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though 5476/2/2 was seropositive at 15 weeks and went on to die
of FCoVV. In the same household only 2 of 6 in l i t t e r  5473/1
were seropositive at 12 weeks. This finding is s im ila r to the 
experimental s itua tion  in which FIPV was shown to have low
in fe c t iv ity  but high m orta lity  [110]. Later experiments showed 
th is  e ffec t to be dose related [112]. In te resting ly , these two
l i t te r s  were kept in a normal environment. I f  the k ittens were
infected by an adult other than th e ir  mother, i t  might be
expected that exposure would be more sporadic and the virus 
dose smaller.
To obtain a more accurate assessment of th e ir  in fection  status, 
k ittens should be tested at 10 weeks of age or over and where 
possible they should be tested twice at a four week in te rva l.
5 .4 .2  Influence o f environment
In the lite ra tu re , reports of na tura lly  occurring FCoV 
in fection in k ittens are rare and the route o f transmission has
remained speculative [97, 98, 110].
As in our prelim inary report o f 200 kittens [1 ], in th is  
survey, the m ajority of seropositive k ittens and most of those 
which died of FCoVV were from households which had allowed the 
k ittens to mix with adult cats other than th e ir  mothers. Those 
kittens which were isolated from a ll adults in the household 
were a ll seronegative. This suggests that transmission of 
coronavirus to kittens generally takes place horizon ta lly  a fte r 
b ir th , in most cases from adults other than the queen. Four 
seronegative queens in the normal environment had kittens which 
became seropositive, supporting th is  theory.
As shown in table 5.2 th is  finding held true fo r successive 
l i t t e r s  from the same queen. The like lihood of seroconversion 
o f the k ittens altered predictably as the environments changed 
between successive l i t t e r s ,  regardless of the antibody t i t r e  o f 
the queen.
Our results indicate that in FCoV seropositive households the
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queens and her kittens should be kept in iso la tion  from a ll 
other cats u n til sold.
5 .4 .3  Virus excretion by queens
Since 11 l i t t e r s  from 30 seropositive queens (37%) in the M 
environment were seropositive, i t  would appear that 
approximately one in three seropositive queens excrete v irus. 
The antibody t i t r e  of the queen was not an ind ica tor or whether 
or not she was excreting v irus. One queen which had two 
l i t t e r s  in the M environment became seropositive between the 
f i r s t  and th ird  l i t t e r s  and the kittens in these l i t t e r s  
remained seronegative. However her second l i t t e r  was reared in 
a N environment and seroconverted. Unfortunately, because the 
kittens o f the second l i t t e r  mixed with adults other than th e ir  
mother, i t  is  not known whether she went through a tra n s ito ry  
phase o f virus excretion a fte r in fection . Her antibody t i t r e  
was 1280 at the time of the second l i t t e r  and 320 at the time 
of the th ird .
Four of the virus-excreting queens (5015, 5419, 5587 and 5717) 
became seronegative 11.5 months a fte r the tes t nearest the 
b ir th  of the seropositive l i t t e r  (range 10-13 months). This 
resu lt indicates that virus excretion does not always la s t fo r 
l i f e .  Cat 5419 had been seropositive fo r 11 months before the 
l i t t e r  was born, therefore had been seropositive a to ta l o f at 
least 26 months, though i t  is not known whether she was 
excreting virus continuously throughout that time.
Cat 5111 had been seropositive fo r 20 months before giving 
b ir th . Circumstantial evidence indicates that she might be a 
virus excretor during th is  time, so that the l i t t e r  was planned 
in order to confirm these suspicions.
No seronegative queens appeared to excrete v irus.
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5 .4 .4  Health o f the k itten s
In th is  study i t  was shown that FCoV is associated with 
diarrhoea in k ittens. Diarrhoea occurred in k ittens from 
households which had no h istory of FCoVV or FECV as well as 
those which did. Experimentally, e n te r it is  due to FIPV or FECV 
occurred 2-3 days a fte r in fection [48, 111] which would be well 
before a serologic response would be expected; therefore, the 
prevalence of FCoV in fection in diarrhoeic k ittens may be 
higher than was found here.
Failure to gain weight was linked both with diarrhoea and the
occurrence of FCoV antibodies.
No p a rticu la r c lin ic a l signs in k ittens were noted more 
frequently in those kittens which went on to die o f FCoVV.
I t  was impossible to know how many seropositive k ittens which 
were sold were subject to re in fection in th e ir  new homes but 
the m ajority were s t i l l  well almost a year la te r. I t  could not
be determined whether th e ir  in i t ia l  exposure rendered them more
susceptible or res is tan t.
5 .4 .5  FIPV/FECV?
One reason fo r proposing the existence of FECV was the apparent 
discrepancy between the low incidence of FCoVV and the high 
incidence of seroconversion in the f ie ld  [102]. In the 
laboratory, FIPV had been shown to have a low in fe c t iv ity  but a^  
high m orta lity , whereas FECV had high in fe c t iv ity  and low 
m orta lity  [111]. However, in these experiments, increasing the 
dose of FIPV increased in fe c t iv ity  and m orta lity  [106, 112] and 
la te r isolates of FIPV had high in fe c t iv ity  and low virulence 
[114]. *
Because virus iso la tion  in the f ie ld  is almost impossible, i t  
was unknown whether the seropositive households in the survey 
had FECV, FIPV or indeed e ither virus present at the time of 
study. However, 31 out of 41 of the households had a h is to ry
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of a case o f FCoVV, often at the beginning of the survey, so 
v iru le n t FCoV must have been present at some time. The
prevalence o f in fection  in.those l i t t e r s  which were infected 
was 92% in N environment and 90% in M environment. Thus, i f  
two d iffe re n t viruses, FIPV and FECV, ex is t outside o f the 
laboratory th e ir  patterns o f in fection are indistinguishable, 
so they presumably occur together.
When experimental cats were dosed with sublethal amounts of 
FIPV, they e ither did not become infected, seroconverted
without developing the disease or developed FIP [112]. This
paradigm closely resembles the sporadic and low incidence of
disease in nature, suggesting that cats are exposed to
re la tiv e ly  small amounts of virus [106].
Although FCoV was shown to be associated with diarrhoea, no 
difference in the incidence of FCoVV was evident between 
households where c lin ic a l h istory indicated FECV in fection  and 
those which indicated FIPV in fection .
I t  could be concluded that FCoVV is a sporadic manifestation of 
a common, asymptomatic or enteritis-causing FCoV in fec tion . I f  
there are tru ly  d iffe re n t FCoVs in the f ie ld  o f varying 
virulence, then they occur together so often that to postulate 
th e ir  presence in iso la tion  causes unnecessary confusion to
veterinary surgeons and cat owners, d i f f ic u l ty  in in te rp re ting  
serology and a false reason fo r complacency among some breeders 
o f seropositive k ittens.
5 .4 .6  K itten  M o rta lity  Complex
While the incidence of se ropos itiv ity  o f queens which fa ile d  to 
conceive, had aborted/resorbed, or had s t il lb o rn , faded or 
deformed kittens seemed high (72%, 64%, 66%, 79% and 86%
respectively) i t  was v ir tu a lly  the same as the incidence in
those queens which had none of those problems (75%.) 
Therefore, FCoV is  un like ly  to be a cause of these conditions.
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There were no cases of cardiomyopathy in the k ittens from 
seropositive households examined by histopathology and only one 
had evidence of FCoVV.
Seventy-four percent of l i t t e r s  with premature, s t illb o rn  or 
fading kittens where antibody status of litte rm ates was known 
had no evidence of FCoV in fection .
In conclusion, as found in a previous investigation [114], i t  
seems un like ly  that FCoV is a cause of KMC.
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CHAPTER 6
THE SEROLOGICAL RESPONSE OF CATS 
TO INDIVIDUAL STRUCTURAL PROTEINS OF FCoV
6.1 INTRODUCTION
As shown in Chapter 4, no difference in antibody t i t re s  by IF 
could be discerned between cats which succumbed to FCoVV and
those which survived. I t  was decided to examine the nature of
the antibody response in more d e ta il, because i t  had been 
postulated that anti-S antibody might be enhancing antibody 
[149] and therefore i t  was possible that cats which survived 
FCoV in fection  would lack th is  antibody. Although i t  has been 
stated that animals which died o f FCoVV and those which were 
considered to be immune had comparable humoral re a c tiv ity , the 
S protein was only detected when certa in , undefined, serum 
samples were used [15]. Ishida noted that a c t iv ity  to a 95K 
protein was found on immunoblots in 14 of 23 FCoVV cases but 
only 3 of 39 healthy seropositive cats. The 95K protein may be 
a p ro teo ly tic  product o f S or monomeric form [67, 68] .
A lte rna tive ly , surviving cats might possess an antibody which 
conferred protection and which those cats which succumbed may
lack. A marker such as the presence or absence of a
pa rticu la r antibody would be a useful tool in the f ie ld  fo r 
d iffe re n tia tin g  healthy, seropositive cats from those which are 
lik e ly  to succumb to FCoVV.
In th is  chapter, experiments to investigate the presence o f 
antibodies to the individual FCoV proteins are described. This 
was done by immunoblotting in which the virus was disrupted in 
reducing buffer, its  components were separated using PAGE and 
tranferred to a n itroce llu lose  membrane which was then probed 
with the serum samples to be tested.
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Our results indicated that there may be a difference between 
the level o f anti-M antibody in cats which succumb to FCoVV 
compared to cats which survive the in fection . Those which 
succumbed appeared to have more anti-M antibody. However, 
quan tifica tion  of antibody was d i f f ic u l t  using immunoblotting 
and i t  was concluded that fu rthe r work was needed to gain 
accurate antibody t it re s  to each of the v ira l components.
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6.2  MATERIALS AND METHODS
FCoV was concentrated as described in 2.10 and quantified by 
comparison with known concentrations o f ovalbumin on PAGE as 
described in 2.8 and illu s tra te d  in f ig  2.1. Immunoblots were 
made and developed as described in 2.10 and 2 . 11.
The MAbs 52D5 which recognises the FCoV N prote in, 6F7.1 
against M and 9A1.1 which is anti-S were kindly donated by Dr 
Mike Bartkowski, Fermenta Animal Health, Omaha, NE 68134. The 
a sc itic  f lu id  sample from a h istopathologica lly confirmed case 
o f FCoVV was kindly supplied by Miss Ann Hutchison. This 
sample was designated 'Mostafa' a fte r the owner of the cat.
Sera were from the survey described in Chapter 4 and from 
routine samples submitted to the FVU fo r FCoV IF and 
histopathology. Th irty  serum samples from 6 cats involved in a 
temperature sensitive FCoV vaccine experiment were kindly 
supplied by Dr Jay Gerber, Smith Kline Beecham, Lincoln, 
Nebraska NE 68501.
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6.3  RESULTS
6 .3 .1  V ira l proteins
The au thentic ity  o f FCoV proteins on immunoblot were confirmed 
by using MAbs and the results are shown in f ig  6.1. From th is  
i t  is  seen that the S forms a band at approximately 210K, N at 
46K and M forms a d iffuse band between 24-30K. Immediately 
above the S band, another, fa in te r band can be seen on track 1 
which is probably an aggregate of the M protein which has 
fa ile d  to enter the gel [144]. A s im ila r band appears more 
p la in ly  in f ig .  6.2 where the anti-M MAb 6F7.1 id e n tifie s  i t  
as M.-
6 .3 .2  Immunoblots o f survivors and cats w ith FCoVV
In the f i r s t  experiment the re a c tiv ity  of 6 sera from cats 
which had died of FCoVV were compared with that of 8 samples 
from 7 in-contact survivors. These results are presented in 
table 6.1. The samples from 3 survivors (5027, 5605, 5691) and 
2 dead cats (Edwards, Canham) reacted with bands at 210K and 
these 5 cats and 2 more cats also produced bands at 95K. A ll 
o f the samples except one (Carroll 2) had anti-N antibody. Of 
in te res t, however, was that while only one survivor (5364) had 
a strong M band, 4 of the FCoVV cases had strong anti-M. In 
three survivors (5027, 5542 and 5691) a weak M band could be 
detected.
Four samples from each of these groups were tested again 
(Experiment 2). In th is  case, a ll 4 o f the dead cats had a n ti- 
S, anti-N and anti-M antibodies. Only one of the survivors 
(5364) had a strong M band as well as N, though in two (5027, 
5357) a fa in t M could be detected. Two survivors (5364, 5605) 
had strong and one (5357) a fa in t anti-S band.
Four sera from FCoVV cases were reacted in a th ird  experiment 
in which 3 (Edwards, Carroll 1 and Matsell) had a M band, a ll 4 
had N and 2 (Edwards and Carroll 1) had S bands. Thirteen more 
samples from 9 cats which had died of FCoVV were then b lo tted.
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Fig. 6.1
T h e  S ,  N  a n d  M  p r o t e in s  o f  F C o V .  A b o v e  t h e  S  is  a  f a i n t e r
b a n d  ( m a r k e d  * )  w h ic h  is  M  a g g r e g a t e  w h ic h  h a s  f a i l e d  t o
e n t e r  t h e  r u n n in g  g e l .
1 . M o s t a f a  a s c i t e s
2 . M A b  5 2  D 5  ( a n t i - N )
3 .  M A b  6 F  7 .1  ( a n t i - M )
4 .  M A b 9 A 1 . 1  ( a n t i - S )
M r  M o l e c u l a r  w e i g h t  m a r k e r s
Table 6.1 Immunoblots on sera from cats which developed 
or survived FCoV in fe c tio n .
Cats which died o f h is to p ath o lo g ica lly  confirmed FCoVV
Sample Cat Household I FA M N S 95K
re f t i t r e 1 2 3 1 2 3 1 2 3 1
P1409C Edwards 1280 ++ , ++ ++ ++ ++ ++ ++ ++ ++ ++
P1112C Carroll 1 640 ++ ++ ++ ++ ++ + - ++ ++ -
P3587C Matsell 1280 + ++ ++ ++ ++ ++ - ++ - ++
P1915C Canham 1280 - ++ - ++ ++ ++ + ++ - ++
P3301C Horton 3123 1280 ++ ++ - -
P1I54C Hancock 3122 320 ++ ++ - -
P6670B 5080 1615 1280 ++ ++ -
P2329C 5097 1615 1280 ++ ++ ++
P6995B 5376 1685 1280 ++ ++ -
P9140B 5376 1685 1280 ++ ++ +
P8276B 5466 1776 20 ++ + -
P7475B 5481 1777 320 - ++ -
P348C 5481 1777 1280 ++ ++ ++
P2I26C 5481 1777 1280 ++ ++ ++
P8505B 5340/2/3 1768 640 + ++ -
P9930B 5340/2/3 1768 640 ++ ++ -
P1743C McTavish 320 ++ ++ -
P1977C 5716 3121 1280 ++ ++ -
P4822C Hancock 3122 320 ++ ++ +
In -contact surviving cats
P6996B 5357 1685 640 - + ++ ++ - + -
P7026B 5027 1596 1280 + + ++ ++ + - ++
P7495B 5605 1789 320 - - ■ ++ ++ ++ ++ ++
P2927C 5605 1789 640 - + ++ ++ + -
P9127B 5364 1685 1280 ++ ++ ++ ++ - ++ -
P6985C 5542 1685 1280 + ++ - -
P1617C 569 3095 1280 + ++ + ++
P1058C Carroll 2 640 - - - - - - +
This table shows that anti-M antibody was usual in cats which succumbed to FCoVV 
and less common in cats which survived. I t  also shows that while anti-N a c t iv ity  
was reproducible from immunoblot to immunoblot, anti-S and anti-M were more 
variable. A band at 95K was only v is ib le  on b lo t 1.
Key:
M = integral membrane glycoprotein N = nucleocapsid S = spike 
1, 2 and 3 = Experiments 1,2 and 3.
++ = strong band 
+ = fa in t band 
- = no band
All but two had strong M bands and a ll had N bands. Three also
had good S bands and two had fa in t S bands.
Of p a rticu la r in te rest in the th ird  experiment is  cat 5466,
which had a IFA t i t r e  o f 20 in duly 1988 and died of FCoVV in 
November 1988. This sample had a strong M band and a weak N 
band.
In order to increase the numbers o f survivors fo r comparison, 
sera from cats in the survey household 1789 and cat 5600 from 
household 1788 were then immunoblotted ( f ig  6.2). On th is  
b lo t, a dramatic contrast is evident between cats which died
of FCoVV in Feb 1989 (5611 and 5660) and the other cats which
were s t i l l  a live  in Mar 1991. Cat 5611 which developed FCoVV 
had noticeable anti-M antibody even 12m before developing FCoVV 
whereas the survivors had very l i t t l e  evidence of anti-M 
a c t iv ity  even in sera with fa ir ly  high IFA t i t re s .  No anti-S 
was v is ib le  although the molecule had transferred to the b lo t 
because i t  was detected by the MAb 9A1.1. Bands were v is ib le  
at 95K on several samples which may or may not have been 
monomeric S or a reduced product of S, although the anti-S MAb 
did not recognise i t .
A fte r co n flic tin g  results of immunoblots from other households, 
the sera from household 1789 were retested and the two blots of 
th is  re test are shown in f ig  6.3. Anti-M a c tiv ity  is  evident
in most samples though i t  is s t i l l  not present in cats 5605,
5609 and 5784 and is fa in t in others. In cat 5600 anti-M was 
seen to diminish as the ca t's  IFA t i t r e  fe l l  from 640 to 40. 
Cats 5611 and 5660 show anti-S a c t iv ity  as do 4 of the 5 
confirmed FCoVV sera and 9 of the 16 survivors. In sera of two 
o f the survivors the S band is very fa in t indeed.
Also included in f ig . 6 .3 are 5 non-survey confirmed cases of 
FCoVV. In te resting ly , the las t of these samples was from an 
IFA negative cat in which only anti-N a c t iv ity  is evident.
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Fig. 6.2
no.
l™ Uin “ b l° t  o f  s e r a  f r ° m  7  c a t s  f r ° m  h o u s e h o l d s  1 7 8 8  a n d  
9  w h ic h  s u r v iv e d  a n d  2  w h ic h  s u c c u m b e d  t o  F C o V  in f e c ­
t io n .  T h is  b lo t  s h o w s  le s s  a n t i - M  s u r v iv in g  c a t s
t h a n  in  t h o s e  w h ic h  d ie d  l i v i n g  c a i s
A n t ib o d y  t i t r e s  a n d  c l in ic a l  h is t o r y  o f  c a t s  1 - 1 0
1 . 5 6 1 4
Jun 68 640 
Feb 89 320 
Well Sep 90
2 .  5 6 1 5
Mar 88 160 
Jun 88 80 
Mar 89 40 
Well Sep 90
3 .  5 6 1 9
Feb 89 320 
Well Sep 90
4 .  5 6 0 0
Apr88 1280 
May 88 1280 
Jun 88 640 
Aug 88 320 
May 89 40 
Well Sep 90
5 .  5 6 1 1
Mar 88 320 
Jun 88 320 
Feb 89 1280 
Died Mar 89 FCo W
6 .  5 6 6 0
Feb 89 1280 
Died Mar 89 FCoW
7 .  5 6 0 5
Feb 89 640 
Well Apr 90
8 .  5 6 0 6
Jun 88 640
Died kidney failure Apr 90
9 .  5 6 0 7
Jun 88 320 
Feb 89 640 
Well Sep 90
1 0 .  5 6 0 8
Jun 88 160 
Mar 89 20 
Well Sep 90
* IS M aggregate which has failed to enter the running gel.
a e o n
^
Fig. 6.3
R e p e a t  i m m u n o b l o t s  o f  s e r a  f r o m  c a t s  in  h o u s e h o l d  1 7 8 9  
T h is  b lo t  s h o w s  a n t i - M  a c t iv i t y  in  b o t h  s u r v iv in g  c a t s  a n d  
t h o s e  w h ic h  d ie d .
IFA antibody titres and clinical histories of cats 1 -19
1. Non- survey cats with FCoW 
Flanger 1280 
Symonds 4 1280 
Giedhill 320 
Buchanan 1280
2. 5611
Jun 88 320 
Feb 89 1280 
Died Mar 89 FCoW
3. 5660
Feb 89 1280 
Died Mar 89 FCoW
4. 5605
Jun 89 40 
Sep 89 160 
Well Apr 90
5. 5606
Jun 88 640
Died kidney failure Apr 90
6. 5607
Jun 88 320 
Jun 89 320 
Sep 89 640 
Mar 90 320 
Well Sep 90
7. 5608
Jun 88 160 
Mar 89 20 
Well Sep 90
8, 5609
Mar 88 40 
Mar 90 10 
Well Sep 90
9. 5610
Jun 88 80 
Mar 89 20 
Well Sep 90
10. 5613
Mar 88 160 
Jun 88 320 
Feb 89 320 
Sep 89 640 
Well Sep 90
11. 5614
Jun 88 640 
Feb 89 320 
Jun 89 80 
Well Sep 90
12. 5615
Mar 88 160 
Mar 89 40 
Sep 89 640 
Mar 90 20 
Well Sep 90
13. 5619
Feb 89 320 
Sep 89 160 
Mar 90 640 
Well Sep 90
14. 5602
Jun 88 80 
Mar 89 160 
Jun 89 80 
Sep 89 80 
Mar 90 40 
Well Sep 90
15. 5664
Feb 89 80 
Sep 89 80 
Mar 90 80 
Well Sep 90
16. 5616
Jun 88 20 
Mar 89 80 
Jun 89 20 
Well Sep 90
17. 5612
Jun 88 80 
Mar 89 0 
Sep 89 20 
Mar 90 20 
Well Sep 90
18. 5784
Mar 89 80 
Sep 89 20 
Mar 90 0 
Well Sep 90
19. 5600 
Jun 88 640 
May 89 40 
Well Sep 90
Th irty  serum samples from 6 cats involved in a temperature 
sensitive FCoV vaccine experiment were also blotted twice. On 
the f i r s t  b lo t ( f ig  6.4) anti-S and anti-M a c t iv ity  were only 
apparent in the sera o f cats 2 and 4 which were the only cats 
to develop FCoVV. On the second b lo t ( f ig  6.5) anti-S a c t iv ity  
was evident in a ll cats except the unvaccinated, unchallenged 
control (no. 5) and a cat which was not vaccinated and did not 
develop FCoVV post challenge (no. 3). Anti-M was evident in 
a ll o f the cats which were challenged and fa in t ly  and b r ie f ly  
in cat 6 which was vaccinated but not challenged.
At th is  stage i t  was necessary to assess whether or not the 
d ispa rity  in band appearance was related to the quantity o f 
v ira l protein on an individual immunoblotting membrane. Virus 
was t it ra te d  in doubling d ilu tions  against two sera (P7926B and 
P2923C) which had given disparate resu lts . The results are 
shown in f ig . 6.6. Clearly these sera cannot detect low 
quantities of S and M, although they can s t i l l  detect N. There 
are several possible explanations fo r th is  re su lt: there may be 
a greater amount o f N protein in the in i t ia l  pu rified  FCoV 
sample; N may be more read ily  transferred from gel to 
n itroce llu lose ; the immunogenic epitopes o f N may be conserved 
more during PAGE than the epitopes of M or S or N may be more 
immunogenic than M or S; or t i t re s  o f anti-M and anti-S 
antibodies may be much lower than anti-N t i t re s .
A fte r th is  experiment the amount of v ira l protein used on each 
gel was increased to 35ug per gel so that low levels o f anti-S 
and anti-M antibody could be detected. However, the gels were 
s t i l l  d i f f ic u l t  to standardise due to inconsistency o f M 
entering the gel.
6 .3 .3  More immunoblots o f survivors and cats w ith FCoVV
Using th is  revised protocol a fu rthe r 26 samples from 6 cats 
which died o f FCoVV and 262 samples from 75 surviving cats from 
21 households were immunoblotted. Of the cats which died, a ll 
26 had anti-N and in addition 22 samples had anti-M. Two
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Fig. 6.4
I m m u n o b l o t  o f  s e r a  f r o m  a  t e m p e r a t u r e - s e n s i t i v e  F C o V  
v a c c i n e  e x p e r i m e n t  s h o w i n g  m o r e  a n t i - M  a c t iv i t y  in  c a t s  2  
a n d  4  w h ic h  d e v e l o p e d  F C o W  t h a n  in  t h o s e  w h ic h  s u r v iv e d .
1 . v a c c in a t e d ,  d id  n o t  d e v e l o p  F C o W  p o s t  c h a l l e n g e
2 . v a c c in a t e d ,  d e v e l o p e d  F C o W  p o s t  c h a l l e n g e
3 . n o t  v a c c in a t e d ,  d id  n o t  d e v e l o p  F C o W  p o s t  c h a l l e n g e
4 . n o t  v a c c i n a t e d ,  d e v e l o p e d  F C o W  p o s t  c h a l l e n g e
5 .  n o t  v a c c i n a t e d ,  n o t  c h a l l e n g e d
6 .  v a c c in a t e d ,  n o t  c h a l l e n g e d
Fig. 6.5
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T h e  s e c o n d  i m m u n o b l o t  o f  s e r a  f r o m  a  t e m p e r a t u r e - s e n s i t i v e  
F C o V  v a c c i n e  e x p e r i m e n t  s h o w in g  a n t i - M  a n d  a n t i - S  a c t iv i t y  
in  s a m p l e s  in  w h ic h  it w a s  n o t  a p p a r e n t  in  f ig .  6 .4 .
1. v a c c in a t e d ,  d id  n o t  d e v e l o p  F C o W  p o s t  c h a l l e n g e
2 . v a c c in a t e d ,  d e v e l o p e d  F C o W  p o s t  c h a l l e n g e
3 . n o t  v a c c in a t e d ,  d id  n o t  d e v e l o p  F C o W  p o s t  c h a l l e n g e
4 . n o t  v a c c i n a t e d ,  d e v e l o p e d  F C o W  p o s t  c h a l l e n g e
5 .  n o t  v a c c i n a t e d ,  n o t  c h a l l e n g e d
6 .  v a c c i n a t e d ,  n o t  c h a l l e n g e d
Fig. 6.6
Mr  1 2 3 4  5 6 7
a.
Mr 1 2 3 4 5 6  7
F C o V  d i lu t io n s  d e v e l o p e d  a g a in s t  P 2 9 2 3 C  ( a . )  a n d  P 7 9 2 6 B  ( b . )  
s h o w i n g  t h e  d i s a p p e a r a n c e  o f  a n t i - S  a n d  a n t i - M  a c t iv i t y  a t  lo w e r  
c o n c e n t r a t io n s  o f  F C o V  o n  t h e  b lo t .
M r  M o l e c u la r  w e i g h t  m a r k e r s
1. F C o V  u n d i lu t e d
2 .  F C o V  1 :2
3 .  F C o V  1 :4
4 .  F C o V  1 :8
5 .  F C o V  1 : 1 6
6 .  F C o V  1 : 3 2
7 .  F C o V  1 : 6 4
hundred and f i f ty -e ig h t  o f 262 survivor samples had anti-N and 
213 had anti-M antibodies. A complication was the variable 
accumulation o f M at the top o f the gel, very close to the S 
band and easily mistaken fo r S.
Unfortunately, the anti-M MAb did not detect M on some b lo ts. 
Although the Mostafa ascites did, i t  was sometimes d i f f ic u l t  to 
be certain whether higher MW bands contained S or M. However, 
o f the blots where a S band was c lea rly  id e n tif ia b le , 8 o f 26 
FCoVV samples and 92 of 219 survivors had anti-S antibodies.
A band at 95K appeared on 90 s trips  cut from blots which had 
been cut in to  a to ta l of 195 s trip s . Only 22 of these appeared 
to lack p220. Seventeen of these 22 s trips  were on blots on 
which the S band was very fa in t and very rare. The postulate 
that p95 is  a p ro teo ly tic  product o f S is therefore quite 
feasib le . Fifteen of 26 samples from cats which died of FCoVV 
and 75 of 169 survivors had anti-p95 antibodies. In a few 
blots a band was also v is ib le  at 69K, which may have been 
another fragment o f S or could have been a product of the ce ll 
culture in which the virus was grown.
Of in te rest in these experiments were sequential samples from 
cats. Cat 5361 had slowly fa llin g  IFA t i t re s  and anti-N 
antibody only. Appearance of anti-S and anti-M fo r the f i r s t
time in 3 years of sampling coincided with a rise  in IFA t i t r e
from 80 to 640 suggesting that a new in fection  resulted in 
the appearance of anti-S and anti-M antibodies. In f ig .  6.3,
loss o f anti-S antibody can be seen in cats 5612 and 5602. In
cat 5615 anti-S antibody can be seen to disappear as the IFA 
t i t r e  fa lls  and rises again. Anti-M can be seen to increase in 
cat 5602 as anti-M fa l ls  although the IFA t i t re s  remain about 
the same. Anti-M disappeared in cat 5600 as the IFA t i t r e  fe l l  
from 640 to 40.
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6 .3 .4  Samples from cats o f known virus excreting status
I t  was noted that sequential samples from cats often showed 
loss o f anti-M and anti-S antibodies a^ these cats became IFA 
negative. I t  therefore seemed possible that cats with only 
anti-N antibodies were not excreting v irus. To tes t th is  
hypothesis samples from queens which had had kittens isolated 
with them and therefore whose virus excreting status was known, 
were examined.
Nine samples from 7 queens which had seropositive k ittens and 
13 samples from 10 queens which had seronegative k ittens were 
immunoblotted. (Where more than one sample was available 
around the time of the k itten ing , a ll samples were used.) 
Anti-M was present in 9/9 samples from queens with seropositive 
kittens and 10/13 samples from queens with seronegative 
k ittens. Anti-S was present in 3 queens with seropositive 
kittens and 2 with seronegative k ittens. Anti-N was present in 
a ll samples except one from a mother o f seronegative k ittens .
Cats in household 3125 which became IFA negative, and therefore 
which had not been excreting v irus, had anti-M antibody on many 
tests . Anti-S antibody was only apparent on 2 s trip s .
I t  was concluded that whether or not a cat was excreting virus 
could not be deduced when antibodies to 2 or 3 of the v ira l 
proteins were present.
6 .3 .5  Presence o f antibodies in IFA negative cats
Of 35 samples from IFA negative cats, 19 had anti-M, 33 had 
anti-N and 2 had clear S bands and 4 had fa in t S bands. Samples 
from two IFA negative confirmed cases of FCoVV (cats 5040 and 
5508) had only anti-N antibody. I t  seemed appropriate then to 
examine a household which was predominantly IFA negative.
A ll of the cats of houshold 1679 were immunoblotted. In th is  
household a ll the cats eventually became IFA negative and a ll 
k ittens that were born into the household were IFA negative
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therefore i t  was concluded that these cats were not excreting 
v irus. Cats 5186 and 5187 which remained IFA positive  longer 
than the others were kept in iso la tion  u n til they too had no 
antibodies detectable by IF. Two kittens and 2 new cats 
introduced to the household were included in the immunoblot.
Only the samples from the introduced cats and one sample from 
5184 showed no re a c tiv ity . The other samples had anti-N 
antibody and sera from cats 5182, 5186, 5187 had anti-M
a c tiv ity . Cat 5184 had anti-M but subsequently lo s t i t .  Cats 
5186 and 5187 had anti-S antibody. Cat 5183 never showed IFA 
a c tiv ity  and cats 5184, 5185 and 5188 were only IFA positive  
each on one or 2 occasions but consistently had anti-N 
antibody. Anti-N antibodies can p la in ly  persist fo r longer 
than 2 years 3 months. Seven samples from 4 IFA negative cats 
had anti-M antibodies, probably re flec tin g  the greater 
s e n s it iv ity  o f immunoblotting compared to IF. I t  appeared that 
cats with only antibodies to the N protein were no longer 
excreting v irus.
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6.4  DISCUSSION
6 .4 .1  V ira l proteins on immunoblots
Considerable d i f f ic u l ty  was encountered in standardising the 
FCoV immunoblot resu lts : two gels from the same virus
preparation run down each side o f the M inib lot ce ll at the same 
time and blotted in exactly the same way did not appear to have 
the same in tens ity  o f virus bands, p a rticu la r ly  the M and S 
proteins. Quantities of M often fa ile d  to travel past the end 
of the stacking gel.
Previously Sturman reported th is  phenomenon fo r p23 (M) of the 
murine coronavirus A59 a fte r bo iling  virus samples in the 
presence of high levels o f reducing agents [144]. However, in 
the present study, an experiment with and without 2-ME in the 
sample buffer and bo iling  fo r 1,2 and 3 mins or incubating at 
37°C fo r 15, 30, 45 or 60 mins fa ile d  to reveal any marked 
improvement in the quantity of M entering the gel fo r any 
p a rticu la r method. Hence bo iling  fo r 3 mins in presence of 2- 
ME was continued.
Other authors have reported d i f f ic u lty  measuring the anti-S 
response of cats and various explanations have been offered: 
loss of c r it ic a l antigenic determinants during SDS-PAGE or 
electrophoretic transfer [15, 59]; preferentia l induction of 
lo w -a ffin ity  antibodies by S [59]; or lack o f humoral response 
to S [15]. The f i r s t  o f these explanations could not be 
applied to most of the immunoblots used here because some sera 
did recognise S. D iffe rent serotypes with d iffe re n t S epitopes 
are also un like ly  to explain the varia tion in a c t iv ity  against 
S since sera from cats w ith in the same household were usually 
compared on the same immunoblot and one would not expect great 
varia tion in serotype w ith in a single household. Therefore, i t  
would appear that many cats e ither mount no antibody response 
to S or produce only lo w -a ffin ity  antibodies.
133
6 .4 .2  Immunoblots o f survivors and cats w ith FCoVV
Despite th is  problem, comparison of antibody a c tiv ity  of 
various samples was s t i l l  possible w ith in the same immunoblot 
and showed that most cats which developed FCoVV had higher 
levels of anti-M and anti-S a c t iv ity  than in-contact cats which 
survived because th e ir  sera picked up lower amounts of v irus on 
blots than did the sera o f survivors.
Higher levels o f anti-M and anti-S a c t iv ity  could re fle c t 
active v ira l rep lica tion  at the time of sampling. 
A lte rna tive ly , these antibodies could be responsible fo r 
enhancing disease. However Vennema et al did not find  that 
recombinant vaccinia expressing M caused ADE on challenge 
[149].
When the quantity of virus on blots was increased, no 
difference in antibody response could be discerned between cats 
which survived or succumbed to FCoV in fection . Anti-S and 
anti-M appeared in samples from cats in each group.
Unfortunately, antibody t it re s  to various virus proteins cannot 
easily be obtained using immunoblotting and fu rthe r work is 
required to establish whether the difference in anti-M and 
anti-S antibodies between surviving and succumbed cats would be 
useful to establish prognosis. However, the pathogenesis of 
th is  disease must be borne in mind since a fte r damage to blood 
vessels occurs and before death has resulted from that damage, 
virus may be eliminated from the body and IFA t i t re s  may return 
to zero.
Antibodies to p220 and p95 were present in many survivors as 
well as cats which died. I t  seemed l ik e ly  that p95 is a 
breakdown product or possibly a monomeric form of p220 since 
most antibodies which recognised the former also recognised the 
la t te r .  Those s trips  which showed p95 and not p220 were from 
blots where no antibody illum inated p220 w e ll, suggesting that 
most of the p220 had been broken down to p95 during processing.
134
The p o s s ib ility  that the S of FCoV is a dimer has been 
mentioned by two authors [15, 67].
6 .4 .3  Presence o f antibody in IFA negative cats
I t  was noted that anti-N a c t iv ity  remained long a fte r cats 
became IFA negative. Many authors have reported that IF 
a c t iv ity  is due to anti-M antibodies [59, 163] and th is  is  one 
possible explanation fo r the absence of IF a c t iv ity  in cats 
with no anti-M antibody. A lte rna tive ly , i t  could be that 
immunoblotting is  more sensitive and detects lower levels of 
antibody than IF. Since estimates o f FCoV prevalence have been 
based on IFA readings, i t  is probable that the real prevalence 
in infected households is even higher than previously believed.
In th is  study i t  was shown that cats with only anti-N 
antibodies were not infectious to other cats. However, the 
converse was not true: cats with antibodies to S and M were not 
necessarily in fectious. Unfortunately, to apply th is  
information to cats in the f ie ld  one'would have to be sure that 
each b lo t had s u ffic ie n t S and M protein to reveal the presence 
of even small amounts of antibodies against S and M.
6 .4 .4  Conclusion
In th is  study i t  was shown that there is  varia tion  in the 
antibody levels in d iffe re n t cats to each of the v ira l proteins 
of FCoV. Many cats which succumb to FCoVV seem to have higher 
levels of anti-M antibody than do cats which survive and th is  
could be apparent as much as .twelve months before the animal 
died. Higher levels of anti-M may represent increased 
systemic, as opposed to gut, v ira l rep lica tion . A lte rna tive ly , 
i t  is  possible that the production of anti-M antibody in these 
cats has an enhancing e ffec t which promotes increased 
in fe c t iv ity .
However, there were cats which los t a ll anti-FCoV antibodies 
except anti-N and s t i l l  went on to die of the lesions sustained 
during the in i t ia l  in fec tion . Therefore i t  has to be
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remembered that the nature of antibody response is not 
prognostic.
Cats which only had detectable levels of anti-N, in the absence 
of antibodies to the other FCoV proteins, appeared not to be 
infectious. This finding could be useful in situations where a 
cat owner has los t one cat and wishes to know i f  a remaining 
cat is infectious in order to purchase a replacement or where a 
cat breeder wishes to know i f  i t  is safe to breed from a 
seropositive animal.
Further work is required to elucidate these findings. We 
propose to devise an IF test based on recombinant vaccinia- 
expressing each of the three FCoV proteins so that accurate 
t i t re s  can be found.
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CHAPTER 7
GENERAL DISCUSSION
The primary aims of th is  research were to evaluate the 
usefulness of the IFA test in the f ie ld  and to determine the 
fate of cats with antibodies to FCoV.
Surprisingly, fo r a disease which has been recognised fo r 
th i r ty  years, th is  study was the f i r s t  longitudinal survey of 
natura lly infected cats in the f ie ld .  The results obtained 
answer many of the questions which trouble practicing 
veterinarians and revealed simple management techniques which 
could reduce the incidence of infection and disease. I t  was 
also found that the situation in natural infections was quite 
d if fe ren t, in a number of areas, to the picture which had 
previously been obtained by-extrapolating from experimental 
situations.
At the beginning of the research, the usefulness of the IFA 
test had been called into question ch ie fly  because of the 
assertion that many strains of FCoV existed: a v iru len t form 
called FIPV, one which caused diarrhoea called FECV and yet 
others which were associated with asymptomatic infections. The 
c l in ica l signs in the cat were attributed more to some property 
of the virus than to the immune response of the cat, although 
th is  response and the cat's environmental circumstances were 
taken into account [106]. This view persisted despite a lack 
of evidence of either major morphological or serological 
differences between pathogenic and non-pathogenic strains of 
FCoV [13].
During the period of the research described in th is  thesis, as 
a result of th is  study and other investigations, the 
d is tinctions between FECV and FIPV were eroded. For example, 
in the survey described in Chapter 4 cases of FCoVV occurred in 
cats from households which had h istories more in keeping with
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FECV infection. Workers in Liverpool University found that a 
cat developed lesions of FCoVV on exposure to CCV [83]. 
F inally , the proponent of the non-virulent coronavirus changed 
his views to a be lie f that a ll FCoV infections are caused by 
FECV, with mutants of the virus occurring within individual 
catsywere able to replicate in the macrophage p re fe ren tia lly  
to the enterocyte and cause vascu lit is  [108]. Thus the argument 
against the IFA test on th is  basis was largely invalidated.
I t  seems clear, a fte r the research described in th is  thesis, 
that in any household where cats are continually being infected 
with FCoV, sooner or la te r  deaths w i l l  occur. Since the 
morta lity  rate is only 3-12%, a household with only a few cats 
s ta t is t ic a l ly  may have to wait some time before a death occurs. 
However, th is  does not mean that the virus endemic to that 
household is any less capable of causing disease. Laboratory 
strains capable of causing d if fe r in g  disease in cats do ex is t, 
though how much they are a product of the passaging system used 
to grow virus stock and how much they are a re flec tion  of real 
v ira l differences in the f ie ld ,  is unknown.
Unfortunately, the actual levels of IFA t i t re s  in an individual 
cat te l ls  one l i t t l e  unless the t i t r e  returns to zero, in which 
case the cat is no longer infectious. In experimental 
infections, antibody t i t re s  c lass ica lly  climb rapidly and 
sometimes decline towards the end un ti l  the development of 
disease [101, 156, 157]. In natural infections the antibody 
patterns of the cats which succumbed were indistinguishable 
from those of cats which s t i l l  appeared to be healthy. Even
some cats which seemed to have recovered and became
seronegative fo r  quite some time, died from the damage caused 
to the blood vessels and the organs they supplied.
Many participants in the survey have agreed to continue to have 
th e ir  cats monitored fo r a further two years. I t  is l ik e ly
that m orta lity  rates due to FCoV w i l l  increase as more animals 
succumb to damage sustained during transient IC-associated
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vascu lit is . I t  seems unlike ly that any test could be developed 
to give an accurate prognosis fo r  the individual cat because of 
the nature of the disease. At best, s ta t is t ic a l p robab ilit ies  
might be a l l  we can o ffe r.
A very s ign if ican t finding of the longitudinal study was the 
appparent lack of ADE of infection in the f ie ld .  ADE of FCoV 
infection is a commonly reported phenomenon in the laboratory 
and therefore was expected to exist also in natural in fections. 
Cats in th is  study were presumed to have been reinfected when 
th e ir  IFA t i t re s  fe l l  and then rose again but no evidence of 
ADE was seen. Presumably many have either resistance to 
infection by local gut or respiratory tra c t immunity or have 
systemic CMI. An interesting study would be to examine the 
cytotoxic T-cell response in these cats.
Total prevention of infection is the obvious course of choice 
and fo r th is  to be achieved, widespread testing of cats by IF 
before introducing into known seropositive or seronegative 
households should be promoted.
Another argument against the IFA test arose because of i t s  
occasional misuse: healthy cats were destroyed on the basis of 
a high antibody t i t r e .  This hazard caused some to advocate 
that no testing was the lesser of two ev ils .  Three aspects of 
the research described in th is  thesis should hopefully 
a llev ia te  th is  s ituation: the finding that cats in 33% of the 
households followed became seronegative; that kittens born into 
seropositive households could be prevented from becoming 
infected by careful management; and that ca rr ie r animals did 
not necessarily have high IFA t i t re s .
Previously, i t  was believed that cats would remain seropositive 
and might be infectious inde f in ite ly .  In the absence of a 
vaccine or test fo r antigen, there seemed to be no way of 
eradicating the infection from a household short of clearing 
out a ll the cats and starting over again. However, sequential
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testing of households shows that many cats do eliminate the 
infection although i t  can take up to 3 years or more. 
Reintroduction of virus to 9 of the 24 households which had 
become seronegative occurred mainly because of the introduction 
of an untested cat, showing the importance of continued 
surveillance using the IFA test.
In the k itten  survey, 1 in 3 seropositive cats was found to 
excrete virus and in the adult survey, cats kept in groups of 
up to three were more l ik e ly  to have fa l l in g  antibody t i t r e s .  
Therefore i t  would seem that FCoV infection may be maintained 
by cats being continually reinfected and shedding fo r a time. 
I f  th is  cycle could be broken, the infection would peter out.
In the past, cat breeders who were found to have cats with
anti-FCoV antibodies were often advised to stop breeding th e ir
cats e ither fo r  a time or permanently. The k itten  survey 
showed that th is  action was not necessary provided the k ittens 
could be isolated from the adult cats in the cattery. This 
regime would also be beneficial in l im it in g  the spread of other 
infectious diseases to susceptible k ittens.
The existence of the healthy carrie r cat has long been
postulated [104, 111, 114, 141] and was d e f in i t iv e ly
established in the study of kittens born into catteries 
followed in th is  study. Previously i t  was suggested that cats 
with higher antibody t i t re s  were more l ik e ly  to be virus 
shedders than cats with low t i t re s  [103, 111]. The present
research established that most carriers had low to moderate 
levels of antibodies. An important finding was that
seronegative cats did not shed virus, something which 
previously was not known and was sometimes used in the anti-IFA 
argument [133]. Further, one th ird  of carriers became 
seronegative showing that the carrie r status is not necessarily 
permanent.
During the period of th is  study i t  became apparent that many
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manifestations of the disease caused by FCoV are not adequately 
described by the classical descriptions of 'wet' and 'd ry ' FIP. 
Cats presented with such diverse c l in ica l signs as Heinz body 
anaemia, pemphigus, kidney fa i lu re  and vestibular signs, many 
of which were seronegative, were found to have th e ir  orig in  in 
FCoV in fection. A more useful approach fo r the c lin ic ia n  in 
understanding the disease is to consider i t s  pathogenesis and 
to remember that the basic lesion is a vascu lit is .
The use of immunoblotting in diagnosis of FCoV had not
previously been examined. Immunoblotting revealed a difference 
in anti-M levels in cats which died of FCoVV compared with 
those which survived infection. Plans fo r future experiments 
include devising an IF assay of antibodies against each of the 
v ira l structural proteins based on target ce lls  infected with 
vaccinia virus recombinants expressing S, N or M so that the 
sera described in Chapter 6 can be re-examined to determine i f  
there is a level of anti-M antibody which indicates a poor
prognosis.
Absence of anti-M and anti-S on immunoblotting indicated that 
a cat was no longer excreting virus, a finding which is useful 
in the situation where a cat owner wishes to obtain a new cat
and needs to know i f  the existing cat(s) would pose a threat to
a newcomer.
In conclusion, i t  is hoped that the value of the longitudinal 
f ie ld  survey has been demonstrated by the research described in 
th is  thesis. A bank of sera now exists from natura lly-in fected 
cats whose fate is known and these sera are available fo r  
future experiments.
On the basis of results presented in th is  thesis, much more 
specific  advice can now be given to veterinary surgeons in the 
f ie ld  about dealing with FCoV antibody positive cats.
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